Document:

ex10-4.htm

Exhibit 10.4

EMPLOYMENT AGREEMENT

 

This Employment Agreement (the “Agreement”) is made and entered into as of July 26, 2012, by and between ACACIA DIVERSIFIED HOLDINGS, INC., a Texas corporation (the “Company”), and Steven L. Sample (the “Executive”).  Notwithstanding any other usage of the term “Company” within this Agreement, each and every instance of that term is intended, through any and all expansions or further illustrations or lack thereof within this Agreement and any addendums, exhibits or notices thereto, shall be construed to mean Acacia Diversified Holdings, Inc. (including any subsequent name changes associated therewith), all its subsidiaries (whether wholly or partially owned), and any and all other assets and holdings of the Company and any of its subsidiaries whether named or not named, including but not limited to the capital stock and all assets owned by and/or associated with each of those entities, whether that terms shall be used in conjunction with but not limited to matters in this Agreement relating to compensation, benefits, change of control, liens and otherwise.

 

Recitals

 

WHEREAS, the Company desires to continue the employment of the Executive as the Chief Executive Officer of the Company beyond July 26, 2012 (the “Commencement Date”), and the Executive desires to continue his employment by the Company in such capacity as of such date, on the terms and subject to the conditions set forth in this Agreement. The Company’s obligations to the Executive shall be individually and collectively due and payable to Executive without limitation.

 

NOW, THEREFORE, in consideration of the mutual covenants and agreements contained herein, and with reference to the above recitals, the parties hereby agree as follows:

 

ARTICLE 1

TERM OF EMPLOYMENT

 

1.1 TERM OF EMPLOYMENT. The Company hereby employs the Executive as the Chief Executive Officer of the Company, and the Executive hereby accepts such employment by the Company, for a period (as such period may be extended, the “Term”) commencing on the Commencement Date and expiring on the first to occur of (a) the termination of the Executive’s employment pursuant to Article 6, and (b) December 31, 2017 (the “Termination Date”). Provided that if the Executive’s employment has not previously been terminated pursuant to Article 6, the Executive’s employment pursuant to this Agreement shall automatically renew on one occasion for an additional one (1) year period unless either party notifies the other party in writing of its desire not to renew the Executive’s employment under this Agreement no later than one-hundred twenty (120) days prior to the Termination Date (a “Non-Renewal Notice”). If the Company delivers the Non-Renewal Notice and the Executive does not terminate his employment prior to the end of the Term, then such non-renewal shall be deemed to be a termination by the Company of the Executive’s employment without Cause (as defined below) as of immediately prior to the expiration of the Term, and Section 6.2 shall govern such termination. If the Executive delivers the Non-Renewal Notice and the Company does not terminate the Executive’s employment prior to the end of the Term, then such non-renewal shall be deemed to be a termination by the Executive of his employment without Good Reason (as defined below) as of immediately prior to the expiration of the Term, and Section 6.4 shall govern such termination. If the Term has been automatically extended for the additional one year period as set forth above and thereafter the Term of this Agreement expires by its terms at the end of the Term without the Company having proffered a new employment agreement to the Executive to extend his term of employment upon terms and conditions at least as favorable to the Executive as the most favorable he received under this Agreement during the Term (including salary, bonus opportunity and benefits as well as authority, functions, services, duties, rights and privileges as or commensurate with the Executive’s position as the Chief Executive Officer as set forth herein), then upon execution by the Executive and delivery to the Company of a release in favor of the Company which is not revoked by its terms (which release shall be substantially in the form attached as Exhibit A) the Company shall pay to the Executive a severance payment equal to (5) times the Executive’s highest annual Base Salary and Annual Bonus during the Term and shall continue to provide for twelve (12) months following such expiration all benefits while the Executive was employed by the Company (or if not allowable under the Company’s then existing policies their substantial equivalents) in accordance with Article 4, except that the Company shall not be required to provide such benefits to the extent that, during such twelve (12) month period, the Executive receives substantially similar (or better, from the Executive’s perspective) benefits from a new employer. The Executive shall inform the Company of any other benefits the Executive is receiving where the Company would have a right to reduce the benefits it is providing to the Executive.

 

  

1

  

 

ARTICLE 2

DUTIES AND OBLIGATIONS; BOARD APPOINTMENT

 

2.1 DUTIES. During the Term, the Executive shall: (i) be employed from the Commencement Date forward as the Chief Executive Officer of the Company or such other lesser office as to which he shall agree to accept in the stead hereof, and shall, commencing on the Commencement Date, have such power and authority as is customarily held by the Chief Executive Officer of similarly situated companies, (ii) devote business time, attention and energies to the business of the Company as he shall deem appropriate; (iii) use his efforts to promote the interests of the Company; (iv) and act in accordance with the policies of the Company in effect as of the Commencement Date.

 

2.2 RESTRICTIONS. Except as provided in Section 8.2(i), the Executive covenants and agrees that, while actually employed by the Company, he shall not engage in any other business duties or pursuits or directly render any services of a business or commercial nature to any other Person or business that is in direct competition with the Company for compensation without the prior written consent of the Board. The expenditure of reasonable amounts of time for educational, charitable, or professional activities, activities in a business not in competition with the Company, service as a director on other boards, or otherwise shall not be deemed a breach of this Agreement, if those activities do not materially interfere with the services required under this Agreement, and such activities shall not require the prior written consent of the Board. Notwithstanding anything herein contained to the contrary, this Agreement shall not be construed to prohibit the Executive from making personal investments or conducting personal business, financial or legal affairs or other personal matters if those activities do not materially interfere with the services required hereunder.

 

2.3 BOARD APPOINTMENT. Concurrently with the inception of this Agreement and thereafter, the Board shall appoint the Executive to the Board of Directors if Executive shall not already be a sitting member of the Board, shall appoint the Executive as Chairman of the Board of Directors if Director shall not already serve in that capacity. For a Term of five years and any partial term in addition to the full term(s) during those five years beginning with the Commencement Date established in “Recitals” to this Employment Agreement, the Executive will be recommended for continuous service on the Board by the Board and/or the Board’s Corporate Governance and Nominations Committee and shall be placed on the ballot and recommended for nomination to re-election by the Company’s stockholders consistent with and subject to the Company’s certificate of incorporation and By-laws, applicable law and rules of any stock exchange on which the Company’s shares are listed, and the Board of Directors shall consistently move to have Executive elected or appointed to the Chairmanship of the Board.

 

ARTICLE 3

COMPENSATION

 

3.1 BASE SALARY. As compensation for the services to be rendered by the Executive pursuant to this Agreement, the Company hereby agrees to pay the Executive a base salary (the “Base Salary”) at an initial rate equal to One Hundred Eighty-Five Thousand Dollars ($195,000.00) per year, beginning with the Commencement Date, during the Term of this Agreement, which rate shall be reviewed by the Board at least annually and shall be increased (but not reduced) by the Board in such amounts as the Board deems appropriate, but in an amount not less than $10,000 per year.  The Base Salary together with all such annual increases shall be paid in substantially equal bimonthly installments, in accordance with the normal payroll practices of the Company.

 

  

2

  

 

3.2 SIGNING BONUS AND ANNUAL BONUS.  The Company shall provide the Executive with an initial bonus for entering into this Agreement (the “Signing Bonus”) of $50,000 due and payable within 90 days of the Commencement Date, with the additional opportunity to earn beginning with January 1, 2013, an annual bonus (“Annual Bonus”) for each fiscal year of the Company, occurring in whole or in part during the Term, notwithstanding the position held by the Executive during the Term. For the Company’s first full fiscal year ending immediately after the Commencement Date, the Executive is entitled to an Annual Bonus of at least thirty five percent (35%) of the Executive’s Base Salary for such fiscal year (the “Target”) without prorating for the Commencement Date. Subject to the Executive’s right to receive the minimum required Annual Bonus for 2012 payable on January 1, 2013, the Board or a committee thereof will establish the criteria for the Executive achieving the Annual Bonus for 2012 within 90 days of the execution of this Agreement and for subsequent years during the Term, or within 90 days of the Board adopting any operating plan for such respective year whichever occurs first. For the Company’s fiscal year ending in 2012, the Executive shall be entitled to participate in a bonus plan where the target is at least thirty five percent (35%) of the Executive’s Base Salary for such year. The Target Annual Bonus for each year shall be at least thirty five percent (35%) of the Executive’s Base Salary for the respective year as to which such bonus relates. The Annual Bonus targets may be based on criteria including, among other things, revenue or EBITDA targets, acquisition, merger, business combination or growth targets, or such other criteria as the board of directors may establish from time to time (the “Performance Goals”). All Annual Bonus Targets and Annual Bonus criteria shall be established utilizing Performance Goals set by the Board or a committee thereof in its sole discretion subject to consulting with the Executive. The Executive shall participate in all other short term and long term bonus or incentive plans or arrangements in which other senior executives of the Company are eligible to participate from time to time in addition to the Executive bonus plans for fiscal 2012 through 2017, which are covered by this Section 3.2. Any Annual Bonus shall be paid as promptly as practicable following the end of the fiscal year, but not later than February 15th immediately following the end of such fiscal year. In the event funds are not immediately available for such payment, the Company shall place its indebtedness to Executive on the balance sheet as an account payable and shall give Executive a security interest in the Company and its assets until fully paid with reasonable interest. The provisions of this Section 3.2 shall be subject to the provisions of Sections 3.3 and 3.4.

 

3.3 WITHHOLDING. The Company shall have the right to deduct or withhold from the compensation due to the Executive hereunder any and all sums required for federal income and employee social security taxes and all state or local income taxes now applicable or that may be enacted and become applicable during the Term.

 

3.4 RIGHT TO SEEK APPROVAL. The Company may provide for approval of any performance-based compensation provided herein by the compensation committee of the Board to establish any reasonable Performance Goals to become applicable and determine whether such Performance Goals have been met. The Performance Goals shall be determined by the compensation committee in its sole discretion subject to consulting with the Executive on the goals. In the absence of a Compensation Committee, the entire Board or a majority thereof may act in its stead. As these Performance Goals are met, the Company shall determine the Bonus to be paid to the Executive; however, the minimum Bonus payable shall be 35% of the Executive’s base salary without regard to performance-based issues or otherwise.

 

3.5 CHANGE OF CONTROL. Notwithstanding Article 1, in the event of a Change of Control (as defined in Section 3.6) of the Company (a) during the Term while the Executive remains employed by the Company, or (b) at any time during the six (6) month period following the termination of the Executive’s employment with the Company (other than for Cause or without Good Reason), the Company shall pay to the Executive, concurrently with the consummation of such Change of Control, a lump sum amount equal to five (5) times the sum of (1) the Executive’s annual Base Salary (determined as the Executive’s highest annual Base Salary during the Term prior to the Change in Control) and (2) the Annual Bonus (determined as a minimum of thirty five percent (35%) of the Executive’s highest annual Base Salary during the Term prior to the Change in Control) (the “Severance Compensation”); provided, that the Company’s obligation to pay the Severance Compensation shall be conditioned on the following: if the Executive is employed by the Company at the time of the Change of Control and the Person or Group (each as defined in Section 3.6.) that acquires the Company requests that the Executive continue as an employee of the Company, the successor entity, or any of their respective affiliates on substantially the same (or better, from the Executive’s perspective) terms relating to salary, bonus, and benefits as contained in this Agreement, the Executive MAY, at his sole option, agree to continue such employment for a period of ninety (90) days from the date of the Change of Control or such lesser period of time as the Person or Group shall request. If the Executive’s employment with the Company is terminated pursuant to Section 6.2 on or after the date Executive becomes entitled to receive the Severance Compensation, then notwithstanding anything set forth in Section 6.2, the Company shall not be required to make any payments to the Executive pursuant to Section 6.2(a), other than continuing to provide all benefits in accordance with Section 4.1 to the extent set forth in Section 6.2(a). If the Executive’s employment with the Company is terminated pursuant to Section 6.2 before the Executive becomes entitled to the Severance Compensation, then notwithstanding the foregoing, the Executive shall continue to receive all amounts due pursuant to Section 6.2 and he shall not be entitled to receive any payments under this Section 3.5. In the event of any proposed, threatened, or actual Change of Control of the Company, the Company shall immediately notify the Executive of same, and the Executive shall immediately become a creditor of the Company and shall promptly thereafter be granted a first lien ahead of all other creditors, secured or unsecured, on all the assets of the Company such that none of the assets of the Company may be sold, bartered, leased, transferred, consolidated, collateralized or otherwise disposed of without the prior written consent of Executive, and the Company shall immediately evidence its collective indebtedness or potential indebtedness to Executive on the balance sheets as an account payable and shall give Executive a security interest in the Company and its assets until any obligations, liabilities or potential liabilities to Executive that may result from a Change of Control and/or other existing obligations of the Company to Executive are fully paid with reasonable interest and Executive shall deliver a written release from any further indebtedness or obligations under the terms of this Agreement.  Executive’s right to a lien hereunder shall not be abridged as a result of the Company’s failure to promptly notify him of issues relating to Change of Control or any of the Company’s obligations hereunder. Executive shall have the exclusive right to assign or transfer his right, title and interest in any lien(s) incurred hereunder to any other party or parties as he shall in his sole discretion deem appropriate or fitting for his own purposes, and any assignee, holder, or holders thereof shall continue to enjoy the benefit of said lien and the status as the primary and first lienholder of the assets attributed thereto.  Executive may, at his sole and exclusive option, waive any of the rights or responsibilities related to this Section 3.5 for such period or periods as he shall see fit, but shall not be obligated to make or continue any such waiver as a result of having granted the waiver on one or more occasions for any reason or for any period or periods of time.  No obligations of the Company to the Executive shall be abridged as the result of any waiver given or not given by Executive under this Section 3.5.

 

  

3

  

 

3.6 DEFINITION OF CHANGE OF CONTROL. For purposes of this Agreement “Change of Control” means the threatened, proposed, or actual occurrence of any of the following: (i) the actual, proposed or threatened sale, lease, transfer, conveyance or other disposition (other than by way of any underwritten public offering registered under the Securities Act of 1933 (“Public Offering”) or any offering of securities under Rule 144A promulgated under the Securities Act of 1933 (“Rule 144A Offering”) in one or a series of related or unrelated transactions, of 30% or more of the current assets of the Company (including one or a series of related or unrelated transactions of 30% or more of the current assets of any subsidiary or business holding wholly or principally owned, individually or collectively, by the Company) as shown on the most recent balance sheet of the Company as total current assets (the “Total Current Assets”) by any individual, corporation, limited liability company, partnership, or other entity (each, a “Person”) or group of Persons acting together, or any Company employee pension or benefits plan (each a “Group”); (ii) the actual, proposed, or threatened consummation of any transactions (including any stock or asset purchase, sale, acquisition, disposition, liquidation, merger, consolidation or reorganization, but not including any Public Offering or Rule 144A Offering) the result of which is that any Person or Group (other than any underwriter temporarily holding securities pursuant to a Public Offering), becomes the beneficial owners of more than thirty percent (30%) of the aggregate voting power of all classes of stock of the Company or any of its subsidiaries or holdings; or (iii) the first day on which any Person or Group in one or a series of related or unrelated transactions acts or seeks to gain a disposition through any other means, including but not limited to any action through the courts or otherwise, of 30% or more of the Total Current Assets of the Company or 30% or more of the current assets of any subsidiary or business holding wholly or principally owned, individually or collectively, by the Company, or 30% of the aggregate voting power of all classes of stock of the Company or any of its subsidiaries or holdings; or (iv) the first day on which a majority of the members of the Board of the Company or any of its subsidiaries or holdings are not individuals who were nominated for election or elected to the Board with the approval of two-thirds of the members of the Board just prior to the time of such nomination or election, including but not limited to any such transaction designed or proposed to promulgate any such change.

 

3.7 STOCK OPTIONS. Under the terms of the original issuance of this Employment Agreement to Executive on January 1, 2011, the Company agreed that on the first day of the 39th month immediately following the original Commencement Date (the original “Grant Date”), and subject to compliance with federal and state securities laws, the Company agreed to grant to the Executive under an Inducement Stock Option Agreement, found in Schedule I hereto, stock options to purchase Two Hundred Thousand (200,000) shares of the Company’s common stock at an exercise price equal to an average of the Fair Market Value (as defined in the Appendix hereto) of the underlying Shares on the first trading day on or after the Grant Date and the thirty days immediately preceding the Grant Date (the “Grant Date Exercise Price”) (all of which constitute the “Stock Options”). The Company and the Executive agree that the terms and conditions set forth on Schedule I hereto are hereby deemed incorporated by reference and shall govern the Stock Options granted under this Agreement. It is hereby agreed by the Company and the Executive to extend the terms of the Stock Options such that they shall now be issued to the Executive on the first day of the 48th month following the new Commencement Date of this Agreement, being July 26, 2012, (the revised “Grant Date”).

 

  

4

  

 

ARTICLE 4

EMPLOYEE BENEFITS

 

4.1 BENEFITS. The Company agrees that the Executive shall be entitled to all ordinary and customary perquisites afforded generally to executive employees of a small public Company (except to the extent employee contribution may be required under the Company’s benefit plans as they may now or hereafter exist), regardless of the specific position he shall hold in the Company, which shall in no event be less than the benefits generally afforded to the other highest-level executive employees of the Company as of the date hereof or from time to time, but in any event shall include any qualified or non-qualified pension, profit sharing and savings plans, any death benefit and disability benefit plans, life insurance coverages, any medical, dental, health and welfare plans or insurance coverages, copays and  and deductibles, for the Executive and his spouse, and any stock purchase programs and other benefits available under the Acacia Diversified Holdings, Inc. 2012 Stock Incentive Plan or other benefits that are approved in writing by the Board. Subject to the Executive’s qualifying for such policies by, among other things, taking and passing all necessary health tests, whether rated or not rated for premiums, and providing required health, personal and financial information, the Company shall arrange to provide to the Executive during the Term (a) aggregate life insurance totaling three (3) times the sum of (1) the Executive’s annual Base Salary and (2) a presumed Annual Bonus for such year equal to his Base Salary for such year and (b) long-term disability coverage of at least seventy percent (70%) of his annual Base Salary with no monthly dollar cap on payments. In addition, the Executive shall be reimbursed for up to $25,000 during the Term for tax and estate planning services upon submission of appropriate documentation. For any benefits provided to Executive under this ARTICLE 4 that are payable by the Executive in the normal course, the Company shall increase Executive’s salary in an amount sufficient to cover the costs of said benefits, including the taxes to effect the payments thereof and/or a Gross-Up payment subject to Section 7.1 hereto.

 

4.2 VACATION. The Executive shall be immediately entitled to four (4) weeks of paid vacation for 2012 and for each full calendar year of his employment hereunder thereafter. To the extent accrued vacation time is unused in any given year, it may be carried over in accordance with the policies of the Company then in effect. Other than in respect of 2012, vacation days shall accrue in accordance with the Company’s policies. Notwithstanding anything to the contrary, however, the Executive shall not be entitled to carry over any unused vacation for a period exceeding five (5) years.

 

ARTICLE 5

BUSINESS EXPENSES, RELOCATION & ATTORNEY’S FEES

 

5.1 EXPENSES. The Company shall pay or reimburse the Executive for all reasonable and authorized business expenses incurred by the Executive during the Term, including but not limited to the costs of any membership fees or dues for civic organizations and similar organizations and entities or private clubs (including one joint membership in an airline’s airport-based business traveler’s lounge); the costs to own (or lease) and operate two (2) company vehicles including the costs for insurance, gas, oil and minor repair thereof, for which such payment or reimbursement shall be paid promptly by the Company.  The aggregate purchase price by the Company of the two combined vehicles shall not exceed sixty-five thousand dollars ($65,000.00) if acquired by the Company, or the monthly aggregate lease payments for the two combined vehicles shall not exceed one thousand dollars ($1,000.00) if leased by the Company, plus taxes and licensing costs whether purchased or leased.  One, the other, or both of the company vehicles may be leased or owned.  Otherwise, the Company shall reimburse Executive five hundred dollars ($500.00) per month for one non-Company owned vehicle or one thousand dollars ($1,000.00) per month for two non-Company owned vehicles in his personal service, plus the costs of operating, insuring and maintaining his vehicles.

 

5.2 TRAVEL COSTS. Subject to the provisions of this Article 5, the Company shall reimburse the Executive for expenses incurred with business-related travel. For business-related flights, Executive shall be reimbursed for business class travel expenses (if available) or for a higher level of class of service when permitted under the Company’s policies. Notwithstanding the foregoing, the Executive shall be reimbursed for first class travel expenses for business-related and relocation-related flights over two hours. Executive shall be authorized to take up to and including three (3) non business-related flights per calendar year at the expense of the Company under the same terms and conditions.

 

  

5

  

 

5.3 RELOCATION EXPENSES. The Company shall promptly reimburse the Executive for all relocation expenses as described below. The Company will only pay for reasonable broker fees in connection with the sale of the Executive’s existing residence, reasonable out-of-pocket fees and expenses but not taxes payable in connection with such sale (other than transfer taxes), the packing and moving of all household goods and shipment of three automobiles based upon a competitive bid obtained through the Company’s human resources department, and fees and expenses, but not broker fees or mortgage financing fees in excess of two points, in connection with the purchase of a residence. The Executive shall be entitled to the preceding relocation expenses as long as they are incurred within eighteen (18) months of such determination to relocate (the “Commencement Date”). Between the Commencement Date and the earlier of (1) the date the Executive’s family relocates or (2) six months after the Commencement Date (the “Transition Period”), the Executive may make no more than fifteen round trips by air at the Company’s expense to commute to his last residence or such other place as Executive shall determine. The Executive will also be reimbursed for reasonable expenses associated with commuting during the Transition Period, including two trips to any such new location for his spouse for purposes of relocation-related planning, and for temporary housing and rental car expenses at any such new location. In respect of the two trips to the new location for the Executive’s spouse, the Company will reimburse the Executive for first-class travel arrangements for the Executive’s spouse only. The Executive will be entitled to receive an additional payment to cover any federal, state, and local income taxes that he incurs in connection with any reimbursement for relocation expenses that are not tax deductible. The Executive will be entitled to reimbursement for miscellaneous household expenses incurred in connection with the relocation in order to put the Executive’s new residence into move-in condition in an amount not to exceed twenty thousand dollars ($20,000.00).

 

5.4 ATTORNEY’S FEES. The Company shall reimburse the Executive for all reasonable attorneys’ fees incurred by the Executive in connection with the negotiation or preparation of this Agreement, up to a limit of fifteen thousand dollars ($15,000).

 

5.5 RECORDS. As a condition to reimbursement under this Article 5, the Executive may be required to furnish to the Company adequate records and other documentary evidence required by federal and state statutes and regulations for the substantiation of each expenditure. The Executive acknowledges and agrees that failure to furnish the required documentation may result in the Company denying all or part of the expense for which reimbursement is sought.

 

ARTICLE 6

TERMINATION OF EMPLOYMENT

 

6.1 TERMINATION FOR CAUSE. The Company may, during the Term, upon notice to the Executive, terminate the Executive’s employment under this Agreement and discharge the Executive for Cause (as defined below) and, in such event, except as set forth in the proviso to this Section 6.1, neither party shall have any rights or obligations under Article 2, Sections 3.1 and 3.2, or Articles 4 and 5; provided, however, that (a) the Company shall pay the Executive any amount due and owing as of the termination date pursuant to Section 3.1 and Section 3.2 (excluding a Bonus for the year in which the termination occurs) and Articles 4 and 5 (subject, in each case, to Section 3.3), and (b) the remaining provisions of this Agreement shall remain in full force and effect in accordance with their terms. As used herein, the term “Cause” shall refer to the termination of the Executive’s employment as a result of any one or more of the following: (i) any conviction of, or pleading of nolo contendre by, the Executive for any felony relating to the willful and knowing disregard of the law in intentionally committing acts detrimental to the Company; (ii) any willful and knowing misconduct of the Executive with intent which has a materially injurious effect on the business of the Company; (iii) the willful and knowing gross dishonesty of the Executive with intent which has a materially injurious effect on the business of the Company; or (iv) a willful and material failure to consistently discharge his duties under this Agreement which failure continues for thirty (30) days following written notice from the Company detailing the area or areas of such failure, other than such failure resulting from his Disability (as defined below); provided, that clause (iv) above shall be deemed to be deleted from this Agreement and shall have no force or effect concurrently with the consummation of a Change of Control. For purposes of this Section 6.1, no act or failure to act, on the part of the Executive, shall be considered “willful” if it is done, or omitted to be done, by the Executive in good faith or with reasonable belief that his action or omission was in the best interest of the Company. The Executive shall have the opportunity to cure any such acts or omissions (other than clause (i) above) within thirty (30) days of the Executive’s receipt of a notice from the Company finding that, in the good faith opinion of the Company, the Executive is guilty of acts or omissions constituting “Cause.”

 

  

6

  

 

6.2 TERMINATION WITHOUT CAUSE OR GOOD REASON. Subject to Section 6.4, the Board acting for the Company shall have the right, at any time in its sole discretion, to terminate the Executive’s employment under this Agreement without Cause upon not less than thirty (30) days prior written notice to the Executive. The term “Termination without Cause” shall mean the termination by the Company of the Executive’s employment for any reason other than those expressly set forth in Section 6.1, or no reason at all, and shall also mean the Executive’s decision to terminate his employment under this Agreement (and he hereby has such right) by reason of any act, decision or omission by the Company or the Board that: (A) materially modifies, reduces, changes, or restricts the Executive’s salary, bonus opportunities, options or other compensation benefits or perquisites, or the Executive’s authority, functions, services, duties, rights, and privileges as, or commensurate with the Executive’s position as the Chief Executive Officer of the Company as described in Section 2.1; (B) relocates the Executive without his consent from certain of the Company’s offices located at or near 2806 SE 29th Street, Ocala, FL  34471 to any other location in excess of twenty-five (25) miles beyond the geographic limits of Ocala, FL; (C) deprives the Executive of his titles and positions of Chief Executive Officer except by promotion or increase to higher office; (D) if prior to the expiration of the Term results in the Company proffering a new employment agreement to the Executive in order to extend the Term and the terms and conditions of such agreement (i) as they relate to the Executive’s salary, bonus opportunity and benefits (assuming the Executive qualifies for such benefits) are not at least as favorable to the Executive as the most favorable salary, bonus opportunity and benefits payable to the Executive in any year during the Term or (ii) change the Executive’s authority, functions, services, duties, rights and privileges as, or commensurate with the Executive’s position as the Chief Executive Officer as set forth in this Agreement; or (E) involves or results in any failure by the Company to comply with any provision of this Agreement, other than an isolated, insubstantial and inadvertent failure not occurring in bad faith and which is remedied by the Company promptly after receipt of notice thereof given by the Executive (each a “Good Reason”). In the event the Company or the Executive shall exercise the termination right granted pursuant to this Section 6.2, then except as set forth in the proviso below, neither party shall have any rights or obligations under Article 1, Article 2, Sections 3.1 and 3.2, or Articles 4 and 5; provided, however, that the Company shall pay to the Executive (a) an amount equal to five (5) times the Executive’s Base Salary (determined as the Executive’s highest annual Base Salary during the Term prior to such termination) plus five (5) times the Annual Bonus (at thirty five percent (35%) of the Executive’s highest annual Base Salary during the Term prior to such termination) and shall continue to provide all benefits that were made available to Executive while the Executive was employed by the Company (or if not allowable under the Company’s then existing policies their substantial equivalents) in accordance with Article 4 at the time they would have been paid had the Executive remained an employee for a period of twenty four (24) months after the effective date of the termination (subject in each case to Section 3.3), except that the Company shall not be required to provide such benefits to the extent that, during such twenty four (24) month period, the Executive receives substantially similar (or better, from the Executive’s perspective) benefits from a new employer, and (b) any amount due and owing as of the termination date pursuant to Section 3.1, Section 3.2 (including an Annual Bonus for the year in which the termination occurs (and if so provided the minimum required Annual Bonus for such year pursuant to Section 3.2) prorated to the date of termination for the entire year in accordance with Section 3.2), Section 4.2 and Article 5 (subject, in each case, to Section 3.3), and the remaining provisions of this Agreement shall remain in full force and effect in accordance with their terms. The Executive shall inform the Company of any other benefits the Executive is receiving where the Company would have a right to reduce the benefits it is providing to the Executive. After the provision of the benefits during the two-year period following such termination as described above, the Executive will be entitled to COBRA or Medicare rights as provided by applicable law. The amounts and benefits required by clause (a) above shall be provided only if the Executive has executed and delivered to the Company (and not revoked) a release in favor of the Company (which release shall be substantially in the form attached as Exhibit A). The amounts payable pursuant to this Section 6.2 shall be in payment for the services rendered by the Executive pursuant to this Agreement during the Term, and the Executive shall not be entitled to any additional amounts in consideration for such services.

 

6.3 TERMINATION FOR DEATH OR DISABILITY. The Executive’s employment shall terminate automatically upon the Executive’s death during the Term. If the Company determines in good faith that the Disability (as defined below) of the Executive has occurred during the Term, it shall give written notice to the Executive of its intention to terminate his employment. In such event, the Executive’s employment with the Company shall terminate effective on the 30th day after receipt of such notice by the Executive, provided that, within the thirty (30) days after such receipt, the Executive shall not have returned to full-time performance of his duties. Upon any such termination under this Section 6.3 the Company shall pay to the Executive or his estate, if applicable, any amounts due and owing as of the termination date pursuant to Sections 3.1, 3.2, 4.2 and Article 5 (subject, in each case, to Section 3.3). For purposes of this Agreement, “Disability” shall mean the inability of the Executive to perform his duties to the Company on account of physical or mental illness or incapacity for a period of one-hundred twenty (120) consecutive calendar days, or for a period of one hundred eighty (180) calendar days, whether or not consecutive, during any three hundred sixty-five (365) day period.

 

  

7

  

 

6.4 TERMINATION WITHOUT GOOD REASON. Anything in this Agreement to the contrary notwithstanding, during the Term the Executive shall have the right, in his sole discretion, to terminate his employment under this Agreement without Good Reason upon not less than thirty (30) days prior written notice to the Company, and in such event, neither party shall have any rights or obligations under Article 2, Sections 3.1 and 3.2, or Articles 4 and 5; provided, however, that (a) the Company shall pay the Executive any amount due and owing as of the termination date pursuant to Section 3.1 and Section 3.2 (for the fiscal year prior to the year of termination if unpaid at the time of termination) and Articles 4 and 5 (subject, in each case, to Section 3.3), and (b) the remaining provisions of this Agreement shall remain in full force and effect in accordance with their terms.

 

6.5 STOCK OPTIONS. Upon the Executive’s termination under this Article 6, the Company’s obligations with respect to any stock option to purchase shares of the Company’s common stock granted to the Executive shall be determined by the terms and conditions of such option as set forth in the Executive’s written option agreement regarding such options, including, with respect to the Stock Options, the terms and conditions set forth on Schedule I hereto.

 

ARTICLE 7

PARACHUTE TAX INDEMNITY

 

7.1 GROSS-UP PAYMENT.

 

(a) If it shall be determined that any amount paid, distributed or treated as paid or distributed by the Company to or for the benefit of the Executive (whether paid or payable or distributed or distributable pursuant to the terms of this Agreement, any stock option agreement between the Executive and the Company or otherwise, but determined without regard to any additional payments required under this Article 7) (a “Payment”) would be subject to the excise tax imposed by Section 4999 of the Internal Revenue Code of 1986, as amended (the “Code”), or any interest or penalties are incurred by the Executive with respect to such excise tax (such excise tax, together with any such interest and penalties, being hereinafter collectively referred to as the “Excise Tax”), then the Executive shall be entitled to receive an additional payment (a “Gross-Up Payment”) in an amount such that after payment by the Executive of all federal, state and local taxes (including any interest or penalties imposed with respect to such taxes), including without limitation, any income taxes (including any interest or penalties imposed with respect thereto) and Excise Tax imposed on the Gross-up Payment, the Executive retains an amount of the Gross-Up Payment equal to the Excise Tax imposed upon the Payments.

 

(b) The determinations of whether and when a Gross-Up Payment is required under this Article 7 shall be made by the Company based on its good faith interpretation of applicable law. The amount of such Gross-Up Payment and the valuation assumptions to be utilized in arriving at such determination shall be made by the Company which shall provide detailed supporting calculations to the Executive within 15 business days of the receipt of notice from the Executive that there has been a Payment subject to the Excise Tax, or such earlier time as is requested by the Company. Any Gross-Up Payment, as determined pursuant to this Article 7, shall be paid by the Company to the Executive within twenty-five (25) days of the receipt of notice from the Executive that there has been a Payment subject to the Excise Tax. Any determinations by the Company shall be binding upon the Executive, provided, however, if it is later determined that there has been an underpayment of Excise Tax and that the Executive is required to make an additional Excise Tax payment(s) on any Payment or Gross-Up Payment, the Company shall promptly provide a similar full gross-up on such additional liability.

 

(c) For purposes of any determinations made by the Company acting under Section 7.1(b):

 

  

8

  

 

(i) All Payments and Gross-Up Payments with respect to the Executive shall be deemed to be “parachute payments” under Section 280G(b) (2) of the Code and to be “excess parachute payments” under Section 280G(b) (1) of the Code that are fully subject to the Excise Tax under Section 4999 of the Code, except to the extent (if any) that the Company determines in good faith that a Payment in whole or in part does not constitute a “parachute payment” or otherwise is not subject to Excise Tax;

 

 (ii) The value of any non-cash benefits or deferred or delayed payments or benefits shall be determined in a manner consistent with the principles of Section 280G of the Code; and

 

(iii) The Executive shall be deemed to pay federal, state and local income taxes at the actual maximum marginal rate applicable to individuals in the calendar year in which the Gross-Up Payment is made, net of any applicable reduction in federal income taxes for any state and local taxes paid on the amounts in question assuming the Executive is subject to applicable phase out rules for the highest income tax payers, notwithstanding the actual income tax rate of the Executive.

 

7.2 CLAIMS AND PROCEEDINGS. The Executive shall notify the Company in writing of any Excise Tax claim by the Internal Revenue Service (or any other state or local taxing authority) that, if successful, would require the payment by the Company of a Gross-Up Payment. Such notification shall be given as soon as practicable but no later than twenty (20) business days after the Executive is informed in writing of such claim and shall apprise the Company of the nature of such claim and the date on which such claim is to be paid. The Executive shall not pay such claim prior to the expiration of the 30-day period following the date on which he gives such notice to the Company (or such shorter period ending on the date that any payment of taxes with respect to such claim is due). If the Company notifies the Executive in writing prior to the expiration of such period that it desires to contest such Excise Tax claim, the Executive shall: (i) give the Company any information reasonably requested by the Company relating to such claim; (ii) take such action in connection with contesting such claim as the Company shall reasonably request in writing from time to time, including, without limitation, accepting legal representation with respect to such claim by an attorney reasonably selected by the Company after consultation in good faith with the Executive and subject to approval by the Executive (which approval shall not be unreasonably withheld) under the circumstances set forth in Section 7.1; (iii) cooperate with the Company in good faith in order to effectively contest such claim; and (iv) permit the Company to participate in any proceeding relating to such claim; provided, however, that the Company shall bear and pay directly all costs and expenses (including additional interest and penalties) incurred in connection with such contest and shall indemnify and hold the Executive harmless, on an after-tax basis, from any Excise Tax or income tax (including interest and penalties with respect thereto) imposed as a result of such representation and payment of costs and expense. Without limitation of the foregoing provisions of this Article 7, the Company shall control the Excise Tax portion of any proceedings taken in connection with such contest and, at its sole option, may pursue or forego any and all administrative appeals, proceedings, hearings and conferences with the taxing authority in respect of such Excise Tax claim and the Executive agrees to prosecute such contest to a determination before any administrative tribunal, in a court of initial jurisdiction and in one or more appellate courts, as the Company shall determine; provided, however, that the Executive may elect at his sole option to pay the tax claimed and require the Company to contest through a suit for a refund. If the Executive elects to pay such Excise Tax claim and contest through a suit for a refund, the Company shall advance the amount of such payment to the Executive, on an interest-free basis, and shall indemnify and hold the Executive harmless, on an after-tax basis, from any Excise Tax or income tax (including interest and penalties) imposed with respect to such advance or with respect to any imputed income with respect to such advance; and provided, however, that any Company-directed extension of the statute of limitations relating to payment of taxes for the Executive’s taxable year with respect to which such contested Excise Tax amount is claimed to be due shall be effective only if it can be and is limited to the contested Excise Tax liability.

 

7.3 REFUNDS. If, after the Executive’s receipt of an amount advanced by the Company pursuant to this Article 7 for payment of Excise Taxes, the Executive files an Excise Tax refund claim and receives any refund with respect to such claim, the Executive shall (subject to the Company’s complying with the requirements of this Article 7) except as provided below, promptly pay to the Company the amount of any such refund of Excise Tax (together with any interest paid or credited thereon, but after any and all taxes applicable thereto), plus the amount (after any and all taxes applicable-thereto) of the refund (if any is applied for and received) of any income tax paid by the Executive with respect to and as a result of his prior receipt of any previously paid Gross-Up Payment indemnifying the Executive with respect to any such Excise Tax later so refunded. In the event the Executive files for a refund of the Excise Tax and such request would, if successful, require the Executive to refund any amount to the Company pursuant to this provision, then the Executive shall be required to seek a refund of the Income Tax portion of any corresponding Gross-Up Payment so long as such refund request would not have a material adverse effect on the Executive (which determination shall be made by independent tax counsel selected by the Executive after good faith consultation with the Company and subject to approval of the Company, which approval shall not be unreasonably withheld). If, after the Executive’s receipt of an amount advanced by the Company pursuant to this Article 7, a determination is made that the Executive shall not be entitled to any refund with respect to such claim and the Company does not notify the Executive in writing of its intent to contest such denial of refund prior to the expiration of thirty (30) days after such determination, then such advance shall be forgiven and shall not be required to be repaid and the amount of such advance shall offset, to the extent thereof, the amount of the Gross-Up Payment required to be paid.

 

  

9

  

 

ARTICLE 8

RESTRICTIVE COVENANTS

 

8.1 COVENANT NOT TO DISCLOSE CONFIDENTIAL INFORMATION. During the Term and following termination of Executive’s employment under this Agreement, the Executive agrees that, without the Company’s prior written consent, he will not use or disclose to any person, firm, association, partnership, entity or corporation, any confidential information concerning: (i) the business, operations or internal structure of the Company or any division or part thereof; (ii) the customers of the Company or any division or part thereof; (iii) the financial condition of the Company or any division or part thereof; and (iv) other confidential information pertaining to the Company or any division or part thereof, including without limitation, trade secrets, computer programs, software, intellectual property, proprietary information, technical data, marketing analyses and studies, operating procedures, customer and/or inventory lists, or the existence or nature of any of the Company’s agreements or agreements of any division thereof; provided, however, that the Executive shall be entitled to disclose such information: (a) to the extent the same shall have otherwise become publicly available (unless made publicly available by the Executive); (b) during the course of or in connection with any actual or potential litigation, arbitration, or other proceeding based upon or in connection with the subject matter of this Agreement; (c) as may be necessary or appropriate to conduct his duties hereunder, provided the Executive is acting or believing himself to act in good faith and in the best interest of the Company; (d) as may be required by law or judicial process; or (e) if the information is generally known to personnel in the Executive’s trade or business.

 

8.2 COVENANT NOT TO COMPETE. The Executive acknowledges that he has established and will continue to establish favorable relations with the customers, clients and accounts of the Company and will have access to trade secrets of the Company. Therefore, in consideration of such relations to further protect trade secrets, directly or indirectly, of the Company, the Executive agrees that at all times during his employment with the Company through the one (1) year anniversary of the date of termination of the Executive’s employment, the Executive will not, directly or indirectly, without the express written consent of the Board:

 

(i) own or have any interest in or act as an officer, director, partner, principal, employee, agent, representative, consultant or independent contractor of, or in any way assist in, any business which is engaged directly in any business competitive with the Company in those markets and/or products lines in which the Company competes within 50 miles of the address of the principal place of business of the parent Company or any or its wholly-owned operating subsidiaries at any time during the Term, or become associated with or render services to any person, firm, corporation or other entity so engaged (“Competitive Businesses”); provided, however, that the Executive may own without the express written consent of the Company not more than four and nine-tenths percent (4.9%) of the issued and outstanding securities of any company or enterprise whose securities are listed on a national securities exchange or actively traded in the over the counter market; provided, further, however that once the Term has terminated the Executive may work for, have an interest in, render services to or assist any business or Competitive Business without violating this Section 8.2;

 

(ii) solicit clients, customers or accounts of the Company for, on behalf of or otherwise related to any such Competitive Businesses;

 

(iii) solicit any person who is or shall be in the employ or service of the Company to leave such employ or service for employment with or service to the Executive, an affiliate of the Executive or any third party.

 

  

10

  

 

In the event that the Company shall merge with, be acquired by, or generally be absorbed into any other business or institution, the Executive’s continued performance on behalf of such other business or institution shall not constitute a violation of Executive’s duties to the Company under Article 8 or other provisions of this Agreement.

 

Notwithstanding the foregoing, if any court determines that the covenant not to compete, or any part thereof, is unenforceable because of the duration of such provision or the geographic area or scope covered thereby, such court shall have the power to reduce the duration, area or scope of such provision to the extent necessary to make the provision enforceable and, in its reduced form, such provision shall then be enforceable and shall be enforced. The Company shall pay and be solely responsible for any attorney’s fees, expenses, costs and court or arbitration costs incurred by the Executive in any matter or dispute between the Executive and the Company which pertains to this Article 8 if the Executive prevails in the contest in whole or in part.

 

8.3 SPECIFIC PERFORMANCE. Recognizing that irreparable damage will result to the Company in the event of the breach of any of the foregoing covenants and assurances by the Executive contained in Sections 8.1 and 8.2, and that the Company’s remedies at law for any such breach may be inadequate, the Company and its successors and assigns, in addition to such other remedies which may be available to them, shall, upon making a sufficient showing under applicable law, be entitled to an injunction to be issued by any court of competent jurisdiction ordering compliance with this Agreement or enjoining and restraining the Executive from the continuation of such breach. The obligations of the Executive and rights of the Company pursuant to this Article 8 shall survive the termination of the Executive’s employment under this Agreement. The covenants and obligations of the Executive set forth in this Article 8 are in addition to and not in lieu of or exclusive of any other obligations and duties the Executive owes to the Company.

 

ARTICLE 9

GENERAL PROVISIONS

 

9.1 FINAL AGREEMENT. This Agreement is intended to be the final, complete and exclusive agreement between the parties relating to the employment of the Executive by the Company and all prior or contemporaneous understandings, representations and statements, oral or written, are merged herein. No modification, waiver, amendment, discharge or change of this Agreement shall be valid unless the same is in writing and signed by the party against which the enforcement thereof is or may be sought.

 

9.2 NO WAIVER. No waiver, by conduct or otherwise, by any party of any term, provision, or condition of this Agreement, shall be deemed or construed as a further or continuing waiver of any such term, provision, or condition nor as a waiver of a similar or dissimilar condition or provision at the same time or at any prior or subsequent time.

 

9.3 RIGHTS CUMULATIVE. The rights under this Agreement, or by law or equity, shall be cumulative and may be exercised at any time and from time to time. No failure by any party to exercise, and no delay in exercising, any rights shall be construed or deemed to be a waiver thereof, nor shall any single or partial exercise by any party preclude any other or future exercise thereof or the exercise of any other right.

 

9.4 NOTICE. Except as otherwise provided in this Agreement, any notice, approval, consent, waiver or other communication required or permitted to be given or to be served upon any person in connection with this Agreement shall be in writing. Such notice shall be personally served, sent by fax or cable, or sent prepaid by either registered or certified mail with return receipt requested or Federal Express and shall be deemed given (i) if personally served or by Federal Express, when delivered to the person to whom such notice is addressed, (ii) if given by fax or cable, when sent, or (iii) if given by mail, two (2) business days following deposit in the United States mail. Any notice given by fax or cable shall be confirmed in writing, by overnight mail or Federal Express within forty-eight (48) hours after being sent. Such notices shall be addressed to the party to whom such notice is to be given at the party’s address set forth below or as such party shall from time to time otherwise direct.

 

  

11

  

 

If to the Company:

 

Acacia Diversified Holdings, Inc.

3512 East Silver Springs Boulevard - #243

Ocala, FL  34470

Facsimile: (877) 513-6295

Attn: CEO or General Counsel

 

If to the Executive:

 

Steven L. Sample

2806 SE 29th Street

Ocala, FL  34471

Facsimile:  (877) 513-6295

 

9.5 SUCCESSORS. The terms and conditions of this Agreement shall inure to the benefit of and be binding upon the successors and assigns of the parties hereto.

 

9.6 GOVERNING LAW. This Agreement shall be construed and enforced in accordance with the laws of the State of Texas, without giving effect to the principles of conflict of laws thereof.

 

9.7 COUNTERPARTS. This Agreement may be executed in any number of counterparts, each of which shall be deemed an original, but all of which shall constitute one instrument. The parties agree that facsimile copies of signatures shall be deemed originals for all purposes hereof and that a party may produce such copies, without the need to produce original signatures, to prove the existence of this Agreement in any proceeding brought hereunder.

 

9.8 SEVERABILITY. The provisions of this Agreement are agreed to be severable, and if any provision, or application thereof, is held invalid or unenforceable, then such holding shall not affect any other provision or application.

 

9.9 CONSTRUCTION. As used herein, and as the circumstances require, the plural term shall include the singular, the singular shall include the plural, the neuter term shall include the masculine and feminine genders, and the feminine term shall include the neuter and the masculine genders.

 

9.10 ARBITRATION. Except as otherwise provided in Section 8.3 hereof, any controversy or claim arising out of, or related to, this Agreement, or the breach thereof, shall be settled by binding arbitration in the Cities of Orlando, Florida, or Dallas, Texas (at the Executive’s election), in accordance with the employment arbitration rules then in effect of the American Arbitration Association including the right to discovery, and the arbitrator’s decision shall be binding and final, and judgment upon the award rendered may be entered in any court having jurisdiction thereof. Each party hereto shall pay its or their own expenses incident to the negotiation, preparation and resolution of any controversy or claim arising out of, or related to, this Agreement, or the breach thereof; provided, however, the Company shall pay and be solely responsible for any attorneys’ fees and expenses and court or arbitration costs incurred by the Executive as a result of a claim brought by either the Executive or the Company alleging that the other party breached or otherwise failed to perform this Agreement or any provision hereof to be performed by the other party if the Executive prevails in the contest in whole or in part.

 

9.11 TAXES. Except as otherwise specifically provided elsewhere in this Agreement or herein, the Executive is solely responsible for the payment of any tax liability (including any taxes and penalties arising under Section 409A of the Code) that may result from any payments or benefits that he receives pursuant to this Agreement. Nevertheless, if the Company reasonably determines that receipt of payments or benefits pursuant to this Agreement would cause the Executive to incur liability for additional tax under Section 409A of the Code and upon notification of same to Executive, then the Company shall upon request of the Executive suspend such payments or benefits until the end of the six-month period following termination of the Executive’s employment (the “409A Suspension Period”). As soon as reasonably practical after the end of the 409A Suspension Period, the Company will promptly make a lump sum payment to the Executive, in cash, in an amount equal to any payments and benefits that the Company does not make during the 409A Suspension Period. Thereafter, the Executive will receive any remaining payments and benefits due pursuant to this Agreement in accordance with its terms (as if there had not been any suspension beforehand). The Company will cooperate with the Executive in making any amendments to this Agreement that the Executive reasonably requests to avoid the imposition of taxes or penalties under Section 409A of the Code provided that such changes do not provide the Executive with additional benefits (other than deminimus benefits) under this Agreement.

 

  

12

  

 

9.12 NO MITIGATION OR OFFSET. The Executive shall not have any duty to seek other employment or to reduce any amounts or benefits payable to him under Section 1.1 or Article 6, and no such amounts or benefits shall be reduced, on account of any compensation received by the Executive from any other employment or source except as specifically provided in Section 1.1 and Section 6.2 with respect to certain benefits. The Company shall not have the right to offset any amount owed to it against payments due to the Executive under Section 1.1, Section 3.5 or Article 6 (other than as expressly provided therein) except that all such payments shall be subject to Section 3.3.

 

IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first above written.

For ACACIA DIVERSIFIED HOLDINGS, INC.

By:          /s/ Patricia Ann Arnold                      

Name:  Patricia Ann Arnold

Title:  Secretary

STEVEN L. SAMPLE (The Executive)

By:          /s/ Steven L. Sample                           

    Name;  Steven L. Sample

Title:  Executive

 

  

13

  

 

EXHIBIT A

 

SEPARATION AGREEMENT AND RELEASE

 

It is hereby agreed by and between you, Steven L. Sample (for yourself, your spouse, agents and attorneys) (jointly, “You”), and Acacia Diversified Holdings, Inc., its predecessors, successors, affiliates, directors, officers, shareholders, fiduciaries, insurers, employees and agents (jointly, the “Company”), as follows:

 

1. You acknowledge that your employment with the Company ended effective [                    ____], 20[___], and that you will perform no further duties, functions or services for the Company subsequent to that date , notwithstanding your right to continue your service on the Company’s Board of Directors.

 

2. You acknowledge and agree that you have received all vacation pay and other compensation due you from the Company as a result of your employment with the Company and your separation from employment, including, but not limited to, all amounts required under your Employment Agreement with the Company effective on the Commencement Date thereof (the “Employment Agreement”), other than those amounts payable pursuant to Paragraph 3 below and those amounts, if any, payable pursuant to Sections 3.5, 5.1, 5.2 and 5.3 or Article 7 of the Employment Agreement if required by the terms of such sections or article. You acknowledge and agree that the Company owes you no additional wages, commissions, bonuses, vacation pay, severance pay, expenses, fees, or other compensation or payments of any kind or nature, other than as provided in this Agreement and those amounts, if any, payable pursuant to Sections 3.5, 5.1, 5.2 and 5.3 or Article 7 of the Employment Agreement if required by the terms of such sections or article. All benefits for which you are eligible pursuant to the Employment Agreement will remain in effect for the periods set forth therein.

 

3. In exchange for your promises in this Agreement and the Employment Agreement, including the release of claims set forth below, if you sign and do not revoke this Agreement the Company will pay you all amounts due to you under Section 1.1 of the Employment Agreement, minus legally required state and federal payroll deductions. The payment provided for in this paragraph will be made in the time periods required by the Employment Agreement (except for benefits that will be paid over time as provided in such section) and, if no time is specified, within twenty-two (22) days of the date of this Separation Agreement and Release.

 

4. You represent and warrant that you have returned to the Company any and all documents, software, equipment (including, but not limited to, computers and computer-related items), and all other materials or other things in your possession, custody, or control which are the property of the Company, including, but not limited to, Company identification, keys, and the like, wherever such items may have been located; as well as all copies (in whatever form thereof) of all materials relating to your employment, or obtained or created in the course of your employment with the Company; except in the event that you remain as a sitting Director of the Company on its Board of Directors, in which circumstance you shall rightfully be authorized to keep and retain in your possession any such documents, software, or equipment as may be reasonably expected or required for performance of your duties as a Director.

 

5. You hereby represent that, except in the event you continue as a sitting Director of the Company on its Board of Directors or other than those materials you have returned to the Company pursuant to Paragraph 4 of this Agreement, you have not copied or caused to be copied, and have not printed-out or caused to be printed-out, any software, computer disks, or other documents other than those documents generally available to the public, or retained any other materials originating with or belonging to the Company. You further represent that you have not retained in your possession, custody or control, any software, documents or other materials in machine or other readable form, which are the property of the Company, originated with the Company, or were obtained or created in the course of or relate to your employment with the Company.

 

6. You shall comply with the obligations set forth in Article 8 of the Employment Agreement which shall remain binding on you.

 

  

14

  

 

7. In consideration for the payment provided for in Paragraph 3, you unconditionally release and forever discharge the Company, and the Company’s current, former, and future controlling shareholders, subsidiaries, affiliates, related companies, predecessor companies, divisions, directors, trustees, officers, employees, agents, attorneys, successors, and assigns (and the current, former, and future controlling shareholders, directors, trustees, officers, employees, agents, and attorneys of such subsidiaries, affiliates, related companies, predecessor companies, and divisions) (referred to collectively as “Releasees”), from any and all known and unknown claims, demands, actions, suits, causes of action, obligations, damages and liabilities of whatever kind or nature and regardless of whether the knowledge thereof would have materially affected your agreement to release the Company hereunder, that arise out of or are related to (a) the Company’s failure to make any payments required under the Employment Agreement (other than those amounts, if any, payable pursuant to Sections 3.5, 5.1, 5.2 and 5.3 and Article 7 of the Employment Agreement if required by the terms of such sections), and (b) those arising under the Age Discrimination in Employment Act (“ADEA”). The Release will not waive the Executive’s rights to indemnification under the Company’s certificate of incorporation or by-laws or any written agreement between the Company and the Executive relating to the Executive’s service on the Board of the Company.

 

With respect to the various rights and claims under the ADEA being waived by you in this Agreement, you specifically acknowledge that you have read and understand the provisions of paragraphs 11, 12, and 13 below before signing this Agreement. This general release does not cover rights or claims under the ADEA arising after you sign this Agreement.

 

8. You represent and warrant that you have not filed, and agree that you will not file, or cause to be filed, any complaint, charge, claim or action involving any claims you have released in the foregoing paragraph. This promise not to sue does not apply to claims for breach of this Agreement. You agree and acknowledge that if you break this promise not to sue, then you will be liable for all consequential damages, including the legal expenses and fees incurred by the Company or any of the Releasees, in defending such a claim.

 

9. The Company hereby represents and warrants that concurrently with your execution and delivery of this Agreement, the Company has paid to you any and all amounts under the Employment Agreement that are required to be paid to you by the Company as of the date hereof, excluding, without limitation, any amounts required to be paid under this Agreement and those amounts, if any, payable pursuant to Sections 3.5, 5.1, 5.2 and 5.3 or Article 7 of the Employment Agreement if and to the extent required by the terms of such sections.

 

10. Excluded from this Agreement are any claims or rights that cannot be waived by law, including the right to file a charge of discrimination with an administrative agency.

 

11. You acknowledge that you have hereby been advised in writing to consult with an attorney before you sign this Agreement. You understand that you have twenty-one (21) days within which to decide whether to sign this Agreement, although you may sign this Agreement at any time within the twenty-one (21) day period. If you do sign it, you also understand that you will have an additional 3 days after you sign to change your mind and revoke the Agreement, in which case a written notice of revocation must be delivered to the CEO or General Counsel, Acacia Diversified Holdings Inc., 3512 E. Silver Springs Boulevard - #243, Ocala, FL 34470, on or before the third (3rd) day after your execution of the Agreement. You understand that the Agreement will not become effective until after that three (3) day period has passed.

 

12. You acknowledge that you are signing this Agreement knowingly and voluntarily and intend to be bound legally by its terms.

 

13. You hereby acknowledge that no promise or inducement has been offered to you, except as expressly stated above and in the Employment Agreement, and you are relying upon none. This Agreement and the Employment Agreement represent the entire agreement between you and the Company with respect to the subject matter hereof, and supersede any other written or oral understandings between the parties pertaining to the subject matter hereof and may only be amended or modified with the prior written consent of you and the Company.

 

14. You certify that you have not experienced a job-related illness or injury for which you have not already filed a claim.

 

15. If any provision of this Agreement is held to be invalid, the remainder of the Agreement, nevertheless, shall remain in full force and effect in all other circumstances.

 

16. This Agreement does not constitute an admission that you, the Company or any other Releasee has violated any law, rule, regulation, contractual right or any other duty or obligation.

 

  

15

  

 

17. This Agreement is made and entered into in the State of Texas and shall in all respects be interpreted, enforced, and governed under the laws of that state, without reference to conflict of law provisions thereof. The language of all parts in this Agreement shall be construed as a whole, according to fair meaning, and not strictly for or against any party.

 

PLEASE READ CAREFULLY. THIS AGREEMENT INCLUDES THE RELEASE OF CERTAIN CLAIMS.

 

	  	  	  	  	  
	  	  	
STEVEN L. SAMPLE

	
Dated: ____________________, 201___

	  	  	  	
   

	  	  	  	  	
Name:  Steven L. Sample

             Executive

	  	  	  	  	  

 

	  	  	  	  	  	  	  	  	  
	
Dated: ____________________, 201___

	  	  	  	
ACACIA DIVERSIFIED HOLDINGS, INC.

	  	  	  	  	  
	  	  	  	  	  	  	
By:

	  	
  

	  	  	  	  	  	  	  	  	
[                                                                    ]

	  	  	  	  	  	  	  	  	
[                                                                    ]

 

  

16

  

 

SCHEDULE I

 

INDUCEMENT STOCK OPTION AGREEMENT

 

THIS AGREEMENT, made as effective the 26th day of July, 2012 (the “Commencement Date”), by and between Acacia Diversified Holdings, Inc. (“Acacia” or the “Company”) and Steven L. Sample (“Optionee”).

 

RECITALS

 

WHEREAS, the Board has determined to offer employment to Optionee pursuant to an employment agreement between the Company and the Optionee effective on the Commencement Date (the “Employment Agreement”).

 

WHEREAS, as an inducement to accept such employment offer, the Board has determined to offer Optionee an option (the “Option”) to purchase 200,000 shares of Common Stock (the shares subject to this award being referred to below as the “Shares”) under the terms and conditions set forth herein for a period of ten years from July 1, 2016 (the “Grant Date”).

 

WHEREAS, the exercise price for the Shares subject to this Option shall be equal to an average of the Fair Market Value (as defined in the Appendix hereto) of the underlying Shares on the first trading day on or after the Grant Date and the thirty days immediately preceding the Grant Date (the “Grant Date Exercise Price”).

 

WHEREAS, all capitalized terms in this Agreement, to the extent not otherwise defined herein, shall have the meaning assigned to them in the attached Appendix.

 

NOW THEREFORE, it is hereby agreed as follows:

 

1. Grant of Option. Acacia Diversified Holdings, Inc. hereby grants to Optionee, as of the Grant Date, an Option to purchase up to 200,000 Shares at the Exercise Price per Share. The Shares shall be purchasable from time to time in accordance with the Vesting Schedule in Paragraph 3.  The Board of Directors shall have the option to issue additional grants of options to the Executive at any time as it sees fit.

 

2. Option Term. The Option shall have a maximum term of ten (10) years measured from the Grant Date and shall accordingly expire at the close of business on the tenth anniversary of the Grant Date, unless sooner terminated in accordance with Paragraph 4 or 5.

 

3. Exercisability/Vesting. The right to exercise the Option shall vest in the Optionee, and the Option shall become exercisable in accordance with the Vesting Schedule set forth herein. The Option shall remain exercisable to the extent vested until the Expiration Date or the sooner termination of the Option term under Paragraph 4 or 5. The right to exercise the Option shall vest in the Optionee as follows:

 

(i) 100,000 of the Options shall vest on the Grant Date;  and

 

(ii) 10,000 of the Options shall vest on each monthly anniversary of the Grant Date over the period beginning on the first (1st) monthly anniversary of the Grant Date and ending on the tenth (10th) monthly anniversary of the Grant Date; and

 

Vesting in the Shares may be accelerated pursuant to the provisions of Paragraph 4 or 5 below.

 

4. Cessation of Service.

 

(a) Termination due to Death or Disability. As of the date of the Optionee’s termination from employment under the terms of the Employment Agreement and service on the Company’s Board (the “Optionee’s Service”) due to death or Disability (as defined below), any unexercised portion of any Option shall be exercisable (to the extent previously vested) from the date of such termination of the Optionee’s Service until two (2) years following such termination date, but in no event later than ten (10) years following the Grant Date. As to unvested Options at the date of the Optionee’s termination due to death or Disability, all time-based Options that have not yet vested shall vest and shall be exercisable from the date of such termination of the Optionee’s Service until one hundred eighty (180) days following such termination date, but in no event later than ten (10) years following the Grant Date. For purposes hereof, “Disability” shall have the same meaning and be determined in the same manner as set forth in the Employment Agreement.

 

  

17

  

 

(b) Termination for Cause. As of the date of the termination of Optionee’s Service for Cause (as defined below), any unvested portion of any Option shall terminate immediately and shall be of no further force or effect. For purposes hereof, “Cause” shall have the same meaning and be determined in the same manner as set forth in the Employment Agreement.

 

 (c) Termination Without Cause or for Good Reason. As of the date of the termination of Optionee’s Service by Acacia Diversified Holdings, Inc. without Cause or by the Optionee for Good Reason (as defined below), any unexercised portion of any Option shall (to the extent previously vested) be exercisable from such termination of the Optionee’s Service until the date that is two (2) years following the termination date, but in no event later than ten (10) years following the Grant Date. As to unvested Options at the date of the termination of Optionee’s Service by Acacia Diversified Holdings, Inc. without Cause or by Optionee for Good Reason, all unvested performance-based Options shall terminate and all time-based Options that have not yet vested shall vest and shall be exercisable from the date of such termination of the Optionee’s Service until one hundred eighty (180) days following such termination date, but in no such event later than ten (10) years following the Grant Date. The term “without Cause” shall mean the termination of the Optionee’s Service for any reason other than those expressly set forth in the definition “for Cause” above, or no reason at all, or for Good Reason. For purposes hereof, “Good Reason” shall have the same meaning and be determined in the same manner as set forth in the Employment Agreement.

 

(d) Termination Without Good Reason. As of the date of any voluntary termination of Optionee’s Service with the Company by the Optionee other than due to death or Disability, and other than for Good Reason, any unvested portion of any Option shall terminate immediately and shall be of no further force or effect. Any previously vested but unexercised portion of any Option shall remain exercisable from the date of such termination of employment until the second anniversary of the termination date, but in no event later than ten (10) years following the Grant Date.

 

(e) Termination upon Expiration of Employment Agreement. As of the date of any termination of Optionee’s Service with the Company at the time of, or subsequent to, the expiration of the Employment Agreement by lapse of time and for no other reason, then any previously vested but unexercised portion of any Option shall remain exercisable from the date of such termination of employment until the second anniversary of such termination date, but in no event later than ten (10) years following the Grant Date.

 

5. Change in Control.

 

In the event of a Change of Control (as defined below) while the Optionee is employed by the Company, any unvested installment of any Option shall immediately vest and become exercisable from the date of such Change of Control until the second anniversary of the Change of Control, but in no event later than ten (10) years following the Grant Date provided, however, that notwithstanding the foregoing, any such stock options shall remain exercisable beyond such dates so long as Executive is an employee or Director of the Company or any successor thereto or affiliate thereof, but in no event later than ten (10) years following the Grant Date. For purposes hereof, “Change of Control” shall have the same meaning and be determined in the same manner as set forth in the Optionee’s employment agreement with the Company.

 

6. Adjustment in Shares. Should any change be made to the Common Stock by reason of any stock split, stock dividend, recapitalization, combination of shares, exchange of shares or other change affecting the outstanding Common Stock as a class without Acacia Diversified Holdings’ receipt of consideration, the Company shall make appropriate equitable adjustments to (i) the number and/or class of securities subject to the Option and (ii) the Exercise Price in order to reflect such change and thereby preclude a dilution or enlargement of benefits hereunder; provided, however, that the aggregate Exercise Price shall remain the same.

 

7. Stockholder Rights. The holder of the Option shall not have any stockholder rights with respect to the Shares until such person shall have exercised the Option, paid the Exercise Price and become a holder of record of the purchased Shares.

 

  

18

  

 

8. Manner of Exercising Option.

 

(a) In order to exercise the Option for all or any part of the Shares for which the Option is at the time exercisable, Optionee or, in the case of exercise after Optionee’s death, Optionee’s executor, administrator, heir or legatee, as the case may be, must take the following actions:

 

(i) The Secretary of Acacia Diversified Holdings, Inc. shall be provided with written notice of the Option exercise (the “Exercise Notice”) in substantially the form of Exhibit I attached hereto, in which there is specified the number of Shares to be purchased under the exercised Option.

 

(ii) The Exercise Price for the purchased Shares shall be paid in one or more of the following alternative forms:

 

	  	
•

	  	
cash or check made payable to Acacia’s order; or

 

	  	
•

	  	
Shares of the Company’s Common Stock held by Optionee (or any other person or persons exercising the Option) for the requisite period necessary to avoid a charge to Acacia’s earnings for financial reporting purposes and valued at Fair Market Value on the Exercise Date; or

 

	  	
•

	  	
if established by Acacia and permitted under applicable law (including the financial accounting rules associated with avoiding additional financial expense through the method of exercise), through a “same day sale” commitment from Optionee and a broker-dealer selected by Acacia whereby the Optionee irrevocably elects to exercise the Option and to sell a portion of the Shares so purchased sufficient to pay for the total Exercise Price for the Shares being exercised and whereby the broker-dealer irrevocably commits upon receipt of such Shares to forward the total Exercise Price for the Shares being exercised directly to Acacia plus the applicable Federal, state and local income taxes required to be withheld by Acacia by reason of such exercise (the “Cashless Exercise”).

 

(iii) Appropriate documentation evidencing the right to exercise the Option shall be furnished to Acacia Diversified Holdings if the person or persons exercising the Option is other than Optionee.  The Company agrees to reasonably assist the person or persons exercising the Option with said appropriate documentation in the normal course.

 

(iv) Appropriate arrangement must be made with Acacia for the satisfaction of all Federal, state and local income tax withholding requirements applicable to the Option exercise.

 

 (b) Except to the extent the Cashless Exercise sale and remittance procedure specified above is utilized in connection with the exercise of the Option, payment of the Exercise Price for the purchased Shares must accompany the Exercise Notice delivered to Acacia in connection with the Option exercise.

 

(c) As soon as practicable after the Exercise Date, Acacia shall issue to or on behalf of Optionee (or any other permitted person or persons exercising the Option) a certificate or certificates representing the purchased Shares. The right to receive Shares under this Agreement may not be assigned, transferred, pledged or otherwise disposed of in any way by the Optionee (other than by will or the laws of descent and distribution).

 

(d) In no event may the Option be exercised for fractional Shares.

 

9. No Impairment of Rights. This Agreement shall not in any way affect the right of Acacia to adjust, reclassify, reorganize or otherwise make changes in its capital or business structure or to merge, consolidate, dissolve, liquidate or sell or transfer all or any part of its business or assets.

 

10. Compliance with Laws and Regulations.

 

(a) The exercise of the Option and the issuance of the Shares upon such exercise shall be subject to compliance by Acacia Diversified Holdings and Optionee with all applicable requirements of law relating thereto and with all applicable regulations of any stock exchange on which the Common Stock may be listed for trading at the time of such exercise and issuance.

 

(b) The inability of Acacia Diversified Holdings to obtain approval from any regulatory body having authority deemed by Acacia to be necessary to the lawful issuance and sale of any Common Stock pursuant to the Option shall relieve Acacia Diversified Holdings of any liability with respect to the non-issuance or sale of the Common Stock as to which such approval shall not have been obtained. However, Acacia shall use its best efforts to obtain all such applicable approvals.

 

11. Successors and Assigns. Except to the extent otherwise provided in Paragraph 4(a) or 5, the provisions of this Agreement shall inure to the benefit of, and be binding upon, Acacia and its successors and assigns and Optionee, Optionee’s assigns and the legal representatives, heirs and legatees of Optionee’s estate.

 

  

19

  

 

12. Governing Law. The interpretation, performance, and enforcement of this Agreement shall be governed by the laws of the State of Texas without resort to its conflict-of-laws rules.

 

13. Non-Statutory Stock Options. The Option granted hereunder is not intended to be an incentive stock option within the meaning of Section 422 of the Code.

 

14. No Right to Continued Service. Nothing in this Agreement shall confer upon Optionee any right to continue in the Service of Acacia Diversified Holdings or shall interfere with or restrict in any way the rights of Acacia Diversified Holdings which are hereby expressly reserved, to discharge Optionee at any time for any reason whatsoever, with or without Cause, the sole exception being the Executive’s right to continue to sit on the Company’s Board in the normal course.

 

15. Notices. Any notice required to be given or delivered to Acacia Diversified Holdings under the terms of this Agreement shall be in writing and addressed to Acacia Diversified Holdings at its principal corporate offices. Any notice required to be given or delivered to Optionee shall be in writing and addressed to Optionee at the most recent address reflected in Acacia Diversified Holdings’s employment records. All notices shall be deemed effective upon personal delivery or upon deposit in the U.S. mail, postage prepaid and properly addressed to the party to be notified.

 

IN WITNESS WHEREOF, the parties have executed this Agreement as of the day and year first above written.

 

	 	  	  	  
	 	
ACACIA DIVERSIFIED HOLDINGS, INC.

	 	  	  
	 	
By:

	  	
  

	 	  	  	
[                                                            ]

	 	  	  	
[                                                            ]

 

	 	  	  	  
	 	
OPTIONEE

	 	  	  
	 	  	  	
   

	 	  	  	
Steven L. Sample

	 	  	  	
Optionee

 

  

20

  

 

EXHIBIT I

 

NOTICE OF EXERCISE

 

I hereby notify Acacia Diversified Holdings, Inc. (the “Corporation”) that I elect to purchase ____________ shares of the Corporation's Common Stock (the "Purchased Shares") at the option exercise price of $__________________ per share (the “Exercise Price”) pursuant to that certain option (the “Option”) granted to me under the Corporation's 2012 Stock Incentive Plan or its successor Plan on _____________________, _______.

 

Concurrently with the delivery of this Exercise Notice to the Corporation, I shall hereby pay to the Corporation the Exercise Price for the Purchased Shares in accordance with the provisions of my agreement with the Corporation (or other documents) evidencing the Option and shall deliver whatever additional documents may be required by such agreement as a condition for exercise. Alternatively, I may utilize the Cashless Exercise sale and remittance procedure specified in my agreement to effect payment of the Exercise Price.

 

_____________________, ________

Date

 

_______________________________________________

Optionee

 

Address: _______________________________________

 

______________________________________________

 

Print name in exact manner it is to appear on the stock certificate: ____________________________________________________________________________________________________________________

 

Address to which certificate is to be sent, if different from address above: ______________________________________________________________________________________________________________

 

 

Social Security Number: ____________________________________

 

  

21

  

 

APPENDIX

 

The following definitions shall be in effect under the Agreement:

 

A. Agreement shall mean this Inducement Stock Option Agreement.

 

B. Board shall mean the Board of Directors of Acacia Diversified Holdings, Inc..

 

C. Code shall mean the Internal Revenue Code of 1986, as amended.

 

D. Common Stock shall mean Acacia Diversified Holdings, Inc. common stock, par value $0.001 per share.

 

E. Exercise Date shall mean the date on which the Option shall have been exercised in accordance with Paragraph 8 of the Agreement.

 

F. Exercise Price shall mean $             per Share.

 

G. Expiration Date shall mean the date on which the Option term expires as specified in Paragraph 2.

 

H. Fair Market Value per share of Common Stock on the Grant Date shall be determined in accordance with the following provisions:

 

(i) If the Common Stock is at the time traded on the OTC Market, then the Fair Market Value shall be an average of the closing selling price per share of Common Stock on the date in question, as the price is reported by the National Association of Securities Dealers on the OTC Market or any successor system, and the closing price of the stock on each of the preceding thirty days. If there is no closing selling price for the Common Stock on the date in question, then the Fair Market Value shall be average of the closing selling price on the last thirty days preceding the date for which such quotation exists.

 

(ii) If the Common Stock is at the time listed on any Stock Exchange, then the Fair Market Value shall be average of the closing selling price per share of Common Stock on the date in question and the thirty days preceding such date on the Stock Exchange determined by the Board to be the primary market for the Common Stock, as such price is officially quoted in the composite tape of transactions on such exchange. If there is no closing selling price for the Common Stock on the date in question, then the Fair Market Value shall be average of the closing selling price on each of the thirty days preceding the date for which such quotation exists.

 

(iii) If the Common Stock is not at the time traded on any Stock Exchange and is not reported on the OTC Market or any successor system, then the Fair Market Value shall be the average between the highest bid and lowest asked prices for the Common Stock on the relevant date and each of the thirty days preceding the relevant date by an established quotation service for over-the-counter securities.

 

(iv) If the Common Stock is not at the time traded on any Stock Exchange, is not reported on the OTC Market or a successor system, and is not otherwise publicly traded, then the Fair Market Value shall be established by taking an average of the most recent sale price for the Common Stock and all sales during each of the thirty days immediately preceding that last sale.

 

I. Grant Date shall mean the date designated in the preamble to the Agreement granting the Option.

 

J. Optionee shall mean the person to whom the Option is granted as specified in the Agreement.

 

K. Service shall mean Optionee’s service with Acacia, whether as an employee, director or consultant, which has not been interrupted or terminated. Optionee’s Service shall not be deemed to have terminated merely because of a change in the capacity in which Optionee renders service to Acacia.

 

  

22

  

 

M. Shares shall mean the number of shares of Common Stock subject to the Option.

 

N. Stock Exchange shall mean the Nasdaq Stock Exchange, the American Stock Exchange, the New York Stock Exchange, the OTC Bulletin Board Exchange, or the Pink Sheets Exchange.

 

O. Vesting Schedule shall mean the vesting schedule specified in Paragraph 3 of the Agreement, pursuant to which Optionee will vest in the Shares in one or more installments over his period of Service, subject to acceleration in accordance with the provisions of the Agreement.

 

 

 

 

  

23Stock Purchase Agreement

 EXHIBIT 10.1 

 
 STOCK PURCHASE AGREEMENT 

BY AND AMONG 
 JACKSONVILLE BANCORP, INC., 
 CAPGEN CAPITAL GROUP IV LP 

AND EACH OF THE OTHER 
 INVESTORS NAMED HEREIN 
 DATED AS OF 

AUGUST 22, 2012 

 TABLE OF CONTENTS 

 

							
	 	  	 	  	Page	 
	 ARTICLE I.
	  	PURCHASE AND SALE OF THE PURCHASED SHARES	  	 	1	  
			
	 Section 1.01
	  	Issuance, Sale and Delivery of the Purchased Shares	  	 	1	  
			
	 Section 1.02
	  	Closing	  	 	2	  
			
	 Section 1.03
	  	Payment of Purchase Price	  	 	2	  
			
	 ARTICLE II.
	  	REPRESENTATIONS AND WARRANTIES OF THE COMPANY	  	 	2	  
			
	 Section 2.01
	  	Organization and Standing	  	 	2	  
			
	 Section 2.02
	  	Corporate Power	  	 	3	  
			
	 Section 2.03
	  	Corporate Authority	  	 	3	  
			
	 Section 2.04
	  	Governmental Authority Approvals; Shareholder Approval; No Violations	  	 	4	  
			
	 Section 2.05
	  	Company Capital Stock; Purchased Shares	  	 	5	  
			
	 Section 2.06
	  	Company Reports; Financial Statements, Etc	  	 	6	  
			
	 Section 2.07
	  	Compliance with Applicable Laws; Regulatory Filings; Permits	  	 	8	  
			
	 Section 2.08
	  	No Undisclosed Liabilities	  	 	10	  
			
	 Section 2.09
	  	Absence of Certain Changes	  	 	10	  
			
	 Section 2.10
	  	Tax Matters	  	 	10	  
			
	 Section 2.11
	  	Transactions with Affiliates	  	 	12	  
			
	 Section 2.12
	  	Loans	  	 	13	  
			
	 Section 2.13
	  	Other Activities of the Company and the Bank	  	 	14	  
			
	 Section 2.14
	  	Material Agreements; No Defaults	  	 	14	  
			
	 Section 2.15
	  	Company Benefit Plans	  	 	15	  
			
	 Section 2.16
	  	Environmental Matters	  	 	16	  
			
	 Section 2.17
	  	Labor Matters	  	 	17	  
			
	 Section 2.18
	  	Insurance	  	 	17	  
			
	 Section 2.19
	  	No Integration	  	 	17	  
			
	 Section 2.20
	  	No Change of Control	  	 	17	  
			
	 Section 2.21
	  	Properties	  	 	18	  
			
	 Section 2.22
	  	Computer and Technology Security	  	 	19	  
			
	 Section 2.23
	  	Data Privacy	  	 	19	  
			
	 Section 2.24
	  	No Restrictive Covenants	  	 	19	  

  
 i 

 TABLE OF CONTENTS 

(continued) 
  

							
	 	  	 	  	Page	 
	 Section 2.25
	  	Litigation	  	 	19	  
			
	 Section 2.26
	  	[Intentionally Omitted.]	  	 	20	  
			
	 Section 2.27
	  	No Brokers; etc	  	 	20	  
			
	 Section 2.28
	  	Voting of Shares by Directors and Executive Officers	  	 	20	  
			
	 Section 2.29
	  	Risk Management Instruments	  	 	20	  
			
	 Section 2.30
	  	Capitalization	  	 	20	  
			
	 Section 2.31
	  	Investment Company	  	 	20	  
			
	 Section 2.32
	  	Price of Common Stock	  	 	21	  
			
	 Section 2.33
	  	Shell Company Status	  	 	21	  
			
	 Section 2.34
	  	Reservation of Purchased Shares	  	 	21	  
			
	 Section 2.35
	  	No Substantially Similar Agreement	  	 	21	  
			
	 Section 2.36
	  	Disclosure	  	 	21	  
			
	 ARTICLE III.
	  	REPRESENTATIONS AND WARRANTIES OF THE INVESTORS	  	 	21	  
			
	 Section 3.01
	  	Organization	  	 	21	  
			
	 Section 3.02
	  	Bank Holding Company Status, etc	  	 	21	  
			
	 Section 3.03
	  	Authorization	  	 	22	  
			
	 Section 3.04
	  	Accredited Investor, etc	  	 	22	  
			
	 Section 3.05
	  	Regulatory Approvals	  	 	24	  
			
	 Section 3.06
	  	Sufficient Funds	  	 	24	  
			
	 Section 3.07
	  	No Acting in Concert, etc	  	 	24	  
			
	 Section 3.08
	  	No Prior Proxies	  	 	25	  
			
	 ARTICLE IV.
	  	CONDITIONS TO THE OBLIGATIONS OF THE INVESTORS	  	 	25	  
			
	 Section 4.01
	  	Representations and Warranties to be True and Correct	  	 	25	  
			
	 Section 4.02
	  	Performance	  	 	25	  
			
	 Section 4.03
	  	Preferred Stock Designation	  	 	25	  
			
	 Section 4.04
	  	No Material Adverse Change	  	 	25	  
			
	 Section 4.05
	  	Corporate Approvals; etc	  	 	25	  
			
	 Section 4.06
	  	Change in Control Waivers	  	 	26	  
			
	 Section 4.07
	  	Regulatory Approvals	  	 	26	  

  

  
 ii 

 TABLE OF CONTENTS 

(continued) 
  

							
	 	  	 	  	Page	 
			
	 Section 4.08
	  	Registration Rights Agreement	  	 	26	  
			
	 Section 4.09
	  	Sales of Shares	  	 	26	  
			
	 Section 4.10
	  	Opinions	  	 	26	  
			
	 Section 4.11
	  	No Suspensions of Trading in Common Stock or Listing	  	 	26	  
			
	 ARTICLE V.
	  	CONDITIONS TO THE OBLIGATIONS OF THE COMPANY	  	 	27	  
			
	 Section 5.01
	  	Representations and Warranties to be True and Correct	  	 	27	  
			
	 Section 5.02
	  	Performance	  	 	27	  
			
	 Section 5.03
	  	Investment Banking Opinion	  	 	27	  
			
	 ARTICLE VI.
	  	COVENANTS	  	 	27	  
			
	 Section 6.01
	  	Commercially Reasonable Best Efforts	  	 	27	  
			
	 Section 6.02
	  	Filings and Other Actions	  	 	27	  
			
	 Section 6.03
	  	Corporate Approvals; Takeover Laws	  	 	29	  
			
	 Section 6.04
	  	Shareholder Approvals	  	 	29	  
			
	 Section 6.05
	  	Proxy Statement	  	 	30	  
			
	 Section 6.06
	  	Registration Rights	  	 	31	  
			
	 Section 6.07
	  	Reservation and Nasdaq Listing of Underlying Shares	  	 	31	  
			
	 Section 6.08
	  	Restricted Shares	  	 	31	  
			
	 Section 6.09
	  	Information, Access and Confidentiality	  	 	33	  
			
	 Section 6.10
	  	Conduct of Business Prior to Closing	  	 	34	  
			
	 Section 6.11
	  	Company Forbearances	  	 	35	  
			
	 Section 6.12
	  	Investor Call	  	 	38	  
			
	 Section 6.13
	  	Press Releases; Public Disclosure	  	 	38	  
			
	 Section 6.14
	  	Use of Proceeds	  	 	39	  
			
	 Section 6.15
	  	Form D Filings	  	 	39	  
			
	 ARTICLE VII.
	  	OTHER AGREEMENTS	  	 	39	  
			
	 Section 7.01
	  	Bank Holding Company Status	  	 	39	  
			
	 Section 7.02
	  	Preemptive Rights	  	 	39	  
			
	 Section 7.03
	  	Compensation Matters	  	 	41	  
			
	 Section 7.04
	  	Commercially Reasonable Best Efforts	  	 	41	  
			
	 Section 7.05
	  	Manner of Offerings	  	 	42	  

  

  
 iii

 TABLE OF CONTENTS 

(continued) 
  

							
	 	  	 	  	Page	 
	 Section 7.06
	  	Indemnification	  	 	42	  
			
	 ARTICLE VIII.
	  	TERMINATION	  	 	43	  
			
	 Section 8.01
	  	Methods of Termination	  	 	43	  
			
	 Section 8.02
	  	Effect of Termination	  	 	44	  
			
	 ARTICLE IX.
	  	MISCELLANEOUS	  	 	44	  
			
	 Section 9.01
	  	Certain Definitions	  	 	44	  
			
	 Section 9.02
	  	Specific Performance	  	 	46	  
			
	 Section 9.03
	  	Expenses; Fee	  	 	46	  
			
	 Section 9.04
	  	Survival	  	 	47	  
			
	 Section 9.05
	  	Notices	  	 	47	  
			
	 Section 9.06
	  	No Assignment; No Delegation	  	 	48	  
			
	 Section 9.07
	  	No Third Party Beneficiaries	  	 	48	  
			
	 Section 9.08
	  	Governing Law	  	 	48	  
			
	 Section 9.09
	  	Amendments and Waivers	  	 	48	  
			
	 Section 9.10
	  	Severability	  	 	48	  
			
	 Section 9.11
	  	Captions	  	 	48	  
			
	 Section 9.12
	  	No Waiver; Cumulative Remedies	  	 	49	  
			
	 Section 9.13
	  	Further Assurances	  	 	49	  
			
	 Section 9.14
	  	No Construction Against Drafter	  	 	49	  
			
	 Section 9.15
	  	Entire Agreement	  	 	49	  
			
	 Section 9.16
	  	Counterparts	  	 	49	  
			
	 Section 9.17
	  	Independent Nature of Investors’ Obligations and Rights	  	 	49	  

  
 iv 

 SCHEDULES 

 

			
	 SCHEDULE I
	  	Form of Preferred Stock Designation
		
	 SCHEDULE II
	  	Subsidiaries
		
	 SCHEDULE III
	  	Form of Share Increase Amendment
		
	 SCHEDULE IV
	  	Form of Incentive Plan Amendment
		
	 SCHEDULE V
	  	Form of Director and Officer Waiver and Acknowledgement Agreement
		
	 SCHEDULE VI
	  	Form of Director and Executive Officer Support Agreement
		
	 SCHEDULE VII
	  	Form of Registration Rights Agreement

  
 v 

 INDEX TO DEFINED TERMS 

 

					
	 2012 MOU
	  	 	8	  
	 Accredited Investor
	  	 	44	  
	 affiliate
	  	 	44	  
	 Agreement
	  	 	1	  
	 Applicable Law
	  	 	44	  
	 Articles of Incorporation
	  	 	1	  
	 Bank
	  	 	1	  
	 beneficial ownership
	  	 	45	  
	 Benefit Plan
	  	 	15	  
	 BHCA
	  	 	2	  
	 Board
	  	 	45	  
	 BOLI
	  	 	9	  
	 Business Day
	  	 	45	  
	 Call Reports
	  	 	6	  
	 CapGen
	  	 	1	  
	 Change of Control Benefits
	  	 	18	  
	 Closing
	  	 	1	  
	 Closing Date
	  	 	2	  
	 Code
	  	 	9	  
	 Commitments
	  	 	27	  
	 Common Stock
	  	 	1	  
	 Company
	  	 	1	  
	 Company Board Recommendation
	  	 	4	  
	 Company Reports
	  	 	6	  
	 Conversion
	  	 	3	  
	 Covered Securities
	  	 	39	  
	 D&O Insurance
	  	 	17	  
	 Designated Securities
	  	 	40	  
	 Disclosure Schedule
	  	 	5	  
	 Enforcement Actions
	  	 	8	  
	 Environmental Law
	  	 	16	  
	 ERISA
	  	 	15	  
	 ERISA Affiliate
	  	 	15	  
	 Exchange Act
	  	 	45	  
	 FDI Act
	  	 	37	  
	 FDIC
	  	 	8	  
	 Federal Reserve
	  	 	8	  
	 Federal Reserve Policy Statement
	  	 	22	  
	 Federal Reserve Resolutions
	  	 	8	  
	 FFIEC
	  	 	6	  
	 Florida OFR
	  	 	8	  
	 GAAP
	  	 	45	  
	 Governmental Authority
	  	 	4	  
	 Green Employment Agreement
	  	 	5	  
	 Group
	  	 	10	  

					
	 Hazardous Substance
	  	 	16	  
	 Incandela Employment Agreement
	  	 	5	  
	 Incentive Plan Amendment
	  	 	3	  
	 Indemnified Person
	  	 	42	  
	 Initial Investment Agreement
	  	 	5	  
	 Initial Investors
	  	 	5	  
	 Initial Preemptive Rights
	  	 	5	  
	 Investment Banker
	  	 	25	  
	 Investor Call
	  	 	2	  
	 Investor Party
	  	 	42	  
	 Investor Percentage Interest
	  	 	39	  
	 Investors
	  	 	1	  
	 Leases
	  	 	18	  
	 Legend Removal Date
	  	 	32	  
	 Liens
	  	 	1	  
	 Losses
	  	 	42	  
	 Material Adverse Effect
	  	 	45	  
	 Money Laundering Laws
	  	 	9	  
	 OFAC
	  	 	9	  
	 Offer Period
	  	 	40	  
	 OREO
	  	 	18	  
	 Original Meeting Date
	  	 	29	  
	 Permits
	  	 	9	  
	 person
	  	 	45	  
	 Placement Agent
	  	 	20	  
	 Plan Asset Regulations
	  	 	33	  
	 Preferred Stock
	  	 	1	  
	 Preferred Stock Designation
	  	 	1	  
	 Press Release
	  	 	39	  
	 Private Placement
	  	 	1	  
	 Private Placement Documents
	  	 	23	  
	 Proposals
	  	 	3	  
	 Proxy Statement
	  	 	30	  
	 Public Offering
	  	 	41	  
	 Purchase Price
	  	 	2	  
	 Purchased Shares
	  	 	1	  
	 Qualified Offering
	  	 	39	  
	 Qualified Offering Notice
	  	 	40	  
	 Regulatory Authority
	  	 	8	  
	 Regulatory Reports
	  	 	8	  
	 Related Interest
	  	 	45	  
	 Requisite Shareholder Vote
	  	 	4	  
	 Resale Registration Statement
	  	 	32	  
	 Restricted Stock
	  	 	5	  
	 Returns
	  	 	11	  

 
 

  

  
 vi 

 

					
	 Reverse Stock Split
	  	 	3	  
	 Rule 144A offering
	  	 	40	  
	 SEC
	  	 	4, 46	  
	 Securities
	  	 	1	  
	 Securities Act
	  	 	46	  
	 Share Increase Amendment
	  	 	3	  
	 Share Price
	  	 	1	  
	 Shareholder Approvals
	  	 	3	  
	 Shareholders’ Meeting
	  	 	28	  

					
	 Stock Incentive Plan
	  	 	3	  
	 Subsidiary
	  	 	46	  
	 Support Agreement
	  	 	20	  
	 Takeover Laws
	  	 	4	  
	 Taxes
	  	 	10	  
	 Termination Date
	  	 	43	  
	 Transaction
	  	 	1	  
	 Underlying Shares
	  	 	1	  
	 VCOC Rights Inspector
	  	 	33	  

 
 

  
 vii

 STOCK PURCHASE AGREEMENT 

THIS STOCK PURCHASE AGREEMENT, dated as of August 22, 2012 (this “Agreement”), is by and among JACKSONVILLE
BANCORP, INC., a Florida corporation (the “Company”), and CAPGEN CAPITAL GROUP IV LP, a Delaware limited partnership (“CapGen”), and each of the respective other investors set forth on the signature pages to this
Agreement (collectively, with CapGen, the “Investors”). 
 The Company is a bank holding company that is the
sole shareholder of The Jacksonville Bank, a Florida state-chartered commercial bank (the “Bank”). 
 The
Company has offered, in a private placement, to issue and sell to the Investors, and the Investors seek to purchase, an aggregate of 50,000 shares of the Company’s Mandatorily Convertible, Noncumulative, Nonvoting Perpetual Preferred Stock,
Series A, liquidation preference $1,000.00 per share, of the Company (the “Preferred Stock”), at a purchase price of $1,000.00 per share (the “Share Price”) on the terms and subject to the conditions set forth in
this Agreement (the “Private Placement”). 
 The Preferred Stock will have the terms set forth in the articles
of amendment to the Company’s amended and restated articles of incorporation (“Articles of Incorporation”) designating the Preferred Stock in the form attached hereto as Schedule I (the “Preferred Stock
Designation”). The Company will file the Preferred Stock Designation with the Florida Secretary of State prior to and as a condition to the closing (the “Closing”) of the Private Placement. The Preferred Stock will be
mandatorily convertible into shares of the Company’s common stock, par value $0.01 per share (the “Common Stock”), subject to and in accordance with the terms and conditions of the Preferred Stock Designation. 

The shares of Preferred Stock to be sold in the Private Placement are collectively referred to as the “Purchased
Shares.” The shares of Common Stock into which the Purchased Shares are to be convertible are referred as the “Underlying Shares” and the Underlying Shares and the Purchased Shares are referred to, collectively, as the
“Securities.” 
 The number of Purchased Shares to be bought by each Investor hereunder is set forth on such
Investor’s signature page. Each of CapGen and the other Investors are acting separately. 
 In consideration of the
premises, and other good and valuable consideration, the receipt of which is acknowledged, the parties, intending to be legally bound, agree as follows: 
 ARTICLE I. 
 PURCHASE AND SALE OF THE PURCHASED SHARES 

Section 1.01 Issuance, Sale and Delivery of the Purchased Shares. Subject to the terms and conditions set forth in this Agreement,
at the Closing, the Company shall issue, sell and deliver to each Investor, and each Investor shall, severally and not jointly, purchase from the Company, the respective number of Purchased Shares set forth on such Investor’s signature page,
free and clear of all liens, pledges, security interests, adverse claims, charges and other encumbrances (“Liens”), other than those placed thereon by or on behalf of an Investor with respect solely to such Investor’s Purchased
Shares (such issuance, sale and purchase of the Purchased Shares, along with the other commitments by each party to the others set forth in this Agreement, the “Transaction”). 

 Section 1.02 Closing. The Closing of the Private Placement shall be held at a
mutually agreeable location upon satisfaction (or waiver, if applicable) of all conditions to Closing; provided that the closing date (“Closing Date”) may not occur prior to the end of the ten Business Days or such shorter
period of not less than five Business Days acceptable to each Investor, including CapGen, commencing upon the issuance of a notice by CapGen to its investors to call funds required to purchase the Purchased Shares that CapGen is acquiring (the
“Investor Call”). The Company and the Investors will cooperate and use their respective commercially reasonable best efforts to close the Private Placement, subject to the terms and conditions hereof, as soon as practicable. At the
Closing, subject to the terms and conditions hereof, the Company shall issue and deliver to each Investor the number of Purchased Shares set forth on such Investor’s signature page in accordance with Section 1.01 in certificate form
or in uncertificated book-entry form pursuant to instructions of such Investor provided to the Company at least three Business Days in advance of the Closing Date. 
 Section 1.03 Payment of Purchase Price. As payment in full for the Purchased Shares, on the Closing Date, upon receipt of the Purchased Shares, each Investor shall deliver to the Company an amount
equal to $1,000.00 per Purchased Share to be acquired by each Investor hereunder (such aggregate amount, the “Purchase Price”). Payment of the Purchase Price shall be made in funds immediately available to the Company by wire
transfer to the bank account designated by the Company at least three Business Days in advance of the Closing Date. 
 ARTICLE
II. 
 REPRESENTATIONS AND WARRANTIES OF THE COMPANY 

The Company represents and warrants to each Investor, as of the date hereof and as of the Closing Date (except to the extent such
representations and warranties are limited expressly to an earlier specific date, in which case such representations and warranties were accurate on and as of such specified date) as follows and understands that each Investor is relying on these
representations and warranties: 
 Section 2.01 Organization and Standing. 

(a) The Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Florida and is
registered as a bank holding company under the Bank Holding Company Act of 1956, as amended (the “BHCA”). The Company is duly qualified to do business and is in good standing as a foreign corporation in each jurisdiction where the
ownership or operation of its assets or properties or conduct of its business requires such qualification, except where the failure to be so qualified or in good standing is not reasonably likely to have, individually or in the aggregate, a Material
Adverse Effect. 
 (b) Schedule II sets forth all Subsidiaries of the Company. The Company owns, directly or indirectly,
all of the capital stock of, or other ownership interests in (except the outstanding trust preferred interests in the Company’s statutory trust Subsidiaries), each Subsidiary free and clear of any and all Liens, and all the issued and
outstanding shares of capital 

  
 2 

 
stock of, or other ownership interests in, each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities.
The Company’s principal Subsidiary and sole banking Subsidiary is the Bank. Each Subsidiary is duly organized, validly existing and in good standing under the laws of its jurisdiction of organization or incorporation. Each Subsidiary is duly
qualified to do business and is in good standing as a foreign corporation in each jurisdiction where the ownership or operation of its assets or properties or conduct of its business requires such qualification, except where the failure to be so
qualified or in good standing is not reasonably likely to have, individually or in the aggregate, a Material Adverse Effect. The Bank’s deposits are insured by the FDIC, and all FDIC insurance premiums and assessments required to be paid have
been paid when due. 
 Section 2.02 Corporate Power. Each of the Company and each Subsidiary has all requisite power and
authority (corporate and other) to carry on its business as it is now being conducted, and to own, lease or operate all its properties and assets. The Company has all requisite corporate power and authority and, subject to obtaining the Shareholder
Approvals and the filing of the Preferred Stock Designation and the Share Increase Amendment with the Florida Secretary of State, has taken all corporate action necessary in order to execute, deliver and perform its obligations under this Agreement
and to consummate the Transaction (including the Private Placement and the issuance of the Securities). 
 Section 2.03
Corporate Authority. 
 (a) This Agreement has been duly executed and delivered by the Company and, assuming the due
authorization, execution and delivery of this Agreement by the Investors, this Agreement is a valid and legally binding agreement of the Company, enforceable against the Company in accordance with its terms, subject to bankruptcy, insolvency,
reorganization, moratorium, fraudulent transfer and similar laws of general applicability relating to or affecting creditors’ rights or to general equity principles. 
 (b) The Board (at a meeting or meetings duly called and held or by written consent) unanimously (i) determined that this Agreement and the Transaction (including the Private Placement and the
issuance of the Securities) are advisable and fair to and in the best interests of, the shareholders of the Company; (ii) directed that each of the following items (the “Proposals”) be submitted to the Company’s
shareholders for approval (collectively, the “Shareholder Approvals”): (A) the amendment of the Articles of Incorporation to increase the number of authorized shares of Common Stock, as set forth in Schedule III (the
“Share Increase Amendment”), (B) the issuance of the shares of Common Stock upon the conversion (“Conversion”) of the Purchased Shares, (C) the amendment to the 2008 Amendment and Restatement of the
Jacksonville Bancorp, Inc. 2006 Stock Incentive Plan (the “Stock Incentive Plan”) as set forth in Schedule IV (the “Incentive Plan Amendment”) to increase the number of shares authorized thereunder to a
number of shares of Common Stock equal to 7.0% of the shares of Common Stock issuable in the Conversion, in order to provide for, among other things, all equity awards to Stephen C. Green and Margaret A. Incandela not to exceed, in the aggregate,
3.50% of the shares of Common Stock issuable in the Conversion, and (D) to authorize an amendment to the Articles of Incorporation to effect, following the Closing, a reverse stock split of the outstanding shares of the Company’s common
stock at a ratio of up to 1-for-20 (the “Reverse Stock Split”), with the exact ratio and timing as determined in the Board’s discretion; 

  
 3 

 
and (iii) resolved to recommend that such shareholders approve each of the Proposals (such recommendation, the “Company Board Recommendation”). After giving effect to the
Board actions described in this Section 2.03(b), no U.S. federal or state “moratorium,” “control share acquisition,” “business combination,” “fair price” or other form of anti-takeover laws or
regulations (such laws or regulations, “Takeover Laws”) are applicable to the execution, delivery or performance of this Agreement or the consummation of the Transaction (including the Private Placement and the issuance of the
Securities). The Company has no shareholder rights plan, poison pill or similar arrangement relating to accumulations of beneficial ownership of Common Stock or a change in control of the Company. 

Section 2.04 Governmental Authority Approvals; Shareholder Approval; No Violations. 

(a) No consents, approvals, permits, orders, authorizations of, exemptions, reviews or waivers by, or notices, reports, filings,
declarations or registrations to or with, any federal, state or local court, governmental, legislative, judicial, administrative authority, Regulatory Authority, taxing authority, agency, commission, body or other governmental entity or self
regulatory organization (each, a “Governmental Authority”) or with any third party are required to be made or obtained by the Company, the Bank or any Subsidiary of either of them in connection with the execution, delivery and
performance by the Company of this Agreement or the sale of the Purchased Shares, the Conversion and the issuance of the Underlying Shares, or any other aspect of the Transaction, except for (i) the Shareholder Approvals, (ii) those
already obtained or made, (iii) filings with the U.S. Securities and Exchange Commission (“SEC”) or any securities or “blue sky” authorities of any other applicable jurisdiction and (iv) filings of amendments to
the Company’s Articles of Incorporation (including the Preferred Stock Designation and the Share Increase Amendment) with the Florida Secretary of State. 
 (b) The only votes of the holders of outstanding securities of the Company required by the Articles of Incorporation, the Company’s bylaws, Applicable Law, Nasdaq Listing Rule 5635, or otherwise, for
the Shareholder Approvals for each of the Proposals are the respective affirmative votes set forth in the following table (in each case, the “Requisite Shareholder Vote”): 

 

			
	 Action
	  	 Requisite Shareholder Vote

	 Share Increase Amendment
	  	Majority of outstanding shares of Common Stock
	 Issuance of Shares of Common Stock upon Conversion
	  	Majority of shares of Common Stock voted on Proposal
	 Incentive Plan Amendment
	  	Majority of shares of Common Stock voted on Proposal
	 Reverse Stock Split
	  	Majority of outstanding shares of Common Stock

 (c) The execution, delivery and performance of this Agreement by the Company does not, and (assuming the
Shareholder Approvals are obtained) the consummation by the Company of the Transaction (including the Private Placement, the filing of the Preferred 

  
 4 

 
Stock Designation and the Share Increase Amendment with the Florida Secretary of State, and the issuances of the Securities) will not, (i) constitute or result in a breach or violation of,
or a default under, the acceleration of any obligations or penalties or the creation of any indebtedness, Lien or exception to title of any kind on the assets of the Company or any Subsidiaries (with or without notice, lapse of time, or both)
pursuant to, or a debt repayment trigger under, agreements to which the Company or any Subsidiary or any of their respective properties is a party or is subject or bound, or any Applicable Law or Nasdaq listing rule to which the Company or any
Subsidiary or any of their respective properties is subject; except for any breach, violation, default, acceleration or debt repayment trigger that, individually or in the aggregate, has not or is not reasonably likely to have a Material Adverse
Effect; or (ii) constitute or result in a breach or violation of, or a default under, the Articles of Incorporation or the bylaws of the Company or the organizational documents of any Subsidiary, in each case, effective as of the Closing Date.

 Section 2.05 Company Capital Stock; Purchased Shares. (a) As of the date hereof, the authorized capital stock of
the Company consists solely of 40,000,000 shares of Common Stock, of which 5,890,880 shares are issued and outstanding, and 10,000,000 shares of preferred stock, par value $0.01 per share, of which no shares have been designated or are issued or
outstanding. As of the date hereof, there are outstanding options on 168,500 shares of Common Stock, at an average exercise price of $12.75 per share. Other than 4,933 shares of restricted Common Stock (“Restricted Stock”) that are
currently outstanding and not vested, there are no other equity incentives or awards of any kind or type issued or outstanding and no shares of Common Stock reserved therefor. The outstanding shares of Common Stock have been duly authorized and are
validly issued, fully paid and nonassessable, were not issued in violation of any preemptive rights, and except for preemptive rights held by CapGen and other investors (the “Initial Preemptive Rights”) pursuant to Stock Purchase
Agreement, dated as of May 10, 2010, by and among the Company, CapGen, and the respective other investors (the “Initial Investors”) named therein (the “Initial Investment Agreement”), all of which have been
waived or exercised except for one Initial Investor, no holders of Company Common Stock have any preemptive or similar rights. No options, rights or warrants have been granted with respect to shares of Common Stock since January 9, 2012.
Section 2.05 of the Company’s disclosure schedule (the “Disclosure Schedule”) shows all outstanding options and shares of Restricted Stock outstanding on the date hereof, as well as those to be granted to Stephen C. Green
and Margaret A. Incandela pursuant to their respective employment agreements. 
 (b) The issuance of the Purchased Shares and the
Underlying Shares have been duly authorized by all necessary corporate action on the part of the Company subject, in the case of the issuance of the Underlying Shares, to the receipt of the Requisite Shareholder Vote, and, when issued and delivered
as provided in this Agreement and the Preferred Stock Designation, all Purchased Shares and Underlying Shares will be duly and validly issued, fully paid and nonassessable, and the issuance thereof will not be subject to any preemptive rights,
except those preemptive rights granted to the Investors hereby. Except with respect to the issuance of the Securities pursuant to this Agreement or as disclosed in Section 2.05(a) above, and with respect to (i) the award of Restricted
Stock to be granted to Stephen C. Green as contemplated by his executive employment agreement dated July 30, 2012 with the Company and the Bank (the “Green Employment Agreement”), subject to the conditions set forth therein,
(ii) the equity incentive to be granted to Margaret A. Incandela as contemplated by her proposed executive employment agreement with the Company and the Bank (the “Incandela Employment 

  
 5 

 
Agreement”), subject to the conditions set forth therein, and (iii) the Public Offering (as defined below), neither the Company nor any Subsidiary has and is bound by any
outstanding subscriptions, options, warrants, calls, commitments, agreements, understandings, arrangements, whether or not binding, of any character calling for the purchase or issuance of, or securities or rights convertible into or exchangeable
for, any shares of capital stock of the Company or any Subsidiary or any securities representing the right to purchase or otherwise receive any shares of capital stock of the Company or any Subsidiary. There are no outstanding securities or
instruments of the Company which contain any mandatory redemption or similar provisions (except for outstanding trust preferred securities, where no redemption provisions are currently applicable), and there are no contracts, commitments,
understandings or arrangements by which the Company is or may become bound to redeem a security of the Company. There are no securities, instruments or agreements containing anti-dilution adjustment or similar provisions that will be triggered by
the issuance of the Purchased Shares or the Underlying Shares, other than the Initial Preemptive Rights. 
 Section 2.06
Company Reports; Financial Statements, Etc. (a) Except as set forth on Section 2.06(a) of the Disclosure Schedule, the Company and each Subsidiary has filed or furnished, as applicable, on a timely basis, all forms, filings,
registrations, submissions, statements, certifications, reports and documents (together with any amendment filed or furnished prior to the date hereof, the “Company Reports”) required to be filed or furnished by it with the SEC
under the Exchange Act or the Securities Act, and all call reports (“Call Reports”) to be filed with the FDIC since December 31, 2008. Each of the Company Reports to the SEC, at the time of its filing or being furnished (or, if
amended, as of the date of the filing or furnishing of such amendment), complied as to form in all material respects with the applicable requirements of the Securities Act and the Exchange Act applicable to the Company Reports, and all Call Reports
filed complied in all material respects with the Federal Financial Institution Examination Council (“FFIEC”) Call Report instructions and requirements. As of their respective dates (or, if amended, as of the date of such amendment),
the Company Reports did not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements made therein, in light of the circumstances in which they were made, not
misleading. 
 (b) The Company’s consolidated financial statements (including, in each case, any notes thereto) contained in
the Company Reports were prepared in accordance with GAAP applied on a consistent basis throughout the periods indicated (except as may be indicated in the notes thereto or, in the case of interim consolidated financial statements, where information
and footnotes contained in such financial statements are not required under the rules of the SEC to be in compliance with GAAP). All consolidated financial statements fairly present, in all material respects, the consolidated financial
position, consolidated results of operations, consolidated changes in shareholder equity and consolidated cash flows of the Company and its consolidated Subsidiaries as of the respective dates thereof and for the respective periods covered thereby
(subject, in the case of unaudited statements, to normal year-end adjustments that were not and that are not expected to be, individually or in the aggregate, material to the Company and its consolidated Subsidiaries taken as a whole). All annual
consolidated financial statements of the Company have been audited by independent registered public accounting firms. The Bank’s consolidated financial statements (including, in each case, any notes and schedules thereto) contained in the Call
Reports: (i) were prepared in accordance with FFIEC instructions applied 

  
 6 

 
on a consistent basis throughout the periods indicated; and (ii) complied as to form, as of their respective filing dates, in all material respects with applicable accounting requirements
and with the published rules and regulations of the FFIEC and FDIC with respect thereto. Such consolidated financial statements fairly present, in all material respects, the consolidated financial position, consolidated results of operations,
consolidated changes in shareholder equity and consolidated cash flows of the Bank and its consolidated Subsidiaries as of the respective dates thereof and for the respective periods covered thereby (subject, in the case of unaudited statements, to
normal year-end adjustments that were not and that are not expected to be, individually or in the aggregate, material to the Bank and its consolidated Subsidiaries taken as a whole). 

(c) As of the date hereof, the Company is in compliance in all material respects with the applicable listing and corporate governance
rules and regulations of the Nasdaq Global Market, its successor or other stock exchange upon which any Company securities are listed, except as disclosed in Section 2.05(c) to the Company Disclosure Schedule, and except for the fact
that Nasdaq has notified the Company, by letter dated July 26, 2012, that the Company had failed to meet the minimum Market Value of Publicly Held Shares required for continued listing on the Nasdaq Global Market, for which the Company has 180
days to cure. 
 (d) The Company maintains internal control over financial reporting (as defined in Rule 13a-15 or 15d-15,
as applicable, under the Exchange Act). Such internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in
accordance with GAAP and includes those policies and procedures that (i) pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the Company,
(ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that receipts and expenditures of the Company are being made only in accordance with
authorizations of management and directors of the Company, and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could have a material
effect on its financial statements. The Company maintains disclosure controls and procedures required by Rule 13a-15 or 15d-15 under the Exchange Act. Such disclosure controls and procedures are designed to ensure that information required to
be disclosed by the Company in the reports that it files or submits under the Exchange Act or otherwise is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Such disclosure controls
and procedures include controls and procedures designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the Company’s
management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. 
 (e) The Company has disclosed, based on the most recent evaluation of its chief executive officer and its chief financial officer prior to the date hereof, to the Company’s auditors and the audit
committee of the Board, (i) any significant deficiencies and material weaknesses in the design or operation of its internal control over financial reporting that are reasonably likely to adversely affect the Company’s ability to record,
process, summarize and report financial information and has identified for the Company’s auditors and audit committee 

  
 7 

 
of the Board any material weaknesses in internal control over financial reporting; and (ii) any fraud, whether or not material, that involves management or other employees who have a
significant role in the Company’s internal control over financial reporting. Since December 31, 2008, no material complaints, allegation, assertion or claim, whether written or oral from any source regarding accounting, internal accounting
controls or auditing matters, and no concerns from Company employees regarding questionable accounting or auditing matters, have been received by the Company. No attorney representing the Company or any Subsidiary, whether or not employed by the
Company or any Subsidiary, has reported evidence of a violation of securities laws, breach of fiduciary duty or similar violation by the Company or any of its officers, directors, employees or agents to the Company’s chief legal officer, audit
committee (or other committee designated for the purpose) of the Board or the Board pursuant to the rules adopted pursuant to Section 307 of the Sarbanes-Oxley Act of 2002. 

(f) There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other
off-balance sheet entity that is required to be disclosed by the Company in its Exchange Act filings, which is not so disclosed. 
 Section 2.07 Compliance with Applicable Laws; Regulatory Filings; Permits. (a) Neither the Company nor its Subsidiaries is in violation of, and has not violated or been charged with a
violation of, any Applicable Law, except for the matters covered by the Enforcement Actions (as defined below) and such violations as have not had and are not reasonably likely to have a Material Adverse Effect. In 2008, the Bank became subject to a
Memorandum of Understanding, by and among the Bank, the Federal Deposit Insurance Corporation (“FDIC”) and the Florida Office of Financial Regulation (the “Florida OFR”) or their delegees, which was replaced by the
Memorandum of Understanding sent to the Bank by letter dated July 13, 2012 (the “2012 MOU”), and the Company is subject to the resolutions adopted by the Company’s board of directors on October 28, 2008 (the
“Federal Reserve Resolutions”) at the request of the Board of Governors of Federal Reserve System or its delegee (the “Federal Reserve”). Herein, the 2012 MOU and the Federal Reserve Resolutions are collectively
called the “Enforcement Actions.” Except for the fact that, as of the date hereof, the Company and the Bank do not meet their minimum capital requirements, and except as otherwise described in Section 2.07 of the Disclosure
Schedule, the Company and the Bank are in compliance in all respects with the Enforcement Actions, and have received no notice from the FDIC, the Florida Division or the Federal Reserve of any breach of or noncompliance with the Enforcement Actions.

 (b) The Company and its Subsidiaries have timely filed all reports and statements, together with any amendments required to be
made with respect thereto (the “Regulatory Reports”), that they were required to file since December 31, 2008 with the Federal Reserve, the FDIC and the Florida OFR (each a “Regulatory Authority”) and any other
Governmental Authority having jurisdiction over its business or any of its assets or properties, and have timely paid all fees and assessments due and payable in connection therewith. As of their respective dates, such reports and statements
complied in all material respects with all the laws, rules and regulations of the applicable Regulatory Authority with which they were filed. As of their respective dates (or, if amended, as of the date of such amendment), the Regulatory
Reports did not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements made therein, in light of the circumstances in which they were made, not misleading.

  
 8 

 (c) The Company and the Subsidiaries hold all material registrations, licenses, permits and
franchises (“Permits”) as are required to conduct their respective businesses as now conducted (including any insurance or securities activities), and all such licenses, permits and franchises are valid and in full force and effect.
No suspension or cancellation of any such Permits has been initiated or threatened, and all filings, applications and registrations with respect thereto are current. 
 (d) The Company and the Subsidiaries are in compliance with Section 409A of the Internal Revenue of 1986, as amended (the “Code”), and Applicable Laws and rules and policies of
applicable Regulatory Authorities with respect to (i) any bank-owned life insurance (“BOLI”) or similar insurance, regardless of where the insurance is held, and (ii) all stock options, equity awards or incentives,
employment and severance agreements, arrangements and understandings. Except as disclosed in Section 2.07 of the Company Disclosure Schedule, all BOLI complies with all Governmental Authority guidelines and policies. 

(e) The operations of the Company and Subsidiaries are and have been conducted at all times in compliance with applicable financial
recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the Bank Secrecy Act, the USA Patriot Act, the money laundering statutes of all applicable jurisdictions, the rules and regulations
thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by any Governmental Authority (collectively, the “Money Laundering Laws”) and no investigation, inquiry, action, suit or
proceeding by or before any court or Governmental Authority or any arbitrator involving the Company or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company, threatened, except, in each case, as is
disclosed in Section 2.07(e) of the Disclosure Schedule. No investigation, suit or proceeding disclosed in Section 2.07(e) of the Disclosure Schedule would reasonably be expected to have a Material Adverse Effect. 

(f) The Company and its Subsidiaries have conducted their operations at all times in compliance with the rules and regulations of the
Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”). Neither the Company nor Subsidiary nor, to the knowledge of the Company, any director, officer, agent, employee or affiliate of the Company or any Subsidiary
is currently subject to any U.S. sanctions administered by OFAC or is not in compliance in all material respects with all OFAC requirements; and the Company will not directly or indirectly use the proceeds of the offering, or lend, contribute or
otherwise make available such proceeds to any subsidiary, joint venture partner or other person or entity, for the purpose of financing the activities of any person currently subject to any U.S. sanctions administered by OFAC. 

(g) Neither the Company nor any of its Subsidiaries, nor any of their respective directors, officers, nor to the Company’s knowledge,
employees, agents or other persons acting at the direction of or on behalf of the Company or any of its Subsidiaries has, in the course of its actions for, or on behalf of, the Company: (a) directly or indirectly, used any corporate funds for
unlawful contributions, gifts, entertainment or other unlawful expenses relating to foreign or domestic political activity; (b) made any direct or indirect unlawful payments to any foreign or domestic governmental officials or employees or to
any foreign or domestic political parties or campaigns from corporate funds; (c) violated any provision of the Foreign Corrupt Practices Act of 1977, as amended; or (d) made any other unlawful bribe, rebate, payoff, influence payment,
kickback or other material unlawful payment to any foreign or domestic government official or employee. 

  
 9 

 (h) The Company has no knowledge of any facts and circumstances, and has no reason to
believe that any facts or circumstances exist, that would cause any of its Subsidiary banking institutions: (i) to be assigned a CRA rating by federal or state banking regulators lower than “satisfactory”; or (ii) to be deemed to
be operating in violation, in any material respect, of the Money Laundering Laws. 
 Section 2.08 No Undisclosed
Liabilities. Neither the Company nor the Subsidiaries have any liabilities of any nature, whether accrued, absolute, matured or unmatured, contingent or otherwise, and whether due or to become due, probable of assertion or not, except
liabilities that (a) were incurred in the ordinary course of business, or (b) are properly reflected in the Company’s most recent consolidated financial statements contained in the Company Reports and the Regulatory Reports to the
extent required to be so reflected or reserved against in accordance with GAAP or requirements of the Governmental Authorities. 

Section 2.09 Absence of Certain Changes. Since December 31, 2011, (a) the Company and Subsidiaries have conducted their
respective businesses in all material respects in the ordinary course, consistent with prior practice; and (b) no event or events have occurred that have had or would be reasonably likely to have, individually or in the aggregate, a Material
Adverse Effect, except for such changes as are contemplated herein and disclosed in Section 2.09 of the Disclosure Schedule. 
 Section 2.10 Tax Matters. (a) For purposes of this Section 2.10, the following definitions shall apply: 
 (i) The term “Group” means, individually and collectively, (A) the Company; (B) the Bank; (C) the affiliated group as defined in Section 1504(a) of the Code of which
the Bank is or has been a member at any time; and (D) any individual, trust, corporation, partnership, limited liability company or any other entity as to which the Company or the Bank is liable for Taxes incurred by such individual or entity
either as a transferee, or pursuant to Treasury Regulations Section 1.1502-6, or pursuant to any other provision of federal, territorial, state, local or foreign law or regulations, including as part of a combined or unitary group. 

(ii) The term “Taxes” means all taxes, however denominated, including any interest, penalties or other additions that
may become payable in respect thereof, imposed by any Governmental Authority, including all income or profits taxes (including federal income taxes and state income taxes), alternative or add-on minimum taxes, estimated taxes, payroll and employee
withholding taxes, back-up withholding and other withholding taxes, unemployment insurance, social security taxes, sales and use taxes, value added taxes, ad valorem taxes, excise taxes, franchise taxes, gross receipts taxes, business license taxes,
occupation taxes, real and personal property taxes, stamp taxes, environmental taxes, document transfer taxes, workers’ compensation and Pension Benefit Guaranty Corporation premiums, self dealing or prohibited transactions taxes, customs,
duties, capital stock and intangibles taxes, and other obligations of the same or of a similar nature to any of the foregoing, which the Group is required to pay, withhold or collect, whether disputed or not. 

  
 10 

 (iii) The term “Returns” means all reports, estimates, declarations of
estimated Taxes, claims for refunds, information statements and returns required to be prepared or filed in connection with, any Taxes, employee agreement or Plan, including any schedule or attachment thereto, and including any amendment thereof.

 (b) All Returns required to be filed by or on behalf of any members of the Group prior to the Closing Date have been, or will
be, duly filed on a timely basis, subject to any applicable extensions. Such Returns are true, correct and complete. All Taxes owed by any members of the Group (whether or not shown on any Return) have been paid in full on a timely basis, and no
other Taxes are owing or payable by the Group with respect to items or periods covered by such Returns or with respect to any taxable period ending on or before the date of this representation and warranty for which a Return was due prior to such
date. No claim has ever been made by any Governmental Authority for any jurisdiction in which any member of the Group does not file Returns that it is or may be subject to taxation by that jurisdiction. No security interests, liens, encumbrances,
attachments or similar interests exist on or with respect to any of the assets of the Group that arose in connection with any failure or alleged failure to pay any Taxes. Each member of the Group has withheld and paid all Taxes required to have been
withheld and paid in connection with amounts paid or owing to any and all officers, directors, employees and agents (including any independent contractor, foreign person or other third person) in compliance with all tax withholding provisions of
applicable federal, state, local and foreign law (including income, social security, employment tax withholding, and withholding under Sections 1441 through 1446 of the Code). The Bank has timely complied with all requirements under Applicable Laws
relating to information, reporting and withholding and other similar matters for customer and other accounts (including back-up withholding and furnishing of Forms 1099 and all similar reports). 

(c) The amount of the Group’s liability for unpaid Taxes for all periods ending on or before the last day of the month before the
Closing Date (including accruals for any exposure item) shall not, in the aggregate, exceed the amount of the liability accruals for Taxes, as such accruals are reflected on the Group’s most recent consolidated balance sheet contained in the
Company Reports. All such accruals are, or will be, recorded in accordance with GAAP. 
 (d) The Company has made and caused the
Bank or any other member of the Group to make available to the Investor true, correct and complete copies of all federal and state income tax Returns for all periods that are open for federal and state tax purposes and all other Returns, including
income tax audit reports, statements of income or gross receipts tax, franchise tax, sales tax and transfer tax, deficiencies, and closing or other agreements relating to income or gross receipts tax, franchise tax, sales tax and transfer tax
received by the Group or on behalf of the Group, as well as draft Returns for the Group for all Taxes for all periods ending on or before the Closing Date. 
 (e) (i) No deficiencies have been asserted with respect to Taxes of the Group or any members of the Group that remain unpaid; (ii) none of the Group or any of its members is a party to any action or
proceeding for assessment or collection of Taxes, and no such action or 

  
 11 

 
proceeding has been asserted or threatened against the Group, any member of the Group or any of their respective assets; and (iii) no waiver or extension of any statute of limitations is in
effect with respect to any Taxes or Returns of the Group or any member of the Group. The Returns of the Group and any of its members for all tax years for which the statute of limitations has not expired have never been audited by a Governmental
Authority, nor is any such audit in process, pending or, to the knowledge of the Company, threatened. Neither the Company nor any director or officer (or employee responsible for Tax matters) of any other member of the Group is aware of any facts or
circumstances that, if known by any Governmental Authority would be reasonably likely to cause the Governmental Authority to assess any additional Taxes for any period for which Returns have been filed. 

(f) No member of the Group has (i) been or shall be required to include any adjustment in taxable income for any Tax period (or
portion thereof) ending after the Closing in accordance with Section 481 of the Code or any comparable provision under state or foreign Tax laws as a result of transactions or events occurring prior to the Closing; (ii) filed any
disclosure under Section 6662 of the Code or comparable provisions of state, local or foreign Law to prevent the imposition of penalties with respect to any Tax reporting position taken on any Tax Return; (iii) engaged in a
“reportable transaction,” as defined in Treasury Regulation Section 1.6011-4(b); (iv) ever been a member of a consolidated, combined, unitary or aggregate group of which the Company or the Bank was not the ultimate parent
company; (v) been the “distributing corporation” or the “controlled corporation” (in each case, within the meaning of Section 355(a)(1) of the Code) with respect to a transaction described in Section 355 of the
Code (A) within the two-year period ending as of the date of this Agreement, or (B) in a distribution that would otherwise constitute part of a “plan” or “series of related transactions” (within the meaning of
Section 355(e) of the Code); (vi) incurred any actual or potential liability under Treasury Regulations Section 1.1502-6 (or any comparable or similar provision of federal, state, local or foreign Law), as a transferee or successor,
as a result of any contractual obligation, or otherwise for any Taxes of any person other than the Company or the Bank; or (vii) ever been a “United States real property holding corporation” within the meaning of Section 897 of
the Code. 
 (g) No member of the Group shall be required to include any item of income in, or exclude any item of deduction
from, taxable income for any period (or any portion thereof) ending after the Closing Date as a result of any: (i) installment sale or other open transaction disposition made on or prior to the Closing Date; (ii) prepaid amount received on
or prior to the Closing Date; (iii) a closing agreement described in Section 7121 of the Code or any corresponding provision of state of foreign Tax Law executed on or prior to the Closing Date; or (iv) any change in method of
accounting for a taxable period or portion thereof ending on or before the Closing Date. 
 (h) There has been no “ownership
change,” as defined in Section 382 of the Code, with respect to any member of the Group. 
 Section 2.11
Transactions with Affiliates. Except as disclosed in the Company Reports, since November 16, 2010, no current or former officer, director or employee of the Company or the Subsidiaries, any of their respective family members, any other
corporation or organization of which any of the foregoing persons is an officer, director or beneficial owner of 10% or more 

  
 12 

 
of any class of its equity securities, or any trust or other estate in which any of the foregoing persons has a substantial beneficial interest or as to which such person serves as a trustee or
in a similar capacity, nor any current or former affiliate of the Company or the Subsidiaries: 
 (a) has any material interest
in any property, real or personal, tangible or intangible, used in or pertaining to the business of the Bank or in any transaction or series of similar transactions to which the Bank is a party; 

(b) is indebted to the Company or the Subsidiaries, except as set forth in Section 2.11(b) of the Disclosure Schedule and except for
normal business expense advances and for loans and extension of credit (i) made in the ordinary course of the Bank’s business, (ii) on substantially the same terms, including interest rates and collateral, as those prevailing at the
time for comparable loans with unrelated persons, (iii) that did not involve more than the normal risk of collectability or present other unfavorable features, and (iv) which are not disclosed as nonaccrual, past due, restructured or
potential problems in the Company’s filings with any Governmental Authority; 
 (c) holds indebtedness of the Company or any
of the Subsidiaries, except for deposit obligations owed by the Bank, and amounts due under normal salary or reimbursement or ordinary business expenses, except as shown in Section 2.11(c) of the Disclosure Schedule (and, in such event, unless
further noted in Section 2.11(c) of the Disclosure Schedule, each such person to whom the Company or any Subsidiary is indebted has fully performed and is not in default or in breach of such person’s agreements to extend credit to the
Company or any Subsidiary and each such person has not refused or indicated such person’s intent not to perform under such agreements); 
 (d) is a party to a material agreement as described in Section 2.14 with the Company or the Subsidiaries other than agreements related to employment or service as a director, except as
expressly provided for by this Agreement or as described in Section 2.11(d) of the Disclosure Schedule; and 
 (e) has any
other relationship or has engaged or engages in any other transaction or series of similar transactions that would be required to be disclosed pursuant to Item 404 of SEC Regulation S-K. 
 All of the transactions referred to in this Section 2.11 are transactions that were entered into in the ordinary course of business on an arm’s-length business pursuant to normal business
terms and conditions. Further, in the case of loans and extensions of credit by the Company or any of its Subsidiaries to any such person, all such loans and extensions of credit also had the same terms, including interest rates and collateral, as
those prevailing at the time for comparable loans to persons unrelated to the lender, and did not involve more than the normal risk of collectability or other unfavorable features. 

Section 2.12 Loans. (a) With respect to each outstanding loan, lease or other extension of credit or commitments to extend
credit by the Bank (a)(i) the Bank has duly performed in all material respects all of its obligations thereunder to the extent that such obligations to perform have accrued; (ii) all documents and agreements necessary for the Bank to enforce
such loan, 

  
 13 

 
lease or other extension of credit are in existence and in the Bank’s possession; (iii) no claims, counterclaims, set-off rights or other rights have been asserted against the Bank,
nor, to the knowledge of the Company, do the grounds for any such claim, counterclaim, set-off rights or other rights exist, with respect to any such loans, leases or other extensions of credit which could impair the collectability thereof; and
(iv) each such loan, lease and extension of credit has been, in all material respects, originated and serviced in accordance with the Bank’s then-applicable underwriting guidelines and policies, the terms of the relevant credit documents
and agreements and Applicable Law, including Federal Reserve Regulations O and W, and applicable limits on loans to one borrower under Applicable Law. 
 (b) There are no loans, leases, other extensions of credit or commitments to extend credit of the Bank that have been or should have been classified by the Bank or its regulatory examiners, auditors or
other credit examination personnel as “watch,” “other assets (or loans) especially mentioned,” “substandard,” “doubtful,” “classified,” “criticized,” “loss” or any comparable
classification, which have not been so classified. 
 (c) Except as disclosed in the Company Reports, there are no loans or
extensions of credit owed to the Bank as to which any payment of principal, interest or any other amount is 90 days or more past due. 
 (d) The allowances for possible loan and lease losses shown on the financial statements included in any Company Report were, on the respective filing dates, adequate in all respects under the requirements
of GAAP and applicable regulatory accounting practices, as applicable, and in each case consistently applied, to provide for possible loan and lease losses as of such filing date, and were in accordance with the safety and soundness standards
administered by, and the practices, procedures, requests and requirements of, the applicable Regulatory Authority. 
 Section
2.13 Other Activities of the Company and the Bank. Except as may be described in Section 2.13 of the Disclosure Schedule, neither the Company nor the Bank, nor any officer, director or employee of the Company or the Bank acting in an
agency capacity on behalf of the Company or Bank, is authorized to engage in or conduct, and does not engage in or conduct, any securities sales, underwriting, brokerage, management or dealing activities, whether as principal or agent, either
directly or under contractual or other arrangements with third parties. The Bank does not engage in any trust or custodial activities. 
 Section 2.14 Material Agreements; No Defaults. There are no material breaches, violations, defaults, or events that have occurred, that with notice, the lapse of time and/or the occurrence of any
other event would constitute a default, or allegations or assertions of any of the foregoing by the Company or the Subsidiaries, as the case may be, or, to the knowledge of the Company, any other party, with respect to any contract or agreement to
which the Company or any of its Subsidiaries is a party that is a “material contract” within the meaning of Item 601(b)(10) of Regulation S-K and that is to be performed in whole or in part after the date of this Agreement, and each
such contract or agreement has been filed as an exhibit to the Company’s SEC filings pursuant to Item 601 of Regulation S-K. 

  
 14 

 Section 2.15 Company Benefit Plans. (a) For purposes of this Agreement,
“Benefit Plan” means all employee welfare benefit plans within the meaning of Section 3(1) of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”), all employee pension benefit plans within
the meaning of Section 3(2) of ERISA, including, but not limited to, plans that provide retirement income or result in a deferral of income by employees for periods extending to termination of employment or beyond, and plans that provide
medical, surgical, or hospital care benefits or benefits in the event of sickness, accident, disability, death or unemployment, and all other employee benefit agreements or arrangements, including, but not limited to, all bonus, incentive, deferred
compensation, vacation, stock purchase, stock option, stock award, severance, employment, change of control, golden-parachute, consulting, dependent care, cafeteria, employee assistance, scholarship, or fringe benefit or similar plans, programs,
agreements or policies, in each case sponsored or maintained by the Company or each person that, together with the Company, would be treated as a single employer under Section 414 of the Code (such person, an “ERISA Affiliate”)
or to which the Company or an ERISA Affiliate contributes on behalf of its employees, in all cases whether written, unwritten or otherwise, funded or unfunded, and whether or not ERISA is applicable to such plan, program, agreement or policy.

 (b) With respect to each Benefit Plan, the Company and each ERISA Affiliate, as well as each Benefit Plan, have complied, and
are in compliance with all provisions of ERISA, the Code and all laws and regulations applicable to such Benefit Plan, including the Pension Protection Act of 2006. Each Benefit Plan has been administered in accordance with its terms and all laws
and regulations applicable to such Benefit Plan, including ERISA and the Code. Each Benefit Plan intended to be qualified under Section 401(a) of the Code has obtained a favorable determination or opinion letter as to its qualified status under
the Code, or application for such letter will be timely filed, or if the Benefit Plan intended to be qualified under Section 401(a) of the Code is maintained pursuant to a prototype or “volume submitter” plan document, the sponsor of
the prototype or volume submitter document has obtained from the National Office of the Internal Revenue Service an opinion or notification letter stating that the form of the prototype or volume submitter document is acceptable for the
establishment of a qualified retirement plan under Section 401(a) of the Code. 
 (c) Except for liabilities fully reserved
for or identified in the financial statements contained in the Company Reports, (i) no claim has been made, or to the knowledge of the Company threatened, against the Company or any ERISA Affiliate related to the employment and compensation of
employees or any Benefit Plan, including any claim related to the purchase of employer securities or to expenses paid under any defined contribution pension plan; and (ii) no event has occurred, and there exists no condition or set of
circumstances, which could reasonably be expected to subject the Company or any Subsidiary to any liability under the terms of, or with respect to, any Benefit Plan or under ERISA, the Code or any other Applicable Law. 

(d) Neither the Company nor any ERISA Affiliate has ever maintained, established, sponsored, participated in, or contributed to, any
(i) Benefit Plan that is or was subject to Title IV of ERISA or Section 412 of the Code; (ii) “multiemployer plan” (as defined in Section 4001(a)(3) of ERISA); (iii) “multiple employer plan”
within the meaning of Section 4001(a)(3) of ERISA or subject to Section 413(c) of the Code; or (iv) “welfare benefit fund” within the meaning of Section 419 of the Code. 

  
 15 

 (e) Other than (i) the award and vesting of Restricted Stock contemplated by the Green
Employment Agreement, subject to the conditions set forth therein, and (ii) the equity incentive contemplated by the Incandela Employment Agreement, subject to the conditions set forth therein, neither the execution and delivery of this
Agreement, nor the consummation of the Transaction (including the Private Placement and the issuance of the Securities) will (i) result in any payment (including severance, unemployment compensation, “excess parachute payment” (within
the meaning of Section 280G of the Code), forgiveness of indebtedness or otherwise) becoming due to any current or former employee, officer or director of the Company or any Subsidiary from the Company or any ERISA Affiliate under any Benefit
Plan or otherwise; (ii) increase any benefits otherwise payable under any Benefit Plan; (iii) result in any acceleration of the time of payment or vesting of any such benefits; (iv) require the funding or increase in the funding of
any such benefits; or (v) result in any limitation on the right of the Company or any ERISA Affiliate to amend, merge, terminate or receive a reversion of assets from any Benefit Plan or related trust; and 

(f) Neither the Company nor any ERISA Affiliate has taken, or permitted to be taken, any action that required, and no circumstances exist
that will require the funding, or increase in the funding, of any benefits or resulted, or will result, in any limitation on the right of the Company or any ERISA Affiliate to amend, merge, terminate or receive a reversion of assets from any Benefit
Plan or related trust. 
 Section 2.16 Environmental Matters. (a) For purposes of this Section 2.16,
(i) “Environmental Law” means any federal, state, local or foreign statute, law, regulation, order, decree, permit, authorization, opinion, common law or agency requirement relating to: (A) the protection, investigation or
restoration of the environment, health, safety, or natural resources, (B) the handling, use, presence, disposal, release or threatened release of any Hazardous Substance or (C) noise, odor, indoor air, employee exposure, wetlands,
pollution, contamination or any injury or threat of injury to persons or property relating to any Hazardous Substance; and (ii) “Hazardous Substance” means any substance that is: (A) listed, classified or regulated
pursuant to any Environmental Law, (B) any petroleum product or by-product, asbestos-containing material, lead-containing paint or plumbing, polychlorinated biphenyls, radioactive material or radon, and (C) any other substance which may be
the subject of regulatory action by any Government Entity in connection with any Environmental Law. 
 (b) Except as,
individually or in the aggregate, has not had or would not be reasonably expected to have a Material Adverse Effect, the Company and the Subsidiaries are in compliance with all applicable Environmental Laws and, to the knowledge of the Company,
(i) no real property currently or formerly owned or operated by the Company or any of its subsidiaries is or has been contaminated with any Hazardous Substance at any time; (ii) neither the Company nor any of its subsidiaries could be
deemed the owner or operator under any Environmental Law of any property which is or has been contaminated with any Hazardous Substance; and (iii) no Hazardous Substance has been transported from any of the properties owned or operated by the
Company or one of the Subsidiaries, other than as permitted under applicable Environmental Law. Since December 31, 2008, neither the Company nor any of the 

  
 16 

 
Subsidiaries has received any written notice from any Governmental Authority or any third party indicating that the Company or any of the Subsidiaries is in violation of any Environmental Law,
other than with respect to any matter that has been resolved, and such violation, if any, would not, individually or in the aggregate, be reasonably expected to have a Material Adverse Effect. The Company and the Subsidiaries are not subject to any
court order, administrative order or decree or any indemnity or other agreement arising under or related to any Environmental Law. 
 Section 2.17 Labor Matters. No employees of the Company or any of the Subsidiaries are represented by any labor union, nor are any collective bargaining agreements otherwise in effect with respect
to such employees. No labor organization or group of employees of the Company or any of the Subsidiaries has made a pending demand for recognition or certification, and there are no representation or certification proceedings or petitions seeking a
representation proceeding presently pending or, to the knowledge of the Company, threatened to be brought or filed with the National Labor Relations Board or any other labor relations tribunal or authority. There are no organizing activities,
strikes, work stoppages, slowdowns, lockouts, material arbitrations or material grievances, or other material labor disputes pending or threatened against or involving the Company or any of the Subsidiaries. The Company is in material compliance
with all U.S. federal, state, local and foreign laws and regulations relating to employment and employment practices, terms and conditions of employment and wages and hours. There are no disputes with any current or former officers, directors or
employees of the Company or its Subsidiaries. 
 Section 2.18 Insurance. The Company and each of the Subsidiaries are
presently insured, and since December 31, 2008 have been insured, for reasonable amounts with financially sound and reputable insurance companies against such risks as companies engaged in a similar business would, in accordance with good
business practice, customarily be insured. As of the date hereof, all such insurance policies are in full force and effect and no written notice of cancellation has been received. There is no existing material default by any insured thereunder. The
Company maintains directors’ and officers’ liability insurance (“D&O Insurance”) in the amount of $5 million and has provided each Investor a copy of, or access to, its policy of D&O Insurance as part of
Section 2.18 of the Disclosure Schedule. 
 Section 2.19 No Integration. Neither the Company nor the Subsidiaries,
nor any of their respective affiliates, nor any person acting on their behalf, has offered or issued any securities of the Company that would be integrated with the sale of the Securities for purposes of the Securities Act, nor will the Company or
the Subsidiaries or affiliates take any action or steps (and neither have they taken any action or steps) that would require registration of any of the Securities under the Securities Act or cause the offering of the Securities to be integrated with
other offerings. Assuming the accuracy of the representations and warranties of the Investor contained in this Agreement, the offer and sale of the Purchased Shares by the Company to the Investor pursuant to this Agreement will be exempt from the
registration requirements of the Securities Act. 
 Section 2.20 No Change of Control. Except as set forth in
Section 2.20 of the Disclosure Schedule, the Company shall not, and neither the execution and delivery of this Agreement nor the Transaction (including the Private Placement and the Conversion) will, trigger any payment, termination,
acceleration or vesting (to the extent not previously vested) of 

  
 17 

 
any payment or other rights of any type under any “change of control” or similar provision in any agreements to which the Company, the Bank or any of the Subsidiaries is a party,
including any equity awards (including stock options and Restricted Stock), employment, “change in control,” severance or other compensatory agreements and any Benefit Plan, which results in payments to the counterparty, the acceleration
or vesting of benefits or payments (including debt repayments) (collectively, “Change of Control Benefits”). Notwithstanding anything to the contrary in the immediately previous sentence, no provision of the awards of an aggregate
of 1,990 shares of Restricted Stock in 2011 to employees (other than executive officers or directors) of the Company and the Bank shall constitute Change of Control Benefits. Section 2.20 of the Disclosure Schedule also lists each recipient of
Restricted Stock in 2011 that has shares of unvested Restricted Stock as of the date hereof, along with the number of such unvested Restricted Shares each such recipient holds as of the date hereof. The Company has provided true and complete copies
of duly executed Waiver and Acknowledgment Agreements substantially in the form of Schedule V from each of the Company’s and the Bank’s directors and executive officers, including Scott M. Hall, Valerie A. Kendall, Price W.
Schwenck, Stephen C. Green and Margaret A. Incandela, waiving all rights, if any, which he or she might otherwise have to any Change of Control Benefits as a result of this Agreement or the Transaction 

Section 2.21 Properties. (a) Except in any such case as is not, individually or in the aggregate, reasonably likely to have a Material
Adverse Effect, the Company or one of the Subsidiaries has good, valid and marketable title to all such real personal and mixed property owned by the Company, free and clear of any Liens, and there are no outstanding options to purchase or sell real
property, except for dispositions of other real estate owned (“OREO”) in the ordinary course or pursuant to the Company’s asset disposition plans. 
 (b) The Company has made available to the Investor copies of all material leases, subleases and other agreements under which the Company or any of the Subsidiaries uses or occupies or has the right to use
or occupy, now or in the future, any real, personal or mixed property (the “Leases”) (including all modifications, amendments, supplements, waivers and side letters thereto). Except as has not had and would not reasonably be
expected to have, individually or in the aggregate, a Material Adverse Effect, (i) each Lease is valid, binding and in full force and effect; and (ii) to the knowledge of the Company, no termination event or condition or uncured default of
a material nature on the part of the Company or, if applicable, any of the Subsidiaries exists under any Lease. The Company and each of the Subsidiaries has a good and valid leasehold interest in each parcel of real property leased by it free and
clear of all Liens, except for Liens which do not interfere with the use or materially affect the value of the property subject to the Lease. Neither the Company nor any of the Subsidiaries has received written notice of any pending, and to the
knowledge of the Company there is no threatened, condemnation or similar proceeding with respect to any property leased pursuant to any of the real property leases. 
 (c) The Company and the Subsidiaries have good, valid and marketable title to their owned assets and properties, or in the case of assets and properties they lease, license, or have other rights in, good
and valid rights by lease, license or other agreement to use, all material assets and properties (in each case, tangible and intangible) necessary to permit the Company and the Subsidiaries to conduct their respective businesses as currently
conducted, except, in all cases, as would not be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect. 

  
 18 

 Section 2.22 Computer and Technology Security. The Company and the Subsidiaries have
taken all reasonable steps to safeguard the information technology systems utilized in the operation of the business of the Company and the Subsidiaries consistent with the guidance of its Regulatory Authorities, including the implementation of
procedures to ensure that such information technology systems are free from any disabling codes or instructions, timer, copy protection device, clock, counter or other limiting design or routing and any “back door,” “time bomb,”
“Trojan horse,” “worm,” “drop dead device,” “virus,” or other software routines or hardware components that in each case permit unauthorized access or the unauthorized disablement or unauthorized erasure of
data or other software by a third party, and to date there have been no successful unauthorized intrusions or breaches of the security of the information technology systems. 
 Section 2.23 Data Privacy. The Company and the Subsidiaries’ respective businesses have complied with and, as presently conducted, are in compliance with, all Applicable Laws applicable to
data privacy, data security, or personal information, as well as industry standards applicable to the Company and the Subsidiaries. The Company and the Subsidiaries have complied with, and are presently in compliance with, its and their respective
policies applicable to data privacy, data security and personal information. Neither the Company nor any of the Subsidiaries has experienced any incident in which personal information or other sensitive data was or may have been stolen or improperly
accessed, and neither the Company nor any of the Subsidiaries is aware of any facts suggesting the likelihood of the foregoing, including any breach of security or receipt of any notices or complaints from any person regarding personal information
or other data. 
 Section 2.24 No Restrictive Covenants. There are no agreements to which the Company or any Subsidiary
is a party or by which the Company or any Subsidiary or any of their respective properties, assets, directors or officers are subject or bound which limits or purports to limit the freedom of the Company or any Subsidiary or any of their respective
directors or officers affiliates to compete in any material line of business or any geographic area to which the Company or any Subsidiary is a party or subject, except for employment, severance, equity awards and similar written agreements between
the Company and/or the Bank and their respective directors and officers disclosed in Section 2.24 of the Disclosure Schedule that, for the benefit of the Company and its Subsidiaries, restrict the activities of such directors or
officers. 
 Section 2.25 Litigation. Other than matters in the ordinary course of its banking business and which have
not had and which are not reasonably likely to have, individually or in the aggregate, a Material Adverse Effect, (a) except for the Enforcement Actions, no civil, criminal or administrative inquiry, litigation, claim, action, suit, hearing,
arbitration, investigation, inquiry, formal or informal enforcement action, civil money penalty or other proceeding before any Governmental Authority or arbitrator is pending or, to the actual knowledge of any of the executive officers of the
Company, threatened against the Company or any Subsidiary; (b) except for the Enforcement Actions, none of the Company nor any Subsidiaries are a party to, and none of the Company nor the Subsidiaries, nor any of their respective assets or
businesses, are subject to or the subject of, any existing, pending or 

  
 19 

 
threatened written agreement, stipulation, conditional approval, memorandum of understanding, notice of determination, judgment, supervisory agreement, order, written directive, actual or
proposed civil money penalty or restitution order, consent order or other agreement with or order of any Governmental Authority; and (c) there are no facts or circumstances that could result in any claims against, or obligations or liabilities
of, the Company or any Subsidiary, except with respect to (a), (b) and (c) for those that are not, individually or in the aggregate, reasonably likely to have a Material Adverse Effect. 

Section 2.26 [Intentionally Omitted.] 
 Section 2.27 No Brokers; etc. Neither the Company nor any Subsidiary nor any of their respective officers, directors, employees, agents or representatives has employed any broker or finder or
incurred any liability for any brokerage fees, commissions or finders or similar fees in connection with the Transaction (including the Private Placement and the issuance of the Securities), except the Company has retained and will compensate
Sandler O’Neill and Partners, L.P., as its exclusive placement agent (“Placement Agent”), as disclosed in Section 2.27 of the Disclosure Schedule. 
 Section 2.28 Voting of Shares by Directors and Executive Officers. The Company’s directors and executive officers have agreed pursuant to the Support Agreement attached as
Schedule VI hereto (the “Support Agreement”) to vote all shares of Company Common Stock which they beneficially own in favor of approving the Proposals, and all other matters requiring a vote of the Company’s
shareholders in connection with the Transaction. The Company agrees that it shall enforce such agreements. 
 Section 2.29
Risk Management Instruments. Except as has not had or would not reasonably be expected to have a Material Adverse Effect, all material derivative instruments, including, swaps, caps, floors and option agreements, whether entered into for the
Company’s own account, or for the account of one or more of the Company Subsidiaries, were entered into (1) only in the ordinary course of business, (2) in accordance with prudent practices and in all material respects with all
applicable laws, rules, regulations and regulatory policies and (3) with counterparties believed to be financially responsible at the time; and each of them constitutes the valid and legally binding obligation of the Company or one of its
Subsidiaries, enforceable in accordance with its terms. Neither the Company nor any of its Subsidiaries, nor, to the knowledge of the Company, any other party thereto, is in breach of any of its material obligations under any such agreement or
arrangement. 
 Section 2.30 Capitalization. As of June 30, 2012, the Bank had the capital ratios shown in its Call
Report as of such date. As of June 30, 2012, the Company and the Bank had less capital than the minimums required under Federal Reserve guidelines and the 2012 MOU, respectively. 

Section 2.31 Investment Company. Neither the Company nor any of its Subsidiaries is required to be registered as, and is not an
affiliate of, and immediately following the Closing will not be required to register as, an “investment company” within the meaning of the Investment Company Act of 1940, as amended. 

  
 20 

 Section 2.32 Price of Common Stock. The Company has not taken, and will not take,
directly or indirectly, any action designed to cause or result in, or that has constituted or that might reasonably be expected to constitute, the stabilization or manipulation of the price of the Common Stock to facilitate the sale or resale of the
Purchased Shares. 
 Section 2.33 Shell Company Status. The Company is not, and has never been, an issuer identified in
SEC Rule 144(i)(1). 
 Section 2.34 Reservation of Purchased Shares. The Company has reserved, and will continue to
reserve, free of any preemptive or similar rights of shareholders of the Company (other than the Initial Preemptive Rights that have not been waived or have not expired), a number of unissued shares of Preferred Stock, sufficient to issue and
deliver the Purchased Shares at Closing. 
 Section 2.35 No Substantially Similar Agreement. The Company has no other
agreements with any other Investor to purchase shares of Common Stock on terms that are not substantially similar to the terms of this Agreement. The Company has no other agreements, understandings or arrangements, including side letters with any
Investor that are not disclosed in Section 2.35 of the Disclosure Schedule, to purchase shares of Common Stock on terms that are different than as set forth in this Agreement. 

Section 2.36 Disclosure. No event or circumstance has occurred or information exists with respect to the Company or any of its
Subsidiaries or its or their business, properties, operations or financial conditions, which, under applicable law, rule or regulation, requires public disclosure or announcement by the Company, but which has not been so publicly announced or
disclosed, except for the announcement of the Private Placement pursuant to Section 6.13. 
 ARTICLE III.

 REPRESENTATIONS AND WARRANTIES OF THE INVESTORS 

Each Investor, for itself and for no other Investor, represents and warrants to the Company, severally and not jointly, as follows:

 Section 3.01 Organization. The Investor is duly organized and validly existing under the laws of the jurisdiction of
its organization. 
 Section 3.02 Bank Holding Company Status, etc. Except for CapGen, no Investor is, and no Investor
will become, a “company” in “control” of the Bank or the Company for BHC Act purposes as a result of this Agreement or the Transactions. 
 (a) Prior to Closing, CapGen will have obtained all necessary Federal Reserve approvals to own the Purchased Shares. 
 (b) No Investor has or is acting in concert with any other person. Except for CapGen, assuming the accuracy of the representations and warranties of the Company, no Investor, either acting alone or
together with any other person will, directly or indirectly, own, control or have the power to vote, after giving effect to the issuance to it of the Underlying 

  
 21 

 
Shares upon conversion of its Purchased Shares, in excess of 9.9% of the outstanding shares of the Company’s voting stock of any class or series. Without limiting the foregoing, each
Investor represents and warrants that it does not and will not as a result of its purchase or holding of the Purchased Shares, Underlying Shares, or any other securities of the Company have “control” of the Company or the Bank, and has no
present intention of acquiring “control” of the Company or the Bank for purposes of the BHCA or the Change in Bank Control Act. 
 Section 3.03 Authorization. This Agreement has been duly authorized, executed and delivered by the Investor and constitutes the valid and binding agreement of the Investor enforceable against it in
accordance with its terms, except as enforcement thereof may be limited by bankruptcy, insolvency, reorganization, moratorium or other similar laws relating to or affecting creditors’ rights generally or by general equitable principles.

 Section 3.04 Accredited Investor, etc. 
 (a) The Investor acknowledges that the Purchased Shares have not been registered under the Securities Act or under any state securities laws. The Investor (i) is acquiring the Purchased Shares
pursuant to an exemption from registration under the Securities Act solely for investment with no present intention to distribute any of the Purchased Shares to any person, (ii) will not sell or otherwise dispose of any of the Purchased Shares,
except in compliance with the registration requirements or exemption provisions of the Securities Act and any other applicable securities laws and the Federal Reserve’s Policy Statement on Equity Investments in Banks and Bank Holding Companies
(Sept. 22, 2008) (the “Federal Reserve Policy Statement”), (iii) is an Accredited Investor and a “qualified institutional buyer” under SEC Rule 144A, and (iv) has such knowledge and experience in financial and
business matters and in investments of this type, including knowledge of the Company, that it is capable of evaluating the merits and risks of the Company and of its investment in the Securities and of making an informed investment decision. The
Investor is not a registered broker-dealer under Section 15 of the Exchange Act or a person engaged in the business of being a broker-dealer. 
 (b) The Investor has, either alone or through its representatives: 
 (i) consulted
with its own legal, regulatory, tax, business, investment, financial and accounting advisers in connection herewith to the extent it has deemed necessary in its sole discretion in connection with this Agreement and the Transactions; 

(ii) had a reasonable opportunity to ask such questions as it has deemed necessary of, and to receive answers from, the officers and
representatives of the Company and the Bank concerning the Company’s and the Bank’s financial condition and results of operations, the business plan for the Company and the Bank, all employment agreements and benefit plans and other
contractual arrangements among the Company, the Bank and their respective management teams, the terms and conditions of the Transaction (including the Private Placement and the issuance of the Securities), its regulatory situation and any additional
relevant information that the Company possesses, and any such questions have been answered to its satisfaction; 

  
 22 

 (iii) had the opportunity to review and evaluate the following, among other things, in
connection with its investment decision with respect to the Securities: (A) all publicly available records and filings concerning the Company and the Bank, as well as all other documents, records, filings, reports, agreements and other
materials provided by the Company regarding its and the Bank’s business, operations and financial condition sufficient to enable it to evaluate its investment; (B) certain investor presentation materials (as these may be supplemented from
time to time) that summarize this offering of Securities and the Transaction; and (C) this Agreement, the Registration Rights Agreement and the exhibits, schedules and appendices attached hereto and thereto (collectively, the documents referred
to in clauses (B) and (C), the “Private Placement Documents”); and 
 (iv) made its own investment
decisions based upon its own judgment, due diligence and advice from such advisers as it has deemed necessary and not upon any view expressed by any other person, including any other Investor. The Investor has not relied upon any other Investor in
making its decisions to purchase Securities, or to enter into this Agreement or participate in the Transaction. Neither such inquiries nor any other due diligence investigations conducted by the Investor or its advisors or representatives, if any,
shall modify, amend or affect the Investor’s right to rely on the Company’s representations and warranties contained herein. The Investor understands that (i) its investment in the Securities is speculative and involves a high degree
of risk and it is able to afford a complete loss of such investment, (ii) no representation is being made as to the business or prospects of the Company or the Bank after completion of the Transaction or the future value of the Securities, and
(iii) no representation is being made as to any projections or estimates delivered to or made available to the Investors (or any of its affiliates or representatives) of the Company’s or the Bank’s future assets, liabilities,
shareholders’ equity, regulatory capital ratios, net interest income, net income or any component of any of the foregoing or any ratios derived therefrom. The Investor, either alone or together with its representatives, if any, has the
knowledge, sophistication and experience in financial and business matters as to fully understand and be capable of evaluating the merits and risks of an investment in the Securities. 

(c) The Investor acknowledges that the information in the Private Placement Documents is as of the date thereof and may not contain all of
the terms and conditions of the offering and sale of the Securities and the Transaction, and understands and acknowledges that it is the Investor’s responsibility to conduct its own independent investigation and evaluation of the Company and
the Subsidiaries, the Bank and the Transaction, including (i) the business prospects and future operations of the Company after completion of the Transaction, if applicable, and (ii) the management team that will operate and manage the
Company following the completion of the Transaction. The Investor is not relying upon, and has not relied upon, any advice, statement, representation or warranty made by any person except for the express written statements, representations and
warranties of the Company made or contained in this Agreement and the other Private Placement Documents. Furthermore, the Investor acknowledges that: (A) the Investor has made, and has relied upon, its own independent examination in purchasing
the Purchased Shares, including of the Company and the Subsidiaries, the Bank, the Transaction and the management team of the Company that will continue to operate and manage the Company after the completion of the Transaction; (B) nothing in
this Agreement or any other materials presented by or on behalf of the Company to the Investor in connection with the purchase of the Purchased Shares constitutes legal, tax or investment advice; and (C) the Investor received or had access to
all of the information the Investor deemed necessary in order to make its investment decision in the Securities. 

  
 23 

 (d) The Investor has read and understands the risk factors outlining certain, but not all,
risks related to the Company, the Bank, and an investment in the Company set forth in (i) the Company’s Form 10-K for the year ended December 31, 2011, (ii) each of the Company’s quarterly reports and other reports on SEC
Form 10-Q or Form 8-K filed or furnished, as applicable, thereafter through the date hereof, and (iii) the Private Placement Documents. 
 (e) The Investor understands that the Purchased Shares are being offered and sold to it by the Company through the Placement Agent in reliance on specific exemptions from the registration requirements of
U.S. federal and state securities laws and regulations and that the Company is relying in part upon the truth and accuracy of, and the Investor’s compliance with, the representations, warranties, agreements, acknowledgments and understandings
of the Investor set forth herein in order to determine the availability of such exemptions and the eligibility of the Investor to acquire the Purchased Shares. 
 (f) The Investor is not purchasing the Purchased Shares as a result of any advertisement, article, notice or other communication regarding the Purchased Shares published in any newspaper, magazine or
similar media or broadcast over television or radio or presented at any seminar or any other general advertisement. 
 (g) The
Investor understands that (i) no representation is being made as to the business or prospects of the Company or the Bank after the Closing or the future value of the Securities; and (ii) no representation is being made as to any
projections or estimates delivered to or made available to the Investor (or any of its affiliates or representatives) of the Company’s or the Bank’s future assets, liabilities, shareholders’ equity, regulatory capital ratios, net
interest income, net income or any component of any of the foregoing or any ratios derived therefrom. The Investor, either alone or together with its representatives, if any, has the knowledge, sophistication and experience in financial and business
matters as to fully understand and be capable of evaluating the merits and risks of an investment in the Securities and has the ability to bear the economic risks of an investment in the Securities and, at the present time, is able to afford a
complete loss of such investment. 
 (h) The Investor understands and agrees that the Securities are not deposits and are not
insured or guaranteed by the FDIC or any other Governmental Authority. 
 Section 3.05 Regulatory Approvals. The Investor
has not been advised by any applicable Regulatory Authority, and has no reasonable basis to believe, that any regulatory approvals required to consummate the Transaction will not be obtained. 

Section 3.06 Sufficient Funds. The Investor at the Closing will have all funds necessary to pay and deliver the Purchase Price.

 Section 3.07 No Acting in Concert, etc. No Investor is acting or will act for or on behalf of, or “in
concert” (as such term is used in the BHC Act or the Change in Bank Control Act or Federal Reserve regulations thereunder) or as part of a “group” with, any other Investor (other than affiliates of the Investor who may also be
Investors). 

  
 24 

 Section 3.08 No Prior Proxies. To the extent the Investor beneficially owns shares of
Common Stock, the Investor has not granted any proxies to a third party that currently are in effect, nor has the Investor granted voting rights that currently are in effect, with respect to such shares (other than the irrevocable proxy granted to
the Company as provided in Section 6.04(c)). 
 ARTICLE IV. 

CONDITIONS TO THE OBLIGATIONS 
 OF THE INVESTORS 
 The obligations of each Investor to purchase and pay for
the Purchased Shares and to perform its obligations under this Agreement are subject to the satisfaction or waiver (other than a waiver of any condition set forth in Section 4.06) by the Investor, on or before such Closing Date, of the
following conditions: 
 Section 4.01 Representations and Warranties to be True and Correct. The representations and
warranties contained in Article 2 were true and correct in all material respects as of the date of this Agreement and are true and correct at and as of the Closing Date with the same effect as though such representations and warranties had
been made on and as of the Closing Date (except to the extent such representations and warranties are limited expressly to an earlier date, in which case such representations and warranties were accurate on and as of such date), and a duly
authorized officer of the Company has certified such compliance to the Investor in writing on its behalf. 
 Section 4.02
Performance. The Company has performed and complied in all material respects with each of its obligations contained herein required to be performed or complied with by it prior to or at the Closing Date, and a duly authorized officer of the
Company has certified such compliance to the Investor in writing on its behalf. 
 Section 4.03 Preferred Stock
Designation. The parties hereto shall have amended Schedule I for the sole purpose of determining the Conversion Price and the initial Conversion Rate (each as defined in the Preferred Stock Designation) and the Company shall have duly filed the
Preferred Stock Designation, substantially in the form of Schedule I as so amended, with the Florida Secretary of State, and such Preferred Stock Designation shall be in full force and effect. 

Section 4.04 No Material Adverse Change. Since June 30, 2012, other than the 2012 MOU, there has not been any event or
occurrence that has had or is reasonably likely to have a Material Adverse Effect. 
 Section 4.05 Corporate Approvals;
etc. All corporate approvals to be taken by the Company in connection with the Transaction (including the Private Placement and the issuance of the Securities), other than the Shareholder Approvals, shall have been obtained and remain in full
force and effect. The Company shall have received an opinion from Hovde Financial, Inc. or another investment banker (“Investment Banker”) that the sale of the Preferred Stock and the Underlying Shares is fair from a financial point
of view. 

  
 25 

 Section 4.06 Change in Control Waivers. Each director and executive officer of the
Company and the Bank, and each other employee of the Company or the Bank with Change of Control Benefits, has executed and delivered to the Investors a Waiver and Acknowledgement Agreement substantially in the form of Schedule V, waiving all
rights, if any, which he or she might otherwise have to any Change of Control Benefits as a result of this Agreement or the Transaction. 
 Section 4.07 Regulatory Approvals. 
 (a) Solely as a result of the
consummation of the Private Placement, the purchase of the Purchased Shares shall not cause any Investor, other than CapGen, to be deemed to own, control or have the power to vote securities which would represent more than 9.9% of the voting
securities of the Company outstanding at such time. 
 (b) CapGen has received all regulatory approvals necessary to complete the
Transaction, including (A) the prior consent, approval, authorization, clearance, exemption, waiver or similar act from the applicable Regulatory Authorities; (B) all notice and waiting periods required by law to pass have passed without
adverse action; and (C) no orders or actions of any Governmental Authority enjoining, restraining, prohibiting or invalidating the Transaction have been issued and remain in effect or are unstayed. 

(c) Except as described in Section 2.07(a), no Regulatory Authority has (i) asserted a violation or noncompliance of any
Enforcement Action; (ii) revoked or restricted any permits held by the Company or any of the Subsidiaries; or (iii) issued, or required the Company or any of the Subsidiaries to consent to the issuance or adoption of, a cease and desist or
consent order, formal or written agreement, directive, commitment or memorandum of understanding, or any board resolution or similar undertaking, formal or informal, that, in the reasonable estimation of the Investor, restricts or materially affects
the conduct of the business or future prospects of the Company or such Subsidiary. 
 Section 4.08 Registration Rights
Agreement. The Registration Rights Agreement has been executed and delivered simultaneously with this Agreement, in substantially the form attached as Schedule VII, and will be effective and in full force and effect upon the Closing.

 Section 4.09 Sales of Shares. At the Closing, the Company shall concurrently sell to all Investors, including CapGen,
Preferred Stock in the Private Placement in the aggregate amount of $50.0 million, in each case, at a Share Price of $1,000.00, in accordance with the terms of this Agreement. 
 Section 4.10 Opinions. The Investors shall have received an opinion of counsel, dated as of the Closing Date and addressed to the Investors, in such form and substance as are customary for
transactions of this type and as reasonably requested by the Investors. The Investors shall have received an opinion of Crowe Horwath LLP dated as of or updated to the Closing Date and addressed to the Company, to the effect that the Transaction
should not be an “ownership change” for purposes of Section 382 of the Code. 
 Section 4.11 No Suspensions of
Trading in Common Stock or Listing. The Common Stock, including the Purchased Shares, (i) shall be designated for listing and quotation on the Nasdaq Global Market or the Nasdaq Capital Market and (ii) shall not have been suspended, as
of the Closing Date, by the SEC or Nasdaq from trading on the Nasdaq Global Market or the Nasdaq Capital Market. 

  
 26 

 ARTICLE V. 
 CONDITIONS TO THE OBLIGATIONS 
 OF THE COMPANY 

The obligations of the Company to issue and sell the Purchased Shares to the Investors and to perform its obligations under this
Agreement are subject to the satisfaction or waiver by the Company, on or before such Closing Date, of the following conditions: 
 Section 5.01 Representations and Warranties to be True and Correct. The several and not joint representations and warranties of each Investor contained in Article 3 are true and correct on
and as of the Closing Date with the same effect as though such representations and warranties had been made severally and not jointly by each Investor on and as of the Closing Date. 

Section 5.02 Performance. Each Investor has performed and complied in all material respects with all agreements by it contained
herein required to be performed or complied with by it prior to or at the Closing Date. 
 Section 5.03 Investment Banking
Opinion. The Company shall have received an opinion from the Investment Banker that the sale of the Preferred Stock and Underlying Shares is fair from a financial point of view. 

ARTICLE VI. 

COVENANTS 

Section 6.01 Commercially Reasonable Best Efforts. Each party and its officers and directors shall use their commercially
reasonable best efforts to take, or cause to be taken, all actions necessary or desirable to consummate and make effective the Transaction as promptly as practicable. If requested by an Investor, the Company shall provide the Investors and its
counsel with copies of all applications, filings, notices to, and correspondence with all Governmental Authorities as well as Nasdaq in connection with the Transaction, all of which shall be held, to the extent of information marked as
“confidential” therein, confidential by the Investors. 
 Section 6.02 Filings and Other Actions. 

(a) Each Investor other than CapGen, with respect to itself only, on the one hand, and the Company, on the other hand, will cooperate and
consult with the other and use their commercially reasonable best efforts to provide all necessary and customary information and data, to prepare and file all necessary and customary documentation, to provide evidence of non-control of the Company
and the Bank, including executing and delivering to the applicable Governmental Authorities passivity commitments, disassociation commitments and commitments not to act in concert, with respect to the Company or the Bank (the
“Commitments”) in the forms customary for transactions similar to the Transactions (including the Private Placement and the issuance of the Securities) contemplated hereby. CapGen shall agree to customary commitments required by the
Federal Reserve in connection with any approvals required in connection with CapGen’s investment. 

  
 27 

 (b) Each Investor, including CapGen, shall promptly file and effect all necessary and
customary applications, notices, petitions, filings and other documents, and to obtain all necessary and customary permits, consents, orders, approvals, determinations of non-control for BHC Act and Change in Bank Control Act purposes, and
authorizations of, or any exemption by, all third parties and Governmental Authorities, and the expiration or termination of any applicable waiting period, in each case, (i) necessary or advisable to consummate the Transactions contemplated by
this Agreement, and to perform their respective covenants herein and in the Agreements attached as Exhibits hereto and (ii) with respect to each Investor, to the extent typically provided by such Investor to such third parties or Governmental
Authorities, as applicable, under such Investor’s policies consistently applied and subject to such confidentiality requests as any such Investor may reasonably seek. Notwithstanding the immediately preceding sentence, the Investor shall not be
required to provide information on its investors solely in their capacities as limited, nonvoting partners or other similar passive, nonvoting, noncontrolling equity investors, and shall be entitled to request confidential treatment from any
Governmental Authority and not disclose to the Company any information that is confidential and proprietary to the Investor. 

(c) Each party shall execute and deliver both before and after the Closing such further certificates, agreements, documents and other
instruments and take such other actions as the other parties may reasonably request to consummate or implement such transactions or to evidence such events or matters, subject, in each case, to clauses (i) and (ii) of Section 6.02(b).
Each Investor and the Company will have the right to review in advance, and to the extent practicable each will consult with the other, in each case subject to applicable laws relating to the exchange of information, all the information relating to
such other party, and any of their respective Affiliates, which appears in any filing made with, or written materials submitted to, any third party or any Governmental Authority in connection with the transactions to which it will be party
contemplated by this Agreement; provided that (i) no Investor shall have the right to review any such information relating to another Investor and (ii) an Investor shall not be required to disclose to the Company any information
that is confidential and proprietary to such Investor. Each party hereto agrees to keep the other party apprised of the status of matters referred to in this Section 6.02(a). Each Investor shall promptly furnish the Company, and the Company
shall promptly furnish each Investor, to the extent permitted by applicable law, with copies of written communications received by it or its Subsidiaries from, or delivered by any of the foregoing to, any Governmental Authority in respect of the
transactions contemplated by this Agreement. 
 (d) Each Investor, on the one hand, agrees to furnish the Company, and the
Company, on the other hand, agrees, upon request, to furnish to each Investor, all information concerning itself, its Affiliates, directors, officers, general partners and managing members and such other matters as may be reasonably necessary or
advisable in connection with the proxy statement in connection with the special shareholders’ meeting at which the Shareholder Approvals of the Proposals are sought (the “Shareholders’ Meeting”). 

  
 28 

 (e) To the extent the Company receives any confidential information under this
Section 6.02, the Company shall not, and shall cause its directors, officers, employees, representatives and agents not to, use, duplicate or disclose, in whole or in part, or permit the use, duplication or disclosure of, any of such
information in any manner whatsoever. The Company shall be responsible for any breach of this Section 6.02 by any of its directors, officers, employees, representatives and agents. All information furnished or disclosed pursuant to this
Section 6.02 shall remain the sole property of the disclosing Investor. 
 Section 6.03 Corporate Approvals;
Takeover Laws. The Company shall obtain all corporate approvals necessary for this Agreement and the Transaction (including the Private Placement and the issuance of the Securities). The Company shall take all reasonable steps to exclude the
applicability of, or to assist in any challenge to the validity or applicability to the Transaction (including the Private Placement and the issuance of the Securities) of, any applicable Takeover Laws, if any. 

Section 6.04 Shareholder Approvals. 
 (a) As promptly as practicable following the date of this Agreement, the Company shall call the Shareholders’ Meeting for the purpose of obtaining the Shareholder Approvals for each of the Proposals
and shall use its commercially reasonable best efforts to cause such Shareholders’ Meeting to occur as promptly as reasonably practicable. The Proxy Statement shall include the Company Board Recommendation and the Board (and all applicable
committees thereof) shall use its commercially reasonable best efforts to obtain from the Company’s shareholders the Shareholder Approvals for the Proposals. 
 (b) Each director and executive officer of the Company and the Bank shall have delivered, upon the execution hereof, a binding agreement in the form of Schedule VI to vote all their respective
shares of Common Stock in favor of the Proposals. 
 (c) Each Investor shall vote (or cause to be voted) all of its shares of
Common Stock it beneficially owns, as of the date hereof or hereafter acquired, in favor of each of the Proposals, and hereby grants the Company an irrevocable proxy, coupled with an interest, to vote all of such shares in favor of the Proposals.
Notwithstanding anything in this Agreement to the contrary, such Investor acknowledges and agrees that this Section 6.04(c) shall include all of such Investor’s shares of Common Stock (whether currently beneficially owned or
hereafter acquired) and shall be binding upon any person to which the legal or beneficial ownership of such shares shall pass, whether by operation of law or otherwise, including such Investor’s successors or assigns. The proxy granted by this
Section 6.04(c) shall be governed by the Florida Business Corporation Act. The obligations set forth in this Section 6.04(c) shall terminate upon the earlier of (i) receipt, by the Company, of all of the Shareholder
Approvals, or (ii) the date upon which this Agreement is terminated pursuant to Article VIII. 
 (d) If on the date
for which the Shareholders’ Meeting is scheduled (the “Original Meeting Date”), the Company has not received proxies representing a sufficient number of votes to approve the Proposals, whether or not a quorum is present, the
Investor shall have the right to require the Company, and the Company shall have the right, to postpone or adjourn the Shareholders’ Meeting to a date that shall not be more than 45 days after the Original

  
 29 

 
Date. If the Company continues not to receive proxies representing a sufficient number of votes to approve the Proposals, whether or not a quorum is present, the Investor shall have the right to
require the Company to, and the Company may, make one or more successive postponements or adjournments of the Shareholders’ Meeting as long as the date of the Shareholders’ Meeting is not postponed or adjourned more than an aggregate of 45
days from the Original Date in reliance on this Section 6.04(d). If the Shareholders’ Meeting is adjourned or postponed as a result of Applicable Law, including the need to disseminate to Company shareholders any amendments or
supplements to the Proxy Statement, any days resulting from such adjournment or postponement shall not be included for purposes of the calculations of the number of days pursuant to this subsection. 

Section 6.05 Proxy Statement. As promptly as reasonably practicable after the date of this Agreement, (a) the Company shall
prepare and file with the SEC a letter to shareholders, notice of meeting, proxy statement and form of proxy that will be provided to shareholders of the Company in connection with seeking the Shareholder Approvals of the Proposals (including any
amendments or supplements) at the Shareholders’ Meeting and any schedules required to be filed with the SEC in connection therewith (collectively, the “Proxy Statement”) as required by the Exchange Act and the rules and
regulations promulgated thereunder. None of the information supplied or to be supplied by the Company or the respective Investors expressly for inclusion or incorporation by reference in the Proxy Statement will, at the time it is filed with the
SEC, on the date it is first mailed to the Company’s shareholders, or at the time of the Shareholders’ Meeting, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary
in order to make the statements therein, in light of the circumstances under which they are made, not misleading. The Proxy Statement will comply as to form in all material respects with the requirements of the Exchange Act. Each of the Company and
each Investor shall obtain and furnish the information concerning itself and its Affiliates required to be included in the Proxy Statement. The Company shall use its commercially reasonable best efforts to (i) respond as promptly as reasonably
practicable to any comments received from the SEC with respect to the Proxy Statement and (iii) seek to have the Proxy Statement declared definitive by the SEC at the earliest reasonably practicable date. The Company shall promptly notify the
Investors upon the receipt of any comments from the SEC or its staff or any request from the SEC or its staff for amendments or supplements to the Proxy Statement (but not the substance of such comments or requests, except to the extent such
comments or requests relate to information regarding the Investor). If, at any time prior to the Shareholders’ Meeting, any information relating to the Company or such Investor, or any of their respective Affiliates, directors or officers
should be discovered by the Company or any Investor, which should be set forth in an amendment or supplement to the Proxy Statement, so that the Proxy Statement shall not contain any untrue statement of a material fact or omit to state any material
fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they are made, not misleading, the party that discovers such information shall promptly notify the other party, and an
appropriate amendment or supplement describing such information shall be filed by the Company with the SEC and, to the extent required by Applicable Law, disseminated to the shareholders of the Company. Notwithstanding anything to the contrary
stated above, prior to filing or mailing the Proxy Statement (or any amendment or supplement thereto) or responding to any comments of the SEC or its staff with respect thereto, and to the extent it involves disclosure regarding any Investor, such
Investor shall be provided upon request, insofar as it relates to such Investor, a reasonable opportunity to review and comment on such document or response insofar as it relates to such Investor, and shall include in such document or response
comments reasonably proposed by the Investors, as applicable. 

  
 30 

 Section 6.06 Registration Rights. The Company and the Investor shall execute and
deliver upon the execution and delivery of this Agreement, the Registration Rights Agreement in substantially the form attached as Schedule VII, and the Registration Rights Agreement shall become effective as of the Closing. 

Section 6.07 Reservation and Nasdaq Listing of Underlying Shares. Upon and following the approval of the Share Increase Amendment,
the Company shall reserve and continue to reserve, free of any preemptive or similar rights, a number of unissued shares of Common Stock sufficient for issuance and delivery upon the Conversion of all issued and outstanding shares of Preferred Stock
in accordance with the Preferred Stock Designation. The Company shall, as far in advance of Closing as practicable, file an application to list the Underlying Shares for trading on the Nasdaq Global Market or the Nasdaq Capital Market, as
applicable, and shall pay all fees and expenses in connection with such listing and related notices. 
 Section 6.08
Restricted Shares. 
 (a) Each Investor acknowledges and agrees that there are substantial restrictions on the
transferability of the Securities. Each Investor further understands and agrees that the Securities have not been registered under the Securities Act and are “restricted securities” within the meaning of Rule 144 under the Securities Act
and may not be sold, transferred, or otherwise disposed of without registration under the Securities Act or pursuant to an exemption therefrom. 
 (b) Notwithstanding any other provision of this Article VI, each Investor covenants that the Securities may be disposed of only pursuant to an effective registration statement under, and in compliance
with the requirements of, the Securities Act, or pursuant to an available exemption from, or in a transaction not subject to, the registration requirements of the Securities Act, and in compliance with any applicable state, federal or foreign
securities laws. In connection with any transfer of the Securities other than (i) pursuant to an effective registration statement, (ii) to the Company or (iii) pursuant to Rule 144, provided that the transferor provides the
Company with reasonable assurances (in the form of seller and broker representation letters) that such Securities may be sold pursuant to such rule, the Company may require the transferor thereof to provide to the Company and the Transfer Agent, at
the transferor’s expense, an opinion of counsel selected by the transferor and reasonably acceptable to the Company and the Transfer Agent, the form and substance of which opinion shall be reasonably satisfactory to the Company and the Transfer
Agent, to the effect that such transfer does not require registration of such transferred Securities under the Securities Act. As a condition of transfer (other than pursuant to clauses (i), (ii) or (iii) of the preceding sentence), any
such transferee shall agree in writing to be bound by the terms of this Agreement and shall have the rights of the transferring Investor under this Agreement and the Registration Rights Agreement with respect to such transferred Securities.

  
 31 

 (c) Each Investor covenants that it will not knowingly make any sale, transfer, or other
disposition of any Securities, or engage in hedging transactions with respect to such Securities, in violation of the Securities Act (including Regulation S) or the Exchange Act, or in the case of Investors that are not bank holding companies, the
Federal Reserve Policy Statement. 
 (d) Each Investor acknowledges and agrees that: (a) each certificate evidencing the
Securities will bear a legend to the effect set forth below; and (b) except to the extent such restrictions are waived by the Company, neither shall transfer any Securities represented by any such certificate without complying with the
restrictions on transfer described in the legend endorsed on such certificate, as follows and which shall be delivered also as instructions to the Company’s transfer agent: 

THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, OR
THE SECURITIES LAWS OF ANY STATE AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT RELATING THERETO UNDER SUCH ACT AND APPLICABLE STATE SECURITIES LAWS
OR PURSUANT TO AN AVAILABLE EXEMPTION FROM REGISTRATION UNDER SUCH ACT OR SUCH LAWS. 
 (e) The restrictive legend set forth in
Section 6.08(d) above shall be removed and the Company shall issue a certificate without such restrictive legend or any other restrictive legend to the holder of the applicable Securities upon which it is stamped or issue to such holder by
electronic delivery at the applicable balance account at DTC, if (i) such Securities are registered for resale under the Securities Act, (ii) such Securities are sold or transferred pursuant to Rule 144 (if the transferor is not an
Affiliate of the Company), or (iii) such Securities are eligible for sale under Rule 144, without the requirement for the Company to be in compliance with the current public information required under Rule 144(c)(1) (or Rule 144(i)(2), if
applicable) as to such Securities and without volume or manner-of-sale restrictions. Following the earlier of (i) the effective date of the registration statement registering the Securities for resale (the “Resale Registration
Statement”) or (ii) Rule 144 becoming available for the resale of Securities, without the requirement for the Company to be in compliance with the current public information required under 144(c)(1) (or Rule 144(i)(2), if applicable)
as to the Securities and without volume or manner-of-sale restrictions, the Company shall, upon delivery of appropriate documentation by the Holder, instruct the Transfer Agent at the Company’s expense, to remove the legend from the Securities.
If a legend is no longer required pursuant to the foregoing, the Company will no later than 3 Trading Days following the delivery by a Holder to the Company or the Transfer Agent (with notice to the Company) of a legended certificate or instrument
representing such Securities (endorsed or with stock powers attached, signatures guaranteed, and otherwise in form necessary to affect the reissuance and/or transfer) and a representation letter to the extent required by Section 6.08(b),
(such third Trading Day, the “Legend Removal Date”) deliver or cause to be delivered to such Investor a certificate or instrument (as the case may be) representing such Securities that is free from all restrictive legends. The
Company may not make any notation on its records or give instructions to the Transfer Agent that enlarge the restrictions on transfer set forth in this Section 6.08(e). Certificates for Securities free from all restrictive legends may be
transmitted by the Transfer Agent to the Investors by crediting the account of the Investor’s prime broker or other broker with DTC as directed by such Investor. 

  
 32 

 (f) Each Investor hereunder acknowledges its primary responsibilities under the Securities
Act and accordingly will not sell or otherwise transfer the Securities or any interest therein without complying with the requirements of the Securities Act and the rules and regulations promulgated thereunder. Except as otherwise provided below,
while the Resale Registration Statement remains effective, each Investor hereunder may sell the Underlying Shares in accordance with the plan of distribution contained in the Resale Registration Statement and if it does so it will comply therewith
and with the related prospectus delivery requirements unless an exemption therefrom is available or unless the Underlying Shares are sold pursuant to Rule 144. Each Investor, severally and not jointly with the other Investors, agrees that if it is
notified by the Company in writing at any time that the Resale Registration Statement registering the resale of the Underlying Shares is not effective or that the prospectus included in such Resale Registration Statement no longer complies with the
requirements of Section 10 of the Securities Act, the Investor will refrain from selling such Underlying Shares until such time as the Investor is notified by the Company that such Resale Registration Statement is effective or such prospectus
is compliant with Section 10 of the Exchange Act, unless such Investor is able to, and does, sell such Underlying Shares pursuant to an available exemption from the registration requirements of Section 5 of the Securities Act. 

Section 6.09 Information, Access and Confidentiality. 
 (a) From the date hereof until the date following the Closing Date on which the Investor Percentage Interest of an Investor (other than CapGen) is less than 5%, the Company and the Subsidiaries will
permit such Investor, whether or not such Investor qualifies, or is intended to qualify, as a “venture capital operating company” (a “VCOC”) as defined in the regulations (the “Plan Asset Regulations”)
issued by the Department of Labor at 29 C.F.R. Section 2510.3 101, as the same may be amended from time to time (each such person a “VCOC Rights Inspector”), to have customary and appropriate VCOC rights, including
consultations rights, inspection and access rights, and rights to receive materials for all meetings of the Board of Directors, and the right to audited and unaudited financial statements, annual budget and other financial and operations
information, including advance notification of and consultation with respect to significant corporate actions) relating to inspection, information and consultation with respect to the Company or the Bank. Any consultation or inspection permitted
pursuant to this Section 6.09 shall be conducted during normal business hours and in such a manner as not to interfere unreasonably with the conduct of the business of the Company or the Subsidiaries, and nothing herein shall require the
Company or the Subsidiaries to disclose any information to the extent (1) prohibited by Applicable Laws or (2) that the Company or the Subsidiaries reasonably believe such information to be competitively sensitive proprietary information
(except to the extent the Investor provides assurances reasonably acceptable to the Company or such Subsidiary, as applicable, that such information shall not be used by the Investor or its affiliates to compete with the Company or such Subsidiary,
as applicable). Such Investor also shall hold and use any information that it receives pursuant to this Section solely for purposes of managing its investment in the Company, and shall not use or disclose any material nonpublic information regarding
the Company to trade in Company securities or any derivatives thereof. Notwithstanding the foregoing, nothing herein shall require the Company or the Subsidiaries to 

  
 33 

 
(1) honor a request from such Investor to visit and inspect any of the offices and properties of the Company and the Subsidiaries and inspect and copy the books and records of the Company and the
Subsidiaries more frequently than once per quarter, or (2) make appropriate officers and directors of the Company and the Subsidiaries available to such Investor for consultation with the Investor or its designated representative with respect
to matters relating to the business and affairs of the Company and the Subsidiaries more frequently than once per quarter. 
 (b)
From the date of this Agreement until the date when CapGen’s Investor Percentage Interest is less than 5%, the Company shall, and will cause each of the Subsidiaries to, give CapGen and its representatives (including officers and employees of
CapGen, and counsel, accountants, investment bankers, potential lenders and other professionals retained by CapGen) full access during normal business hours to all of their properties, books and records (including tax returns and appropriate work
papers of independent auditors under normal professional courtesy, but excluding those books and records that under Applicable Laws, or under confidentiality agreements, are required to be kept confidential) and to knowledgeable personnel of the
Company and to such other information as CapGen may reasonably request. As long as CapGen is a bank holding company deemed by the Federal Reserve to “control” the Company and the Bank under the BHC Act, the Company and the Bank shall
cooperate with CapGen, and provide all information requested by CapGen to prepare and fill all reports, applications and other filings with the Federal Reserve and other Governmental Authorities. 

(c) Each Investor shall, and shall cause its representatives to, hold all material nonpublic information received as a result of its
access to the properties, books and records of the Company or the Subsidiaries in confidence, except to the extent that information (i) is or becomes available to the public (other than through a breach of this Agreement), (ii) becomes
available to the Investor or its representatives from a third party that, insofar as the Investor is aware, is not under an obligation to the Company or to a Subsidiary to keep the information confidential, (iii) was known to the Investor or
its representatives on a non-confidential basis before it was made available to the Investor or its representative by the Company or a Subsidiary, or (iv) otherwise is independently developed by the Investor or its representatives. Each
Investor shall, at the Company’s request made at any time after the termination of this Agreement without the Closing having occurred, or at any time such Investor’s Investor Percentage is less than 5%, deliver to the Company all documents
and other material nonpublic information obtained by the Investor or its representatives from the Company or its Subsidiaries, or certify that such material has been destroyed by the Investor. The Investor acknowledges that it is aware of, and will
comply with, applicable restrictions on the use of material nonpublic information with respect to the Company and its Subsidiaries imposed by the United States federal securities laws. Any examination or investigation made by the Investor, its
representatives or any other persons as contemplated by this Section 6.09 shall not affect any of the representations and warranties hereunder. 
 Section 6.10 Conduct of Business Prior to Closing. Except as otherwise expressly contemplated or permitted by this Agreement or with the prior written consent of CapGen (which consent shall not be
unreasonably withheld or delayed) (which is a separate right granted to CapGen for itself and no other Investor), during the period from the date of this Agreement to the Closing Date, the Company shall, and shall cause each Subsidiary to,
(a) conduct its business only in the usual, regular and ordinary course consistent with past practice; and (b) take no action that would reasonably be expected to adversely affect or delay the receipt of any Shareholder Approvals.

  
 34 

 Section 6.11 Company Forbearances. Except as expressly contemplated or permitted by
this Agreement, during the period from the date of this Agreement to the Closing, the Company shall not, and shall not permit any Subsidiary to, without the prior written consent of CapGen (which is a separate right granted to CapGen for itself and
no other Investor): 
 (a) declare or pay any dividends or distributions on its capital stock, or directly or indirectly redeem,
purchase or otherwise acquire, any shares of its capital stock, trust preferred securities issued by a Company Subsidiary or any junior subordinated debentures issued in connection therewith, or other equity interest or any securities or obligations
convertible into or exchangeable for any shares of its capital stock or other equity interest or stock appreciation rights or grant any person any right to acquire any shares of its capital stock or other equity interest, other than dividends paid
by any wholly-owned Subsidiaries; 
 (b) issue or commit to issue any additional shares of capital stock or other equity
interest, or any trust preferred securities, securities convertible into or exercisable for, or any rights, warrants or options to acquire, any additional shares of capital stock or other equity interest (except (i) options, restricted stock or
other equity grants approved by the Board or the Organization and Compensation Committee of the Board under the Company’s equity incentive plans in accordance with past practice, or in accordance with the terms of any employment agreements in
existence as of the date hereof (including the Green Employment Agreement) or the Incandela Employment Agreement, (ii) pursuant to the exercise of outstanding options, or (iii) the Securities; 

(c) amend the Articles of Incorporation, the Company’s bylaws or other governing instruments of the Company or any Subsidiary, except
that the Company shall adopt and use its best efforts to obtain the Shareholder Approval of the Share Increase Amendment attached as Schedule III hereto and shall adopt and file the Preferred Stock Designation attached as
Schedule I hereto; 
 (d) incur any additional debt obligation or other obligation for borrowed money except in the
ordinary course of the business of the Subsidiaries consistent with past practices (which shall include, for the Subsidiaries that are depository institutions, creation of deposit liabilities, purchases of federal funds, sales of certificates of
deposit consistent with and subject to requirements of Governmental Authorities, advances from Federal Home Loan Bank of Atlanta or the Federal Reserve Bank of Atlanta, entry into repurchase agreements fully secured by U.S. government or agency
securities of the Disclosure Schedule), or impose, or suffer the imposition, on any shares of capital stock or other equity interest held by the Company or any Subsidiary of any lien or permit any such lien to exist; 

(e) adjust, split, combine or reclassify any capital stock or equity interests of the Company or any Subsidiary or issue or authorize the
issuance of any other securities with respect to or in substitution for shares of its capital stock or sell, lease, mortgage or otherwise encumber or agree to any Liens upon any shares of capital stock or equity interests of any Subsidiary or any
asset of the Company or any Subsidiary other than (i) in the ordinary course of business as permitted by Section 6.11(d) for reasonable and adequate consideration, or (ii) as contemplated in Section 6.11(e) of the
Disclosure Schedule; 

  
 35 

 (f) acquire any direct or indirect equity interest in any person, other than in connection
with (i) foreclosures in the ordinary course of business of debts previously contracted in good faith and (ii) holdings of securities solely in its fiduciary capacity; 

(g) except as contemplated by the Incandela Employment Agreement, grant any increase in compensation or benefits to the directors,
officers or employees of the Company or any Subsidiary, except in accordance with past practices previously disclosed; pay any bonus except in accordance with past practices and pursuant to the provisions of an applicable program or plan adopted by
the Board prior to the date of this Agreement as previously disclosed; or, enter into or amend, except to waive or eliminate any provision that would deem the acquisition of the Purchased Shares by the Investors or that any other aspect of the
Transactions are a change in control or acceleration event under, any severance, change in control agreements or equity awards with or to directors, officers or employees of the Company or any Subsidiary; 

(h) enter into or amend any employment agreement (other than entering into the Incandela Employment Agreement) between the Company or any
Subsidiary and any person (unless such amendment is required by Applicable Law) that the Company does not have the unconditional right to terminate without liability (other than liability for services already rendered), at any time on or after the
Closing; 
 (i) except as set forth on Section 6.11(i) of the Disclosure Schedule, adopt any new employee benefit plan or
employee benefits of the Company or any Subsidiary or make any material change in or to any existing employee benefit plans or employee benefits of the Company or any Subsidiary, other than the Incentive Plan Amendment and any such change that is
required by Applicable Law or that, in the opinion of counsel, is necessary or advisable to maintain the tax qualified status of any such plan; 
 (j) make any material change in any accounting methods or systems of internal accounting controls, except as may be appropriate to conform to changes in GAAP or as required by any Regulatory Authority;

 (k) (i) commence any litigation other than in connection with collections of debt consistent with past practice,
(ii) settle any litigation involving any liability of the Company or any Subsidiary for money damages which individually or in the aggregate, exceed or impose restrictions upon the operations of the Company or any Subsidiary, or
(iii) modify, amend or terminate any material contract described in Section 2.14 or waive, release, compromise or assign any material rights or claims; 
 (l) enter into any material transaction not in the ordinary course of business, or not consistent with safe and sound banking practices or Applicable Law; 

(m) fail to file timely any report required to be filed by it with any Regulatory Authority, including the SEC; 

  
 36 

 (n) make any loan or advance to any 5% or greater shareholder, director or officer of the
Company or any of the Subsidiaries, or any member of the immediate family of the foregoing, or any Related Interest or any affiliate of any of the foregoing, except for renewals of any loan or advance outstanding as of the date of this Agreement on
terms and conditions substantially similar to the original loan or advance; 
 (o) cancel without payment in full, or modify in
any material respect any agreement relating to, any loan or other obligation receivable from any 5% shareholder, director or officer of the Company or any Subsidiary or any member of the immediate family of the foregoing, or any Related Interest or
any affiliate of any of the foregoing; 
 (p) except as expressly contemplated by this Agreement or the Incandela Employment
Agreement, enter into any agreement for services or otherwise with any 5% shareholders, directors, officers or employees of the Company or any Subsidiary or any member of the immediate family of the foregoing, or any Related Interest or any
affiliate of any of the foregoing; 
 (q) modify, amend or terminate any material contract described in Section 2.14
or waive, release, compromise or assign any material rights or claims, except in the ordinary course of business consistent with past practice and for fair consideration; 
 (r) close any banking office where a notice of such closure is required under Section 42 of the Federal Deposit Insurance Act, as amended (the “FDI Act”) and applicable regulations
thereunder; 
 (s) except as required by Applicable Law or as required by applicable Regulatory Authority, change its or any of
the Subsidiaries’ lending, investment, liability management and other material banking policies in any material respect; 

(t) take any action that would cause the Transactions to be subject to requirements imposed by any Takeover Law, or fail to take all
necessary steps within its control to exempt (or ensure the continued exemption of) the Transactions from, or if necessary challenge the validity or applicability of, any applicable Takeover Law, as now or hereafter in effect; 

(u) make or renew any loan or extension of credit to any person (including, in the case of an individual, his or her immediate family) or
to any Related Interest or otherwise, except in accordance with the Bank’s policies, Applicable Law and the 2012 MOU; 
 (v)
increase or decrease the rates of interest paid on deposits or increase the amount of brokered or internet deposits, except consistent with the Bank’s past practices, the 2012 MOU and Applicable Law; 

(w) purchase or otherwise acquire any investment securities for its own account, except in accordance with the Bank’s policies,
including its asset/liability policy, and in accordance with Applicable Law and the 2012 MOU; 

  
 37 

 (x) except for the disposition of substandard assets consistent with the Company’s
overall strategy as disclosed in the Company’s quarterly report on Form 10-Q as of and for the period ended June 30, 2012, or except for OREO reflected on the books of the Company or the Bank as of the date hereof, the sale of which will
not result in a loss, individually or in the aggregate of $100,000 or more, sell, transfer, convey or otherwise dispose of any real property or other assets or interests therein having a book value individually or in the aggregate in excess of or in
exchange for consideration in excess of, $100,000 without prior Board approval, and in accordance with the Company’s policies, Applicable Law and the 2012 MOU; 
 (y) make or commit to make any capital expenditures in excess of $100,000, individually or in the aggregate, without prior Board approval; or 

(z) agree to, or make any commitment to, take any of the actions prohibited by this Section 6.11. 

Section 6.12 Investor Call. CapGen will issue the Investor Call to its investors promptly after receipt of the last approval of
the Regulatory Authorities needed for Closing of the Private Placement, or at such other later date and time as may agreed upon by CapGen and the Company. 
 Section 6.13 Press Releases; Public Disclosure. 
 (a) The Company and CapGen
shall consult with each other before issuing any press release with respect to the Transaction or this Agreement and shall not issue any such press release or make any such public statements without the prior consent of the other, which consent
shall not be unreasonably withheld or delayed; provided, however, that the Company may, without the prior consent of CapGen (but after such consultation, to the extent practicable in the circumstances), issue such press release or make
such public statements or filings as may be required by Applicable Law or the Nasdaq Global Market. 
 (b) Subject to each
party’s disclosure obligations imposed by law or regulation or the Nasdaq listing rules applicable to the Company, each of the parties hereto will cooperate with each other in the development and distribution of all news releases and other
public information disclosures with respect to this Agreement and any of the transactions contemplated by this Agreement, and neither the Company nor any Investor will make any such news release or public disclosure without first notifying the
other, and, in each case, also receiving the other’s consent (which shall not be unreasonably withheld or delayed), provided that nothing in this Section 6.13 shall prevent the Company from making timely disclosures under the
Securities Act, the Exchange Act and the Nasdaq listing rules. CapGen authorizes the Company to publicly disclose its name but otherwise no such public disclosure of an Investor or its investment advisor will be made by the Company (other than in a
Resale Registration Statement), except to the extent required by Applicable Law or authorized in writing by such Investor, and to all applicable Governmental Authorities and Nasdaq. The Company and each Investor agree that within three business days
following the Closing, the Company shall publicly disclose the closing of the transactions contemplated by this Agreement including the Private Placement. On or before 9:00 A.M. New York City time, on the fourth business day immediately following
the Closing Date, the Company will file a Current Report on Form 8-K with the SEC describing the terms of this Agreement. 

  
 38 

 (c) By 9:00 A.M., New York City time, on the fourth Business Day immediately following
execution of this Agreement, the Company shall issue one or more press releases (collectively, the “Press Release”) disclosing all material terms of the transactions contemplated hereby (including the Private Placement). On or
before 9:00 A.M., New York City time, on the fourth Business Day immediately following the execution of this Agreement, the Company will file a Current Report on Form 8-K with the SEC describing the terms of the Private Placement Documents (and
including as exhibits to such Current Report on Form 8-K the material Private Placement Documents, including this Agreement and the Registration Rights Agreement). Notwithstanding the foregoing, the Company shall not publicly disclose the name of
the Investor or any affiliate or investment adviser of the Investor, or include the name of the Investor or any affiliate or investment adviser of the Investor in any press release or in any filing with the SEC (other than a Resale Registration
Statement) or any regulatory agency or Nasdaq, without the prior written consent of the Investor, except (i) as required by the federal securities laws and (ii) to the extent such disclosure is required by law, at the request of applicable
Governmental Authorities or Nasdaq. 
 Section 6.14 Use of Proceeds. The Company shall use the net proceeds from the sale
of the Preferred Stock primarily to support the Bank’s capital, as disclosed in the Private Placement Documents. 
 Section
6.15 Form D Filings. The Company will timely file all Form Ds required with respect to the Transaction under SEC Regulation D with the SEC and with all other applicable securities and blue sky jurisdictions, and will pay any applicable filing
fees. 
 ARTICLE VII. 
 OTHER AGREEMENTS 
 Section 7.01 Bank Holding Company Status. No
Investor other than CapGen shall exercise “control” for purposes of the BHCA or the Change in Bank Control Act, of the Company or the Bank, upon or following the Closing or the Conversion. 

Section 7.02 Preemptive Rights. (a) Except as provided in Section 7.02(f), if the Company offers to sell Covered
Securities (as defined below) in a public or private offering of Covered Securities solely for cash any time during a period of 24 months commencing on the Closing Date (a “Qualified Offering”), each Investor shall be afforded the
opportunity to acquire from the Company, for the same price and on the same terms as such Covered Securities are offered, in the aggregate up to the amount of Covered Securities required to enable it to maintain its Investor Percentage Interest.
“Investor Percentage Interest” means, as of any date of determination, the percentage equal to (A) the aggregate number of shares of Common Stock beneficially owned by the Investor as of the date of determination divided by
(B) the total number of outstanding shares of Common Stock as of such date. “Covered Securities” means Common Stock and any rights, options or warrants to purchase or securities convertible into or exercisable or exchangeable
for Common Stock, other than securities that are (A) issued by the Company pursuant to any employment contract, employee incentive or benefit plan, stock 

  
 39 

 
purchase plan, stock ownership plan, stock option or equity compensation plan or other similar plan where stock is being issued or offered to a trust, other entity to or for the benefit of any
employees, consultants, officers or directors of the Company, (B) issued by the Company in connection with a business combination or other merger, acquisition or disposition transaction, partnership, joint venture, strategic alliance or
investment by the Company or similar non-capital raising transaction, or (C) issued as a dividend or in connection with a dividend reinvestment or shareholder purchase plan. 

(b) Prior to making any Qualified Offering of Covered Securities, the Company shall give the Investor written notice at the address shown
on each Investor’s signature page hereto of its intention to make such an offering, describing, to the extent then known, the anticipated amount of securities, and other material terms then known to the Company upon which the Company proposes
to offer the same (such notice, a “Qualified Offering Notice”). The Investor shall then have 10 days after receipt of the Qualified Offering Notice (the “Offer Period”) to notify the Company in writing that it
intends to exercise such preemptive right and as to the amount of Covered Securities the Investor desires to purchase, up to the maximum amount calculated pursuant to Section 7.02(a) (the “Designated Securities”). Such
notice constitutes a non-binding indication of interest of the Investor to purchase the amount of Designated Securities specified by the Investor (or a proportionately lesser amount if the amount of Covered Securities to be offered in such Qualified
Offering is subsequently reduced) at the price (or range of prices) established in the Qualified Offering and other terms set forth in the Company’s notice to it. Any failure to respond or to confirm the Investor’s interest in purchasing
all Covered Securities to which it is entitled under this Section 7.02 during the Offer Period constitutes a waiver of its preemptive rights in respect of such offering or as to the Covered Securities as to which no interest in
purchasing is received, as applicable. The sale of the Covered Securities in the Qualified Offering, including any Designated Securities, shall be closed not later than 30 days after the end of the Offer Period except as to any Investor that
requires prior approval of the Federal Reserve and/or other Governmental Authorities, in which case the closing of any the sale of Covered Securities to such Investor shall occur as soon as practicable following the receipt of all necessary
Governmental Authority approvals and the expiration of statutory waiting periods. The Covered Securities to be sold to other investors in such Qualified Offering shall be sold at a price not less than, and upon terms no more favorable to such other
investors than, those specified in the Qualified Offering Notice. If the Company does not consummate the sale of Covered Securities to other investors within such 30-day period (excluding Investors that require prior approval of the Federal Reserve
and/or other Governmental Authorities), the right provided hereunder shall be revived and such securities shall not be offered unless first reoffered to the Investors in accordance herewith. Notwithstanding anything to the contrary set forth herein
and unless otherwise agreed by the Investor, by not later than the end of such 30-day period, the Company shall either confirm in writing to the Investor that the Qualified Offering has been abandoned or shall publicly disclose its intention to
issue the Covered Securities in the Qualified Offering, in either case in such a manner that the Investor will not be in possession of any material, non-public information thereafter. 

(c) If the Investor exercises its preemptive right provided in this Section 7.02 with respect to a Qualified Offering that is
an underwritten public offering or an offering made to qualified institutional buyers (as such term is defined in SEC Rule 144A under the Securities Act) for resale pursuant to Rule 144A under the Securities Act (a “Rule 144A
offering”), a 

  
 40 

 
private placement or other offering, whether not registered under the Securities Act, the Company shall offer and sell the Investor, if any such offering is consummated, the Designated Securities
(as adjusted, upward to reflect the actual size of such offering when priced but not in excess of each Investor’s Investor Percentage Interest) at the same price as the Covered Securities are offered to third persons (not including the
underwriters or the initial purchasers in a Rule 144A offering that is being reoffered by the initial purchasers) in such offering and shall provide written notice of such price upon the determination of such price. 

(d) Anything to the contrary in this Section 7.02 notwithstanding, the preemptive right to purchase Covered Securities granted
by this Section 7.02 shall terminate as of and not be available any time after the date on which the Investor sells all of the Purchased Shares or all of its interest therein. 

(e) In addition to the pricing provision of Section 7.02(c), the Company will offer and sell the Designated Securities to the
Investor upon terms and conditions not less favorable than the most favorable terms and conditions offered to other persons or entities in a Qualified Offering. 
 (f) Notwithstanding anything to the contrary contained herein, (i) the preemptive rights set forth in this Section 7.02 or the Initial Investment Agreement shall not apply to a Qualified
Offering, including any rights offering, that is a public offering of up to $10 million that commences within six months of the Closing (the “Public Offering”), and each Investor waives any and all rights it has or may have to
participate in the Public Offering; and (ii) if the Investor is offered the opportunity to exercise the preemptive rights set forth in this Section 7.02 as part of a private placement offering by the Company, then the Company shall
have no obligation to provide similar preemptive rights in any concurrent public offering or related rights offering, at the same price per share as such private placement, to its existing shareholders other than the Investors. 

Section 7.03 Compensation Matters. Prior to the Closing, the Board (or, if appropriate, any committee thereof) shall adopt
appropriate resolutions and take all other actions necessary and appropriate (including securing any necessary waivers or consents) to provide that the issuance of the Purchased Shares to the Investor as contemplated by this Agreement will not
trigger any Change of Control Benefits under any “change of control” provision in any agreements to which the Company, the Bank or any of the Subsidiaries is a party, including any employment, “change in control,” equity award,
option, severance or other compensatory agreements and any Benefit Plan, and shall deliver true and complete copies of duly executed Waiver and Acknowledgement Agreements substantially in the form of Schedule V from each director and
executive officer of the Company and the Bank, and each other employee of the Company or the Bank with Change of Control Benefits, waiving all rights, if any, which he or she might otherwise have to any Change of Control Benefits as a result of this
Agreement or the Transaction. 
 Section 7.04 Commercially Reasonable Best Efforts. After the Closing Date, each party
and its officers and directors shall use their respective commercially reasonable best efforts to take, or cause to be taken, all further actions necessary or desirable to carry out the purposes of this Agreement and their respective covenants,
agreements and obligations hereunder. 

  
 41 

 Section 7.05 Manner of Offerings. The Company is offering the Purchased Shares
through the Placement Agent to Investors that are Accredited Investors in transactions exempt from registration under Section 4(2) of the Securities Act on terms and conditions, including price, no more favorable than provided to CapGen,
without CapGen’s prior written consent, following full disclosure of all such terms and conditions (including any side letters or other agreements, arrangement or understandings) to CapGen. If CapGen determines that the other Investors are
receiving a more favorable price, or terms and conditions more favorable than those granted to the Investor hereby, the Company will cooperate with CapGen to provide CapGen with terms, conditions and rights in favor of CapGen no less favorable than
those granted to any other person in the Transaction (including the Private Placement and the issuance of the Securities). CapGen shall purchase its Purchased Shares at the same per share price being offered to the other Investors, and the complete
terms and conditions of CapGen’s purchase of its Purchased Shares are set forth herein. 
 Section 7.06
Indemnification. 
 (a) Indemnification of Each Investor. In addition to the indemnity provided in the Registration
Rights Agreement, to the extent allowed under Applicable Law, the Company will indemnify and hold each Investor and its directors, officers, shareholders, members, partners, employees, agents and representatives (and any other persons with a
functionally equivalent role of a person holding such titles notwithstanding a lack of such title or any other title), each person who controls the Investor (within the meaning of Section 15 of the Securities Act and Section 20 of the
Exchange Act), and the directors, officers, shareholders, members, partners, employees, agents and representatives (and any other persons with a functionally equivalent role of a person holding such titles notwithstanding a lack of such title or any
other title) of such controlling person (each, an “Investor Party”), from any and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in permitted
settlements, court costs and reasonable attorneys’ fees and expenses of one counsel and costs of investigation (“Losses”) that any such Investor Party may suffer or incur as a result of (i) any material breach of any of
the representations, warranties, covenants or agreements made by the Company in this Agreement or (ii) any action instituted against an Investor Party in any capacity, by any shareholder of the Company who is not Investor Party or an affiliate
of that Investor Party, with respect to any of the transactions contemplated by this Agreement. The Company will not be liable to any Investor Party under this Agreement to the extent, but only to the extent that, Losses are attributable to any
Investor’s material breach of any of the representations, warranties, covenants or agreements made by such Investor in this Agreement or in the other Private Placement Documents. 

(b) Conduct of Indemnification Proceedings. Promptly after receipt by any Investor Party (the “Indemnified
Person”) of notice of any demand, claim or circumstances which would or might give rise to a claim or the commencement of any action, proceeding or investigation in respect of which indemnity may be sought pursuant to
Section 7.06(a), such Indemnified Person shall promptly notify the Company in writing and the Company shall assume the defense thereof, including the employment of one counsel reasonably satisfactory to such Indemnified Person, and shall
assume the payment of all fees and expenses of such counsel; provided, however, the failure of any Indemnified Person so to notify the Company shall not relieve the Company of its obligations hereunder except to the extent that the
Company is 

  
 42 

 
actually and materially and adversely prejudiced by such failure to receive such notice. In any such proceeding, any Indemnified Person shall have the right to retain its own counsel, but the
fees and expenses of such counsel shall be at the expense of such Indemnified Person unless: (i) the Company and the Indemnified Person shall have mutually agreed to the retention of such counsel at the Company’s expense; (ii) the
Company shall have failed promptly to assume the defense of such proceeding and to employ counsel reasonably satisfactory to such Indemnified Person in such proceeding; or (iii) in the reasonable judgment of counsel to such Indemnified Person,
representation of both parties by the same counsel would be inappropriate due to actual or potential differing interests between them. The Company shall not be liable for any settlement of any proceeding effected without its written consent, which
consent shall not be unreasonably withheld, delayed or conditioned. Without the prior written consent of the Indemnified Person, which consent shall not be unreasonably withheld, delayed or conditioned, the Company shall not affect any settlement of
any pending or threatened proceeding in respect of which any Indemnified Person is or could have been a party and indemnity could have been sought hereunder by such Indemnified Party, unless such settlement includes an unconditional, irrevocable
release of such Indemnified Person from all liability and Losses arising out of such proceeding. 
 ARTICLE VIII.

 TERMINATION 
 Section 8.01 Methods of Termination. This Agreement may be terminated at any time prior to the Closing by: 
 (a) the mutual written consent in writing of an Investor and the Company, but only as to the terminating Investor; 
 (b) any Investor but only with respect to the terminating Investor or the Company if the Closing of the sale of an aggregate of $50 million of Preferred Stock shall not have occurred by October 31,
2012 (the “Termination Date”), provided, however, that the right to terminate this Agreement under this Section 8.01(b) shall not be available to any party whose breach of any representation or warranty or
failure to perform any obligation under this Agreement shall have caused or resulted in the failure of the Closing; 
 (c) the
Company if there has been a breach of any representation, warranty, covenant or agreement made by an Investor in this Agreement, or any such representation and warranty shall have become untrue after the date of this Agreement, such that
Section 5.01 would not be satisfied and such breach or condition is not curable or, if curable, is not cured within the earlier of (i) 30 days after written notice thereof is given by the Company to the Investor and (ii) the
Termination Date; provided that the Company is not then in breach of any representation, warranty, covenant, agreement or other obligation contained in this Agreement and, provided further, that such termination by the Company shall
only be as to the breaching Investor; 
 (d) an Investor if there has been a breach of any representation, warranty, covenant or
agreement made by the Company in this Agreement, or any such representation and warranty shall have become untrue after the date of this Agreement, such that Section 4.01  

  
 43 

 
would not be satisfied and such breach or condition is not curable or, if curable, is not cured within the earlier of (i) 30 days after written notice thereof is given by the Investor to the
Company and (ii) the Termination Date; provided that the terminating Investor is not then in material breach of any representation, warranty, covenant, agreement or other obligation contained in this Agreement and provided further
that such termination by an Investor shall only be as to such Investor; 
 (e) the Company or an Investor in writing at any time
after any applicable Regulatory Authority has denied finally or requested the withdrawal of any application by an Investor for approval of the Transaction; or 
 (f) CapGen, if other Investors are no longer parties to this Agreement and replacement Investors do not enter into this Agreement within 45 days after the termination by such initial other Investor(s)
such that the total aggregate commitment by all Investors other than CapGen is not less than $25 million; 
 (g) any Investor if
CapGen terminates this Agreement. 
 A termination by an Investor or by the Company with respect to one or more Investors, shall not effect a
termination of this Agreement or the rights and obligations of the remaining parties to this Agreement, including each remaining Investor’s ability to terminate this Agreement. 

Section 8.02 Effect of Termination. In the event of termination of this Agreement as to any Investor pursuant to
Section 8.01 hereof, and except as otherwise stated therein, written notice thereof shall be given to the other parties, and this Agreement shall terminate immediately to the extent provided in Section 8.01 upon receipt of
such notice (or as otherwise set forth in Section 8.01(d) and Section 8.01(e)), unless an extension is consented to in writing by the party having the right to terminate. If this Agreement is terminated as provided herein,
this Agreement shall become void as and to the extent provided in Section 8.01, except that Section 7.06, this Section 8.02 and Article 9 shall survive any such termination; provided, however, that
nothing herein shall relieve any breaching party from liability for an uncured willful breach of a representation, warranty, covenant, obligation or agreement giving rise to such termination. 

ARTICLE IX. 

MISCELLANEOUS 
 Section 9.01 Certain Definitions. (a) The following definitions shall be applicable to the terms set forth below as used in this Agreement: 

“Accredited Investor” has the meaning set forth in Rule 501 promulgated under the Securities Act. 

“affiliate” means, with respect to any person, any other person which directly, or indirectly through one or more
intermediaries, controls, is controlled by or is under common control with, such person. 
 “Applicable Law”
means any domestic or foreign, federal, state or local, statute, law, ordinance, rule, administrative interpretation, regulation, holding, order, determination, writ, 

  
 44 

 
injunction, directive, judgment, decree, permit, license or other requirement of any Governmental Authority applicable to the Company or the Subsidiaries, or their respective properties, assets,
officers, directors, employees or agents (in connection with such officers’, directors’, employees’ or agents’ activities on behalf of such entity). 
 “beneficial ownership” and correlative terms have the meaning ascribed in Section 13(d)(3) of the Exchange Act and Rule 13d-3 thereunder) 

“Board” means the Board of Directors of the Company. 

“Business Day” means any day that it is not a Saturday, Sunday or other day in which banks in the State of Florida or New
York are authorized or required by law to be closed. 
 “Exchange Act” means the Securities Exchange Act of
1934, as amended, and the regulations promulgated thereunder. 
 “GAAP” means U.S. generally accepted accounting
principles. 
 “Material Adverse Effect” means any event, effect, circumstance, occurrence or change that,
individually or in the aggregate, (i) is material and adverse to the business, assets, liabilities, results of operations, financial condition, cash flows or prospects of the Company and the Subsidiaries (as defined below), taken as a whole or
(ii) would materially impair the ability of the Company to perform its obligations under this Agreement or consummate the Closing; provided, however, that Material Adverse Effect shall not be deemed to include
(a) any events, effects, circumstances, occurrences or changes, after the date hereof, generally affecting the commercial banking industry, the economy, or the financial, real estate, securities or credit markets in the United States or
elsewhere in the world, including effects on such industry, economy or markets resulting from any regulatory or political conditions or developments, or any outbreak or escalation of hostilities, declared or undeclared acts of war or terrorism,
(b) changes or proposed changes, after the date hereof, in GAAP, (c) changes or proposed changes, after the date hereof, in laws governing financial institutions and laws of general applicability or related policies or interpretations of
any Governmental Authority (in the case of each of clauses (a), (b) and (c), other than effects, circumstances, occurrences or changes to the extent that such effects, circumstances, occurrences or changes have a materially disproportionate
adverse affect on the Company and the Subsidiaries relative to other companies in the commercial banking industry), or (d) changes in the market price or trading volume of Common Stock (it being understood and agreed that the exception set
forth in this clause (d) does not apply to the underlying reason or cause giving rise to or contributing to any such change). 
 “person” means an individual, corporation, limited liability company, partnership, association, trust, unincorporated organization, other entity or group (as defined in
Section 13(d) of the Exchange Act) and shall include any successor (by merger or otherwise) of such entity. 

“Related Interest” has the meaning ascribed to it by Regulation O promulgated by the Federal Reserve Board. 

  
 45 

 “SEC” means the U.S. Securities and Exchange Commission. 

“Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 “Subsidiary” means any person of which (i) the Company or any of its Subsidiaries is a general partner,
(ii) the voting power to elect a majority of the board of directors or others performing similar functions is held by the Company and or any one or more of its Subsidiaries, or (iii) more than 50% of the equity interests is, directly or
indirectly, owned or controlled by the Company or any one or more of its Subsidiaries. 
 (b) In this Agreement, (i) the
words “include,” “includes,” and “including” and derivatives thereof are deemed to include and mean “without limitation,” whether by enumeration or otherwise; (ii) any reference to an agreement means that
agreement as amended or supplemented, subject to any restrictions on amendment contained in that agreement; (iii) unless specified otherwise, any reference to a statute or regulation means that statute or regulation as amended or supplemented
from time to time and any corresponding provisions of successor statutes or regulations; (iv) if any date specified in this Agreement as a date for taking action falls on a day that is not a Business Day, then that action may be taken on the
next Business Day; and (v) the words “party” and “parties” refer only to a named party to this Agreement. The singular shall include the plural and vice versa, and any reference to gender shall include all genders.

 Section 9.02 Specific Performance. Each party acknowledges that the other party would be damaged irreparably in the
event any provision of this Agreement is not performed in accordance with its specific terms or otherwise is breached, so that a party shall be entitled to injunctive relief to prevent breaches of this Agreement and to enforce specifically this
Agreement and its terms and provisions in addition to any other remedy to which such party may be entitled, at law or in equity. In particular, the parties acknowledge that the business of the Company and the Subsidiaries is unique and recognize and
affirm that in the event the Company breaches this Agreement, money damages may be inadequate and the Investor would have no adequate remedy at law, so that Investors shall have the right, in addition to any other rights and remedies existing in its
favor, to enforce its rights and the Company’s obligations under this Agreement not only by action for damages but also by action for specific performance, injunctive, or other equitable relief. 

Section 9.03 Expenses; Fee. At the Closing, the Company shall reimburse CapGen for all expenses incurred by CapGen in connection
with its due diligence investigation of the Company and the Transaction and all preliminary, planning, preparation and pre-offering activities, the negotiation, drafting, execution, delivery, and performance of this Agreement and the Transaction,
and the filing or pursuit of all regulatory approvals necessary to complete the Transaction (including, in all cases, the fees and expenses of its agents, representatives, attorneys, and accountants). In addition, at the Closing, the Company shall
pay a fee of $500,000 to the Investors, to be divided among the Investors based on each Investor’s pro rata amount of the aggregate Purchased Shares purchased in the Private Placement. Except as otherwise provided in this
Section 9.03, each party shall pay its own fees and expenses (including the fees and expenses of its agents, representatives, attorneys, and accountants) incurred in connection with the negotiation, drafting, execution, delivery, and
performance of this Agreement and the Transaction. 

  
 46 

 Section 9.04 Survival. The representations and warranties of the Company contained
herein shall survive the Closing and the delivery of and payment for the Purchased Shares. 
 Section 9.05 Notices. All
notices, requests, consents and other communications hereunder shall be in writing and shall be delivered in person or mailed by certified or registered mail, return receipt requested, or sent by a recognized overnight courier service, addressed as
follows: 
 If to the Company, at: 
 Jacksonville Bancorp, Inc. 
 100 North Laura Street, Suite 1000

 Jacksonville, Florida 32202 

Attention: Stephen C. Green 
 with a copy to: 
 McGuireWoods 

Bank of America Tower 
 50 North Laura Street, Suite 3300 
 Jacksonville, Florida
32202-3661 
 Attention: Halcyon E. Skinner 

If to the Investor, at: 
 CapGen Capital Group IV LP 
 c/o CapGen Financial 

280 Park Avenue 

40th Floor West, Suite 401 
 New York, New York 10017 
 Attention: John P. Sullivan 

with a copy to: 
 Jones Day 
 1420 Peachtree Street, N.E. 

Suite 800 
 Atlanta, Georgia 30309-3053 
 Attention: Ralph F. MacDonald, III

 If to any other Investor: 
 As provided on such Investor’s signature page hereto or, in any such case, at such other address or addresses as shall have been furnished in writing by such party to the others. 

  
 47 

 Section 9.06 No Assignment; No Delegation. (a) No party may assign any of its
rights under this Agreement, except with the prior written consent of the other parties, provided the Investor may assign its rights to the Purchased Shares to an affiliate or any person that shares a common discretionary investment adviser
with the Investor without consent. All assignments of rights are prohibited under this subsection, whether they are voluntary or involuntary, by merger (regardless of whether the party is the surviving or disappearing entity), consolidation,
dissolution, operation of law, or any other manner. For purposes of this Section 9.06, a “change of control” is deemed an assignment of rights. 
 (b) No party may delegate any performance under this Agreement. 
 (c) Any purported
assignment of rights or delegation of performance in violation of this Section 9.06 is void. 
 Section 9.07 No
Third Party Beneficiaries. This Agreement is not intended to and shall not confer any rights or remedies upon any person other than the parties hereto, whether as third party beneficiaries or otherwise, other than Indemnified Persons.

 Section 9.08 Governing Law. Except as otherwise provided in Section 6.04(c), the laws of the State of New York
(without giving effect to its conflicts of law principles) govern all matters arising out of or relating to this Agreement, including its validity, interpretation, construction, performance, and enforcement. 

Section 9.09 Amendments and Waivers. The parties may amend this Agreement only by a written agreement of the parties that is
identified as an amendment to this Agreement. No waiver shall be effective unless it is in writing and signed by an authorized representative of the waiving party, and such waiver shall be limited to the time and purpose specified therein. No
consideration shall be offered or paid to any Investor to amend or consent to a waiver or modification of any provision of the Private Placement Documents, or to exercise any consent right hereunder, unless the same consideration also is offered to
all of the Investors pro rata to their agreed-upon investment in Purchased Shares provided herein; provided, however, that CapGen may be reimbursed for any expense (including legal fees and charges) it incurs in connection with any
such amendment, waiver or consent. 
 Section 9.10 Severability. If any provision of this Agreement is determined to be
invalid, illegal or unenforceable, the remaining provisions of this Agreement shall remain in full force, as long as both the economic and legal substance of the transactions that this Agreement contemplates are not affected in any manner materially
adverse to any party. 
 Section 9.11 Captions. The descriptive headings of the Articles, Sections and subsections and
the table of contents of this Agreement are for convenience of reference only, do not constitute a part of this Agreement, and do not affect this Agreement’s construction or interpretation. 

  
 48 

 Section 9.12 No Waiver; Cumulative Remedies. No failure or delay on the part of any
party to this Agreement in exercising any right, power or remedy hereunder shall operate as a waiver thereof; nor shall any single or partial exercise of any such right, power or remedy preclude any other or further exercise thereof or the exercise
of any other right, power or remedy hereunder. The remedies herein provided are cumulative and not exclusive of any remedies provided by law. 
 Section 9.13 Further Assurances. From and after the date of this Agreement, upon the request of the Investors, on the one hand, or the Company and the Bank, on the other, the Investors, the Company
and the Bank, as applicable, shall execute and deliver such other instruments, documents and other writings as may be reasonably necessary or desirable to confirm and carry out and to effectuate fully the intent and purposes of this Agreement.

 Section 9.14 No Construction Against Drafter. Each party has participated in negotiating and drafting this Agreement,
so if an ambiguity or a question of intent or interpretation arises, this Agreement is to be construed as if the parties had drafted it jointly, as opposed to being construed against a party because it was responsible for drafting one or more
provisions of this Agreement. 
 Section 9.15 Entire Agreement. This Agreement, including the schedules and exhibits
hereto constitutes the complete and exclusive expression of the parties’ agreement on the matters contained in this Agreement. All prior and contemporaneous negotiations and agreements between the parties on the matters contained in this
Agreement are expressly merged into and superseded by this Agreement. The provisions of this Agreement may not be explained, supplemented or qualified through evidence of trade usage or a prior course of dealings. In entering into this Agreement,
neither the Company and the Bank on the one hand, or the Investors on the other, have relied upon any statement, representation, warranty or agreement of the other party except for those expressly contained in this Agreement. No Investor has relied
upon any statement, representation, warranty or agreement of any other Investor in determining to enter into this Agreement or to invest in any Securities. There are no conditions precedent to the effectiveness of this Agreement, other than those
expressly stated in this Agreement. 
 Section 9.16 Counterparts. The parties may execute this Agreement in multiple
counterparts, each of which constitutes an original, and all of which, collectively, constitute only one and the same agreement. The signatures of all of the parties need not appear on the same counterpart, and delivery of an executed counterpart
signature page by facsimile shall have the same force and effect as a manually executed original. This Agreement is effective upon delivery of one executed counterpart from each party to the other parties. 

Section 9.17 Independent Nature of Investors’ Obligations and Rights. The obligations of each Investor under the Private
Placement Documents are several and not joint with the obligations of any other Investor, and no Investor shall be responsible in any way for the performance of the obligations of any other Investor under any Private Placement Document. Nothing
contained herein or in any other Private Placement Document, and no action taken by any Investor pursuant hereto or thereto, shall be deemed to constitute the Investors as, and the Company acknowledges that the Investors do not so constitute, a
partnership, an association, a joint venture or any other kind of group or entity, or create any implication or presumption that 

  
 49 

 
the Investors are in any way acting in concert or as a group or entity with respect to such obligations or the transactions contemplated by the Private Placement Documents or any matters. The
Company acknowledges that the Investors are not acting (i) jointly, (ii) in concert or (iii) as a group, and the Company shall not assert any such claim, with respect to such obligations or the transactions contemplated by the Private
Placement Documents. The decision of each Investor to purchase Securities pursuant to the Private Placement Documents has been made by such Investor independently of, and without reliance on, any other Investor. Each Investor acknowledges that no
other Investor has acted as agent or fiduciary for or representative of such Investor in connection with such Investor making its investment hereunder and that no other Investor will be acting as agent or fiduciary for or representative of such
Investor in connection with monitoring such Investor’s investment in the Securities or enforcing its rights under the Private Placement Documents. The Company and each Investor confirms that each Investor has independently participated with the
Company in the negotiation of the transaction contemplated hereby with the advice of its own counsel and advisors. Each Investor shall be entitled to independently protect and enforce its rights, including the rights arising out of this Agreement or
out of any other Private Placement Documents, and it shall not be necessary for any other Investor to be joined as an additional party in any proceeding for such purpose. The use of a single agreement to effectuate the purchase and sale of the
Securities contemplated hereby is solely for convenience. It is expressly understood and agreed that each provision contained in this Agreement and in each other Private Placement Document is between the Company and a Investor, solely, and not
between the Company and the Investors collectively and not between and among the Investors. 
 [SIGNATURE PAGES FOLLOW]

  
 50 

 The parties have caused this Agreement to be executed as of the date first above written by
their respective duly authorized officials. 
  

					
	JACKSONVILLE BANCORP, INC.
			
	By:	 	/s/ Stephen C. Green	 	 
		 	Name: Stephen C. Green
		 	Title: Chief Executive Officer

							
	Subscription Amount1	 		 	
	 Up to $25,000,000.00
	 	CAPGEN CAPITAL GROUP IV LP
	 Number of Purchased Shares: Up to 25,000
	 		 	BY:	 	CAPGEN CAPITAL GROUP IV LLC,
		 		 		 	 AS GENERAL PARTNER OF CAPGEN

CAPITAL GROUP IV LP

		 		 		 	
				
		 		 	By:	 	/s/ John R. Caughey
		 		 		 	Name: John R. Caughey
		 		 		 	Title: Vice President and Chief Financial Officer

  
  
  

 

1 The Subscription Amount and the number of Purchased Shares to be bought by CapGen are subject to the condition that in
no event will such Purchased Shares (when considered on a fully converted basis), together with all other shares of Company Common Stock held by CapGen and its affiliates, exceed 49.9% of the Company’s outstanding shares of Company Common Stock
at any time. The actual Subscription Amount and the Number of Purchased Shares shall be reduced, as necessary, from the maximum amount and maximum number of Purchased Shares shown above to an amount and number that, assuming Conversion of all
Purchased Shares sold hereunder, will not exceed 49.9% of the Company’s outstanding shares of Common Stock upon the Closing. 

 SCHEDULE I 

FORM OF PREFERRED STOCK DESIGNATION 

 JACKSONVILLE BANCORP, INC. 

ARTICLES OF AMENDMENT 
 to the 
 AMENDED AND RESTATED ARTICLES OF INCORPORATION 

DESIGNATING 

MANDATORILY CONVERTIBLE, NONCUMULATIVE, NONVOTING, PERPETUAL PREFERRED STOCK, 

SERIES A 

JACKSONVILLE BANCORP, INC., a corporation organized and existing under the laws of the State of Florida (the
“Corporation”), in accordance with the provisions of Section 607.0602 of the Florida Business Corporation Act (the “FBCA”), hereby certifies: 

I. 
 The name of
the Corporation is “Jacksonville Bancorp, Inc.” 
 II. 

The Corporation’s Board of Directors, in accordance with the Corporation’s Amended and Restated Articles of Incorporation, as
amended (the “Articles”) and bylaws, as amended (the “Bylaws”) and applicable law, including Sections 607.0602 and 607.0621 of the FBCA, has adopted the following resolution on
[            ], 2012 for the purpose of designating and establishing a series of shares of $0.01 par value preferred stock of the Corporation designated as “Mandatorily Convertible,
Noncumulative, Nonvoting, Perpetual Preferred Stock, Series A”: 
 RESOLVED, that pursuant to the Corporation’s
Articles and Bylaws and applicable law, a series of preferred stock, par value $0.01 per share, from the Corporation’s authorized shares hereby is created, and that the designation and number of shares of such series, and the voting and other
powers, preferences and relative, participating, optional or other rights, and the qualifications, limitations and restrictions thereof, of the shares of such series, are as follows: 

Section 1. Designation. There is created hereby from the Corporation’s authorized, undesignated and unissued shares of
Preferred Stock, a series of Preferred Stock designated as the “Mandatorily Convertible, Noncumulative, Nonvoting, Perpetual Preferred Stock, Series A”, $0.01 par value per share (the “Series A Preferred Stock”).

 Section 2. Number of Shares. The total number of authorized shares of Series A Preferred Stock shall be 75,000
shares, which may from time to time be increased or decreased (but not below the number then outstanding) by the Corporation’s Board of Directors. 
 Section 3. Definitions. As used herein, the following terms shall have the meanings specified below: 
 “Affiliate” of any Person means any other Person controlling, controlled by or under common control with such particular person or entity. The term “control” (including the
terms “controlling”, “controlled” and “under common control with”) as used with respect to any Person means the possession, direct or indirect, of the power to direct or cause the direction of the management and
policies of such Person, whether through the ownership of voting securities, by contract or otherwise. 

 “Articles” has the meaning set forth in the recitals.

 “Average VWAP” means the average of the VWAP for each Trading Day in the relevant period. 

“BHC Act” means the federal Bank Holding Company Act of 1956, as amended, and the Federal Reserve regulations
thereunder. 
 “Board” or “Board of Directors” means the Corporation’s board of directors
or, with respect to any action to be taken by such board of directors, any committee of the board of directors duly authorized to take such action. 
 “Business Day” means any day, other than a Saturday or a Sunday, that is neither a legal holiday nor a day on which banking institutions in New York, New York or Jacksonville, Florida are
authorized or required by law, regulation or executive order to close. 
 “CapGen” has the meaning set forth in
Section 5(a). 
 “CIBC Act” means the federal Change in Bank Control Act, as amended, and the Federal
Reserve regulations thereunder. 
 “Common Stock” means the common stock, par value $0.01 per share, of the
Corporation. 
 “Conversion” means a Mandatory Conversion. 

“Conversion Date” has the meaning set forth in Section 5(a). 

“Conversion Price” means the Liquidation Amount per share of Series A Preferred Stock divided by the Conversion Rate
then in effect. The initial Conversion Price is $[            ]. 
 “Conversion Rate” means, initially, [            ] shares of Common Stock per share of Series A Preferred Stock issuable
upon Conversion, based on an initial Conversion Price of $[            ] per share of Common Stock, and is subject to adjustment as provided herein. 

“Corporation” has the meaning set forth in the preamble. 

“Current Market Price” of the Common Stock on any day, means the Average VWAP of the Common Stock for the 10 consecutive
Trading Days ending on the earlier of the day in question and the day before the ex-date or other specified date with respect to the issuance or distribution requiring such computation, appropriately adjusted to take into account the occurrence
during such period of any event described in clauses (i) through (vi) of Section 6(e). For purposes of this definition, “ex-date” means the first date on which the shares of the Common Stock trade on the applicable
exchange or in the applicable market, regular way, without the right to receive an issuance or distribution. 

“Depositary” means DTC or its nominee, Cede & Co., or any successor appointed by the Corporation. 

“Dividend Payment Date” means [__________ 15] and [__________ 15] of each year, commencing [__________
15], 2012. 
 “Dividend Payment Commencement Date” means [__________ 15], 2012. 

“Dividend Period” means the period commencing on and including a Dividend Payment Date (or, with respect to the first
Dividend Period, commencing on and including the Issue Date) and ending on and including the day immediately preceding the next succeeding Dividend Payment Date. 

  
 2 

 “Dividend Threshold Amount” has the meaning set forth in
Section 6(g)(D). 
 “DTC” means The Depository Trust Company. 

“Electing Share” has the meaning set forth in Section 7. 

“Exchange Property” has the meaning set forth in Section 7. 

“Expiration Date” has the meaning set forth in Section 6(d)(vi). 

“FBCA” has the meaning set forth in the preamble. 

“Federal Reserve” means the Board of Governors of the Federal Reserve System. 

“Holder” means the Person in whose name the shares of the Series A Preferred Stock are registered, which may be treated
by the Corporation and the Transfer Agent as the absolute owner of the shares of Series A Preferred Stock for the purpose of making payment and settling conversions and for all other purposes. 

“Issue Date” means the first date of issuance of shares of Series A Preferred Stock. 

“Junior Stock” means the Common Stock and any other class or series of Corporation capital stock (including Preferred
Stock of any other series) issued in the future, unless the terms of which expressly provide that it ranks senior to, or on a parity with, Series A Preferred Stock as to rights dividend rights and/or as to on liquidation, dissolution or winding up
of the Corporation. 
 “Liens” has the meaning set forth in Section 8(b). 

“Liquidation Amount” means, initially, $1,000 per share of Series A Preferred Stock (as subsequently adjusted for any
split, subdivision, combination, consolidation, recapitalization or similar event with respect to the Series A Preferred Stock). 
 “Liquidation Preference” has the meaning set forth in Section 10(a). 
 “Mandatory Conversion” has the meaning set forth in Section 5(a). 
 “Market Disruption Event” means any of the following events has occurred: (i) any suspension of, or limitation imposed on, trading by the SEC or the relevant exchange or quotation
system during any period or periods aggregating one half-hour or longer and whether by reason of movements in price exceeding limits permitted by the SEC or relevant exchange or quotation system or otherwise relating to the Common Stock or in
futures or option contracts relating to the Common Stock on the relevant exchange or quotation system, (ii) any event (other than a failure to open or a closure as described below) that disrupts or impairs the ability of market participants
during any period or periods aggregating one half-hour or longer in general to effect transactions in, or obtain market values for, the Common Stock on the relevant exchange or quotation system or futures or options contracts relating to the Common
Stock on any relevant exchange or quotation system, or (iii) the failure to open of the exchange or quotation system on which the Common Stock or futures or options contracts relating to the Common Stock are traded or the closure of such
exchange or quotation system prior to its respective scheduled closing time for the regular trading session on such day (without regard to after hours or other trading outside the regular trading session hours), unless such earlier closing time is
announced by such exchange or quotation system at least one hour prior to the earlier of the actual closing time for the regular trading session on such day and the submission deadline for orders to be entered into such exchange or quotation system
for execution at the actual closing time on such day. 
 “Nasdaq” means the Nasdaq Global Market or other
Nasdaq market in which the Corporation’s Common Stock is then traded. 

  
 3 

 “Notice of Mandatory Conversion” has the meaning set forth in
Section 5(b). 
 “Parity Stock” means any class or series of Corporation capital stock (other than the
Series A Preferred Stock) authorized in the future, the terms of which expressly provide that such class or series will rank on a parity with Series A Preferred Stock as to dividend rights and/or as to rights on liquidation, dissolution or winding
up of the Corporation (in each case without regard to whether dividends accrue cumulatively or noncumulatively). 

“Person” means a legal person, including any individual, corporation, estate, partnership, joint venture, association,
joint-stock company, limited liability company or trust. 
 “Preferred Stock” means any and all series of the
Corporation’s preferred stock, including the Series A Preferred Stock. 
 “Purchased Shares” has the
meaning set forth in Section 6(d)(vi). 
 “Record Date” means, (i) with respect to payment of
dividends on outstanding shares of Series A Preferred Stock, the 1st calendar day immediately preceding the relevant Dividend Payment Date or such other record date fixed by the Board of Directors that is not more than 60 nor less than 10 days prior
to such Dividend Payment Date, and (ii) for purpose of an adjustment to the Conversion Rate pursuant to Section 6, with respect to any dividend, distribution or other transaction or event in which the holders of Common Stock have the right
to receive any cash, securities or other property or in which the Common Stock (or other applicable security) is exchanged for or converted into any combination of cash, securities or other property, the date fixed for determination of holders of
the Common Stock entitled to receive such cash, securities or other property (whether such date is fixed by the Board of Directors or by statute, contract or otherwise). 
 “Record Holder” means, as to any day, the Holder of record of outstanding shares of Series A Preferred Stock as they appear on the stock register of the Corporation or its Transfer Agent
at the close of business on such day. 
 “Regulatory Approvals” with respect to any Holder, means the
collective reference, to the extent applicable and required to permit such Holder to convert such Holder’s shares of Series A Preferred Stock into Common Stock and to own such Common Stock without such Holder being in violation of applicable
law, the receipt of approvals and authorizations of, filings and registrations with, notifications to, or expiration or termination of any applicable waiting period under, the BHC Act, the CIBC Act or any similar state laws, Hart-Scott-Rodino
Antitrust Improvements Act of 1976 or the competition or merger control laws of other jurisdictions, in each case to the extent necessary to permit such Holder to convert such shares of Series A Preferred Stock and own shares of Common Stock
pursuant to these Articles of Amendment. 
 “Reorganization Effective Time” has the meaning set forth in
Section 7. 
 “Reorganization Event” has the meaning set forth in Section 7. 

“SEC” means the United States Securities and Exchange Commission. 

“Series A Preferred Stock” has the meaning set forth in Section 1. 

“Series A Preferred Stock Certificate” has the meaning set forth in Section 20. 

“Shareholder Approvals” means all approvals by the Corporation’s shareholders necessary to (i) approve the
issuance of Common Stock upon the Mandatory Conversion for purposes of Rule 5635 of the Nasdaq Listing Rules, and (ii) amend the Articles to increase the number of authorized shares of Common Stock to permit the Mandatory Conversion in full and
to provide additional authorized shares of Common Stock for general corporate purposes. 
 “Spin-Off” has the
meaning set forth in Section 6(d)(iv)(B). 

  
 4 

 “Trading Day” means any day on which (i) there is no Market Disruption
Event and (ii) the Nasdaq is open for trading, or, if the Common Stock (or any other securities, cash or other property into which shares of the Series A Preferred Stock becomes convertible in connection with any Reorganization Event) is not
listed on the Nasdaq, any day on which the principal national securities exchange or trading system on which the Common Stock (or such other property) is listed or traded is open for trading, or, if the Common Stock (or such other property) is not
listed on a national securities exchange or traded on a trading system, any Business Day. A “Trading Day” only includes those days that have a scheduled closing time of 4:00 P.M. Eastern Time or the then standard closing time for
regular trading on the relevant exchange or trading system. 
 “Transfer Agent” means, initially, Registrar and
Transfer Company, and any successor transfer agent as provided in Section 19. The Transfer Agent shall also be the registrar for the Series A Preferred Stock. 
 “U.S. Alien Holder” means a Holder that is not treated as a United States person for U.S. federal income tax purposes as defined under Section 7701(a)(30) of the Internal Revenue
Code of 1986, as amended from time to time. 
 “Voting Parity Stock” means, with regard to any matter as to
which the holders of Series A Preferred Stock are entitled to vote as specified in Section 13(b) of these Articles of Amendment, any and all series of Parity Stock upon which like voting rights have been conferred and are exercisable with
respect to such matter. 
 “VWAP” means, on any Trading Day the volume weighted average price per share of
Common Stock as displayed on Bloomberg (or any successor service) in respect of the period from 9:30 A.M. to 4:00 P.M., Eastern Time, on such Trading Day; or, if such price is not available, the volume weighted average price means the market value
per share of our Common Stock on such trading day as determined by a nationally recognized independent investment banking firm retained by the Corporation for this purpose. 
 Section 4. Dividends. 
 (a) Commencing on the Issue Date, Holders of shares
of outstanding Series A Preferred Stock shall be entitled to receive, when, as and if declared by the Board of Directors out of Corporation funds legally available therefor, noncumulative dividends in arrears at the rate per annum of 15% per
share on the Liquidation Amount (equivalent to $150.00 per annum per share), payable semi-annually on each Dividend Payment Date beginning on the Dividend Payment Commencement Date until the Conversion Date. Dividends will be payable on a Dividend
Payment Date to Holders that are Record Holders as of the applicable Record Date with respect to such Dividend Payment Date, but only to the extent a dividend has been declared to be payable on such Dividend Payment Date. If any Dividend Payment
Date is not a Business Day, the dividend payable on such date shall be paid on the next succeeding Business Day without adjustment and without interest. Accumulations of dividends on shares of Series A Preferred Stock shall not bear interest.
Dividends payable for any period other than a full Dividend Period (based on the number of actual days elapsed during the period) shall be computed on the basis of days elapsed over a 360-day year consisting of twelve 30-day months. 

(b) Dividends on the Series A Preferred Stock are not cumulative. To the extent that the Corporation’s Board of Directors does not
declare and pay dividends on the Series A Preferred Stock for a Dividend Period prior to the related Dividend Payment Date, in full or otherwise, such unpaid dividend shall not accrue and shall not be payable. The Corporation shall have no
obligation to pay dividends for such Dividend Period after the Dividend Payment Date for such Dividend Period or to pay interest (or any other sum of money in lieu of interest) with respect to such scheduled, but missed dividends, whether or not the
Corporation declares dividends on the Series A Preferred Stock for any subsequent Dividend Period. 
 (c) So long as any share of
Series A Preferred Stock remains outstanding, no dividend or distribution shall be declared or paid upon, or any sum set apart for the payment of dividends upon, the Common Stock or any other shares of Junior Stock (other than dividends payable
solely in shares of Common Stock) or Parity Stock, subject to this Section 4(d) in the case of Parity Stock, and no Common Stock, Junior Stock or Parity Stock shall be, directly or indirectly, purchased, redeemed or otherwise acquired for
consideration by the Corporation or any of its subsidiaries unless all dividends on all outstanding shares of the Series A Preferred Stock for any Dividend Period have been declared and paid in full (or have been declared and a sum sufficient for
the 

  
 5 

 
payment thereof has been set aside for the benefit of the Holders of shares of Series A Preferred Stock on the applicable Record Date). The foregoing limitation shall not apply to (i) any
dividends or distributions of rights or Junior Stock in connection with a shareholders’ rights plan or any redemption or repurchase of rights pursuant to any shareholders’ rights plan; (ii) the acquisition by the Corporation or any of
its subsidiaries of record ownership in Junior Stock or Parity Stock for the beneficial ownership of any other persons (other than for the beneficial ownership by the Corporation or any of its subsidiaries), including as trustees or custodians; and
(iii) the exchange or conversion of Junior Stock for or into other Junior Stock or of Parity Stock for or into other Parity Stock (with the same or lesser aggregate liquidation amount) or Junior Stock, in each case, solely to the extent
required pursuant to binding contractual agreements entered into prior to the Issue Date or any subsequent agreement for the accelerated exercise, settlement or exchange thereof for Common Stock. 

(d) When dividends are not paid (or declared and a sum sufficient for payment thereof set aside for the benefit of the Holders thereof on
the applicable Record Date) on any Dividend Payment Date (or, in the case of Parity Stock having dividend payment dates different from the Dividend Payment Dates, on a dividend payment date falling within a Dividend Period related to such Dividend
Payment Date) in full upon shares of Series A Preferred Stock and any shares of Parity Stock, all dividends declared on shares of Series A Preferred Stock and all such Parity Stock and payable on such Dividend Payment Date (or, in the case of Parity
Stock having dividend payment dates different from the Dividend Payment Dates, on a dividend payment date falling within the Dividend Period related to such Dividend Payment Date) shall be declared pro rata so that the respective amounts of
such dividends declared shall bear the same ratio to each other as full dividends payable on the Series A Preferred Stock for such Dividend Period and all Parity Stock payable on such Dividend Payment Date (or, in the case of Parity Stock having
dividend payment dates different from the Dividend Payment Dates, on a dividend payment date falling within the Dividend Period related to such Dividend Payment Date) (subject to the dividends being declared by the Board of Directors out of legally
available funds and including, in the case of Parity Stock that bears cumulative dividends, all accrued but unpaid dividends) bear to each other. If the Board of Directors determines not to pay any dividend or a full dividend on a Dividend Payment
Date, the Corporation will provide written notice to the Holders of shares of Series A Preferred Stock prior to such Dividend Payment Date. 
 (e) If the Conversion Date is on or prior to the Dividend Payment Commencement Date, no Holder of shares of Series A Preferred Stock will have any right to receive any dividends on the Series A Preferred
Stock with respect to such Dividend Period, whether upon Conversion or otherwise. 
 (f) All dividends on shares of Series A
Preferred Stock shall be paid solely in cash. 
 (g) Prior to the Conversion Date, shares of Common Stock issuable upon
Conversion of any shares of Series A Preferred Stock shall not be deemed outstanding for any purpose, and Holders of shares of Series A Preferred Stock shall have no rights as holders or otherwise with respect to the Common Stock (including voting
rights, rights to respond to tender offers for the Common Stock and rights to receive any dividends or other distributions on the Common Stock) by virtue of holding shares of Series A Preferred Stock. 

Section 5. Mandatory Conversion; Conversion Procedures. 
 (a) Effective as of the close of business on the Business Day on which the Shareholder Approvals are received (the “Conversion Date”) with respect to Series A Preferred Stock, all shares
of Series A Preferred Stock shall, without any action by the holders, automatically convert into the number of shares of Common Stock as set forth below (the “Mandatory Conversion”). Upon the Conversion Date, each certificate
representing shares of Series A Preferred Stock shall represent solely the right to receive a certificate representing the number of shares of Common Stock issued upon the Conversion Date for the shares of Series A Preferred Stock represented by
each such certificate, upon proper surrender of such certificates to the Corporation or cancellation of such book entries on the Corporation’s or its Transfer Agent’s records, as applicable. The number of shares of Common Stock into which
a share of Series A Preferred Stock shall be convertible shall be determined by dividing the Liquidation Amount by the Conversion Price (subject to the conversion procedures of Section 6 hereof) plus cash in lieu of fractional shares in
accordance with Section 9 hereof. 

  
 6 

 (b) Upon receipt of the Shareholder Approvals, the Corporation shall provide promptly, but
in any event within five (5) Business Days thereafter, notice of conversion to each Holder (such notice a “Notice of Mandatory Conversion”). In addition to any information required by applicable law or regulation, the Notice of
Mandatory Conversion with respect to such Holder shall state, as appropriate: 
  

	 	(i)	the Conversion Date; 

  

	 	(ii)	a form of letter of transmittal to be completed and returned to the Transfer Agent; 

 

	 	(iii)	the number of shares of Common Stock (plus cash in lieu of fractional shares, if any pursuant to Section 9) received upon Conversion of each share of Series A
Preferred Stock held of record by such Holder upon such Mandatory Conversion; and 

  

	 	(iv)	the place or places where Series A Preferred Stock Certificates (if held in certificated form) held of record by such Holder are to be surrendered for issuance of
certificates representing shares of Common Stock. 

 (c) Upon receipt by the Transfer Agent of a completed and duly
executed letter of transmittal as contemplated by Section 5(b), and proper surrender of the Series A Preferred Stock certificate (if held in certificated form), the Corporation shall, within two (2) Business Days following notification
from the Transfer Agent of the proper surrender of such certificate, instruct the Transfer Agent to issue a certificate for that number of shares of Common Stock issuable upon the Conversion of the shares of Series A Preferred Stock represented by
such certificate. 
 Section 6. Certain Conversion Procedures and Adjustments. 

(a) On the Conversion Date, the Series A Preferred Stock shall no longer be outstanding, and dividends shall no longer accrue, be declared
or paid on any shares of Series A Preferred Stock for the current Dividend Period and any prior Dividend Periods and, in each case, subject to the right of Holders of such shares to receive solely (i) the number of shares of Common Stock into
which such shares of Series A Preferred Stock are convertible, and (ii) payments, if any, to which such Holders are entitled pursuant to Sections 5 and 9, as applicable. 
 (b) Shares of Series A Preferred Stock duly converted in accordance herewith, or otherwise reacquired by the Corporation, shall resume the status of authorized and unissued Preferred Stock, undesignated
as to series and available for future issuance, provided that any such cancelled shares of Series A Preferred Stock may be reissued only as shares of any series of Preferred Stock other than Series A Preferred Stock. 

(c) The Record Holder of the Series A Preferred Stock shall be solely entitled to receive the Common Stock and/or cash, securities or
other property issuable upon the Conversion, and, prior to the Conversion, shall not be treated for any purpose as the Record Holder(s) of such shares of Common Stock and/or other securities. No shares of Common Stock issuable upon the Conversion
shall be issued to a Person other than the respective Record Holders of shares of Series A Preferred Stock. 
 (d) The Conversion
Rate shall be adjusted from time to time as follows: 
  

	 	(i)	If the Shareholder Approvals are not received within 75 calendar days following the Issue Date, the Conversion Price will be decreased (in addition to any other
adjustments pursuant to this Section 6) by 10% effective as of 76th day following the Issue Date and the Conversion Rate shall concurrently be adjusted to give effect to such change. 

  
 7 

	 	(ii)	If the Corporation issues Common Stock as a dividend or distribution on the Common Stock to all holders of the Common Stock (other than in connection with a
Reorganization Event), or if the Corporation effects a share split or share combination of the Common Stock, the Conversion Rate will be adjusted based on the following formula: 

 

					
	CR1	  	=	    	CR0 × [OS1
/OS0]
			
	where	  		    	
			
	CR0	  	=	    	the Conversion Rate in effect at the close of business on the Record Date
			
	CR1	  	=	    	the new Conversion Rate in effect immediately after the Record Date
			
	OS0	  	=	    	the number of shares of Common Stock outstanding at the close of business on the Record Date prior to giving effect to such event
			
	OS1	  	=	    	the number of shares of Common Stock that would be outstanding immediately after, and solely as a result of, such event.

 Any adjustment made pursuant to this clause (ii) shall become effective on the date that is
immediately after (x) the Record Date or (y) the date on which such split or combination becomes effective, as applicable. If any dividend or distribution described in this clause (ii) is declared but not so paid or made, the new
Conversion Rate shall be readjusted to the Conversion Rate that would then be in effect if such dividend or distribution had not been declared. 
  

	 	(iii)	If the Corporation issues to all holders of Common Stock any rights, warrants, options or other securities (other than rights issued pursuant to a shareholder rights
plan or rights or warrants issued in connection with a Reorganization Event) entitling them for a period of not more than 60 days after the date of issuance thereof to subscribe for or purchase shares of Common Stock, or if the Corporation issues to
all holders of Common Stock securities convertible into Common Stock for a period of not more than 60 days after the date of issuance thereof, in either case at an exercise price per share of Common Stock or a conversion price per share of Common
Stock less than the Current Market Price of the Common Stock on the Record Date, the Conversion Rate will be adjusted based on the following formula: 

 

					
	CR1	  	=	    	CR0 × [(OS0 +
X) / (OS0 + Y)]
			
	where	  		    	
			
	CR0	  	=	    	the Conversion Rate in effect at the close of business on the Record Date
			
	CR1	  	=	    	the new Conversion Rate in effect immediately after the Record Date
			
	OS0	  	=	    	the number of shares of Common Stock outstanding at the close of business on the Record Date

  
 8 

 
					
	X	  	=	  	the total number of shares of Common Stock issuable pursuant to such rights, warrants, options, other securities or convertible securities (or upon conversion of such
securities)
			
	Y	  	=	  	the number of shares of Common Stock equal to the quotient of (A) the aggregate price payable to exercise such rights, warrants, options, other securities (or the conversion price
for such securities paid upon conversion) and (B) the Current Market Price per share of Common Stock immediately preceding the date of announcement for the issuance of such rights, warrants, options, other securities or convertible
securities.

 For purposes of this clause (iii), in determining whether any rights, warrants, options, other
securities or convertible securities entitle the holders to subscribe for or purchase, or exercise a conversion right for, Common Stock at less than the applicable Current Market Price per share of Common Stock on the applicable date, and in
determining the aggregate exercise or conversion price payable for such Common Stock, there shall be taken into account any consideration the Corporation receives for such rights, warrants, options, other securities or convertible securities and any
amount payable on exercise or conversion thereof, with the value of such consideration, if other than cash, to be determined in good faith by the Board of Directors. If any right, warrant, option, other security or convertible security described in
this clause (iii) is not exercised or converted prior to the expiration of the exercisability or convertibility thereof, the new Conversion Rate shall be readjusted to the Conversion Rate that would then be in effect if such right, warrant,
option, other security or convertible security had not been so issued. 
 Any adjustment made pursuant to this clause
(iii) shall become effective on the date that is immediately after the Record Date. 
  

	 	(iv)	(A) If the Corporation distributes capital stock (other than Common Stock), evidences of indebtedness or other assets or property of the Corporation to all holders
of the Common Stock, excluding: 

  

	 	(x)	dividends, distributions, rights, warrants, options, other securities or convertible securities referred to in clause (ii) or (iii) above,

  

	 	(y)	dividends or distributions paid exclusively in cash, and 

  

	 	(z)	Spin-Offs (as described below), 

then the Conversion Rate will be adjusted based on the following formula: 

 

					
	CR1	  	=	  	CR0 × [SP0
/(SP0 - FMV)]
			
	where	  		  	

  
 9 

 
					
			
	CR0	  	=	  	the Conversion Rate in effect at the close of business on the Record Date
			
	CR1	  	=	  	the new Conversion Rate in effect immediately after the Record Date
			
	SP0	  	=	  	the Current Market Price of the Common Stock on the Record Date
			
	FMV	  	=	  	the fair market value (as determined in good faith by the Board of Directors) of the capital stock, evidences of indebtedness, assets or property distributed with respect to each
outstanding share of Common Stock on the Record Date.

 Notwithstanding the immediately preceding sentence, if “FMV” with
respect to any distribution of shares of capital stock, evidences of indebtedness or other assets or property of the Corporation is equal to or greater than “SP0” with respect to such distribution, then in lieu of the foregoing adjustment, adequate provision shall be made so
that each holder of Series A Preferred Stock shall have the right to receive on the date such shares of capital stock, evidences of indebtedness or other assets or property of the Corporation are distributed to holders of Common Stock, for each
share of Series A Preferred Stock, the amount of shares of capital stock, evidences of indebtedness or other assets or property of the Corporation such holder of Series A Preferred Stock would have received had such holder of Series A Preferred
Stock owned a number of shares of Common Stock into which such Series A Preferred Stock is then convertible at the conversion rate in effect on the Record Date for such distribution. 

An adjustment to the Conversion Rate made pursuant to this clause (iv)(A) shall be made successively whenever any such distribution is
made and shall become effective on the Record Date. 
 (B) If the Corporation distributes to all holders of the Common Stock,
capital stock of any class or series, or similar equity interest, of or relating to a subsidiary or other business unit of the Corporation (a “Spin-Off”), the Conversion Rate will be adjusted based on the following formula:

  

					
			
	CR1	  	=	  	CR0 × [(FMV0
+ MP0) /MP0]
			
	where:	  		  	
			
	CR0	  	=	  	the Conversion Rate in effect at the close of business on the Record Date
			
	CR1	  	=	  	the new Conversion Rate in effect immediately after the Record Date
			
	FMV0	  	=	  	the average volume weighted average price of the capital stock or similar equity interest distributed to holders of the Common Stock applicable to one share of Common Stock for the
10 consecutive Trading Days commencing on, and including, the third Trading Day after the date on which “ex-distribution

  
 10 

					
		  		  	trading” commences for such dividend or distribution with respect to the Common Stock on the Nasdaq or such other national or regional exchange or association or
over-the-counter market or if not so traded or quoted, the fair market value (as determined in good faith by the Board of Directors) of the capital stock or similar equity interests distributed to holders of the Common Stock applicable to one share
of the Common Stock
			
	MP0	  	=	  	the Average VWAP of the Common Stock for the 10 consecutive Trading Days commencing on, and including, the third Trading Day after the date on which “ex-distribution
trading” commences for such dividend or distribution with respect to the Common Stock on the Nasdaq or such other U.S. national or regional exchange or market that is at that time the principal exchange or market for the Common
Stock.

 An adjustment to the Conversion Rate made pursuant to this clause (iv)(B) will occur on the 10th
Trading Day from and including the effective date of the Spin-Off; provided that in respect of any conversion within the 10 Trading Days immediately following and including the date of the Spin-Off, references with respect to the Spin-Off to
“the 10 consecutive Trading Days” shall be deemed replaced with a period of consecutive Trading Days containing such lesser number of Trading Days as have elapsed between the effective date of such Spin-Off and the Conversion Date and the
adjustment in respect of such conversion shall occur immediately prior to the conversion. 
 If any such dividend or
distribution described in this clause (iv) is declared but not paid or made, the new Conversion Rate shall be readjusted to be the Conversion Rate that would then be in effect if such dividend or distribution had not been declared. 

 

	 	(v)	If the Corporation pays or makes any dividend or distribution consisting exclusively of cash to all holders of Common Stock in excess of regular quarterly dividends
equal to the Dividend Threshold Amount, the Conversion Rate will be adjusted based on the following formula: 

  

					
	CR1	  	=	  	CR0 × [SP0
/(SP0 - C)]
			
	where:	  		  	
			
	CR0	  	=	  	the Conversion Rate in effect at the close of business on the Record Date
			
	CR1	  	=	  	the new Conversion Rate in effect immediately after the Record Date
			
	SP0	  	=	  	the Current Market Price of the Common Stock as of the Record Date
			
	C	  	=	  	the excess of the amount in cash per share that the Corporation distributes to holders of the Common Stock over the Dividend Threshold Amount.

  
 11 

 An adjustment to the Conversion Rate made pursuant to this clause (v) shall become
effective on the date fixed for determination of the holders of Common Stock entitled to receive such dividend or distribution. If any dividend or distribution described in this clause (v) is declared but not so paid or made, the new Conversion
Rate shall be readjusted to the Conversion Rate that would then be in effect if such dividend or distribution had not been declared. 
  

	 	(vi)	If the Corporation or any of its subsidiaries makes a payment in respect of a tender offer or exchange offer for the Common Stock to the extent that the cash and value
of any other consideration included in the payment per share of Common Stock exceeds the Current Market Price per share of Common Stock on the Trading Day next succeeding the last date on which tenders or exchanges may be made pursuant to such
tender or exchange offer (the “Expiration Date”), the Conversion Rate will be adjusted based on the following formula: 

 

					
	CR1	  	=	  	CR0 × [(FMV + (SP1 × OS1)) /
(SP1 × OS0)]
			
	where:	  		  	
			
	CR0	  	=	  	the Conversion Rate in effect at the close of business on the Expiration Date
			
	CR1	  	=	  	the new Conversion Rate in effect immediately after the Expiration Date
			
	FMV	  	=	  	The fair market value (as determined in good faith by the Board of Directors) on the Expiration Date, of the aggregate value of all cash and any other consideration paid or payable
for the Common Stock validly tendered or exchanged and not withdrawn as of the Expiration Date (the “Purchased Shares”)
			
	OS0	  	=	  	the number of shares of Common Stock outstanding on the Expiration Date, including any Purchased Shares
			
	OS1	  	=	  	the number of shares of Common Stock outstanding on the Expiration Date, excluding any Purchased Shares
			
	SP1	  	=	  	the Average VWAP of the Common Stock for the 10 consecutive Trading-Day period commencing on the Trading Day next succeeding the Expiration Date.

 If the application of the foregoing formula would result in a decrease in the Conversion Rate, no
adjustment to such Conversion Rate will be made. Any adjustment to a Conversion Rate made pursuant to this clause (vi) shall become effective on the date immediately following the last Trading Day included in the determination of the Average
VWAP of the Common Stock for purposes of SP1 

  
 12 

 
above; provided that in respect of any conversion within the 10 Trading Days commencing on the Trading Day next succeeding the Expiration Date, references to the “10 consecutive
Trading Days” with respect to this clause (vi) shall be deemed replaced with a period of consecutive Trading Days containing such lesser number of Trading Days as have elapsed between the Expiration Date and the Conversion Date, and the
adjustment in respect of such conversion shall occur immediately prior to the conversion. If the Corporation or one of its subsidiaries is obligated to purchase Common Stock pursuant to any such tender or exchange offer but is permanently prevented
by applicable law from effecting any such purchase or all such purchases are rescinded, the new Conversion Rate shall be readjusted to be the Conversion Rate that would be in effect if such tender or exchange offer had not been made. 

 

	 	(vii)	If the Corporation has in effect a shareholder rights plan while any shares of Series A Preferred Stock remain outstanding, Holders of Series A Preferred Stock will
receive, upon a conversion of Series A Preferred Stock, in addition to Common Stock, rights under the Corporation’s shareholder rights agreement unless, prior to such conversion, the rights have expired, terminated or been redeemed or unless
the rights have separated from the Common Stock. If the rights provided for in the shareholder rights plan have separated from the Common Stock in accordance with the provisions of the applicable shareholder rights agreement so that Holders of
Series A Preferred Stock would not be entitled to receive any rights in respect of the Common Stock, if any, that the Corporation is required to deliver upon conversion of Series A Preferred Stock, the Conversion Rate will be adjusted at the time of
separation as if the Corporation had distributed to all holders of the Common Stock, capital stock, evidences of indebtedness or other assets or property pursuant to clause (iv) above, subject to readjustment upon the subsequent expiration,
termination or redemption of the rights. A distribution of rights pursuant to a shareholder rights plan will not trigger an adjustment to the Conversion Rates pursuant to clauses (iii) or (iv) above. 

(e) The Corporation may make such increases in the Conversion Rate, in addition to any other increases required by this Section 6,
if the Board of Directors deems it advisable in order to avoid or diminish any income tax to holders of the Common Stock resulting from any dividend or distribution of the Corporation’s shares (or issuance of rights or warrants to acquire
shares) or from any event treated as such for income tax purposes or for any other reasons. If any adjustment to the Conversion Rate is treated as a distribution to any U.S. Alien Holder which is subject to withholding tax, the Corporation (or the
Transfer Agent or any paying agent on behalf of the Corporation) may set off any withholding tax that is required to be collected with respect to such deemed distribution against cash payments and other distributions otherwise deliverable to such
Holder. 
 (f) No adjustment in any Conversion Rate will be required unless the adjustment would require an increase or decrease
of at least 1% of the Conversion Rate. If the adjustment is not made because the adjustment does not change the Conversion Rate by at least 1%, then the adjustment that is not made will be carried forward and taken into account and included in any
future adjustment. All required calculations will be made to the nearest cent or 1/10,000th of a share. Notwithstanding the foregoing, all adjustments not previously made shall have effect with respect to the Conversion. No adjustment to the
Conversion Rates need be made if Holders may participate in the transaction that would otherwise give rise to such adjustment, so long as the distributed assets or securities the Holders would receive upon conversion of shares of Series A Preferred
Stock—if such assets or securities are convertible, exchangeable or exercisable—are convertible, exchangeable or exercisable, as applicable, without any loss of rights or privileges for a period of at least 45 days following conversion of
shares of Series A Preferred Stock. 

  
 13 

 (g) The applicable Conversion Rate shall not be adjusted: 

 

	 	(A)	upon the issuance of any shares of Common Stock pursuant to any present or future plan providing for the reinvestment of dividends or interest payable on the
Corporation’s securities and the investment of additional optional amounts in the Common Stock under any plan; 

  

	 	(B)	upon the issuance of any shares of Common Stock or options or rights to purchase those shares pursuant to any present or future employee, director or consultant benefit
plan, employee agreement or arrangement or program of the Corporation; 

  

	 	(C)	upon the issuance of any shares of Common Stock pursuant to any option, warrant, right, or exercisable, exchangeable or convertible security outstanding as of the Issue
Date; 

  

	 	(D)	as a result of payment of regular quarterly dividends on the Common Stock not in excess of $0.01 per share (the “Dividend Threshold Amount”);

  

	 	(E)	for a change in the par value of the Common Stock; or 

  

	 	(F)	as a result of a tender offer made solely to holders of fewer than 100 shares of the Common Stock. 

(h) The Corporation shall have the power to resolve any ambiguity and its action in so doing, as evidenced by a resolution of the Board,
shall be final and conclusive unless clearly inconsistent with the intent hereof. 
 (i) Whenever the Conversion Rate is to be
adjusted, the Corporation shall: (i) compute such adjusted Conversion Rate and prepare and transmit to the Transfer Agent an Officers’ Certificate setting forth such adjusted Conversion Rate, the method of calculating the adjusted
Conversion Rate in reasonable detail and the facts requiring such adjustment; (ii) as soon as practicable following the determination of a revised Conversion Rate, provide, or cause to be provided, a written notice to the Holders of shares of
Series A Preferred Stock of the occurrence of such event, a statement setting forth such revised Conversion Rate, the method of calculating the adjusted Conversion Rate in reasonable detail and the facts requiring such adjustment. Failure to deliver
such notice shall not affect the legality or validity of any such adjustment. 
 Section 7. Reorganization Events.

 (a) In the event that any of the following events occurs prior to the Conversion Date: 

 

	 	(i)	any consolidation or merger of the Corporation with or into another Person (other than a merger or consolidation in which the Corporation is the continuing corporation
and in which the shares of Common Stock outstanding immediately prior to the merger or consolidation are not exchanged for cash, securities or other property of the Corporation or another Person), 

 

	 	(ii)	any sale, transfer, lease or conveyance to another Person of all or substantially all of the Corporation’s property and assets, or 

 

	 	(iii)	any reclassification of the Common Stock into securities including securities other than the Common Stock (any such event specified in paragraphs (a) through
(c) of this Section 7, a “Reorganization Event”), 

  
 14 

 then each share of Series A Preferred Stock outstanding immediately prior to such Reorganization Event
shall, without the consent of the Holders thereof, remain outstanding but shall at each Holder’s option, subject to the applicable rules of Nasdaq Global Market or any other national securities exchange or automated quotation system where the
Common Stock is listed and other applicable laws and regulations, upon the effective date and time (“Reorganization Effective Time”) of such Reorganization Event, be convertible into the kind of securities, cash and other property
receivable in such Reorganization Event (without any interest thereon and without any right to dividends or distributions thereon which have a record date that is prior to the Reorganization Event) per share of Common Stock (the “Exchange
Property”) as if the Holder of such share of Series A Preferred Stock had converted such share into Common Stock immediately prior to such Reorganization Event and exercised his rights of election, if any, as to the kind or amount of
securities, cash and other property receivable upon such Reorganization Event (provided that if the kind or amount of securities, cash and other property receivable upon such Reorganization Event is not the same for each share of Common Stock
held immediately prior to such Reorganization Event and in respect of which such rights of election shall have been exercised (“Electing Share”), then, for the purpose of this Section 7 the kind and amount of securities, cash
and other property receivable upon such Reorganization Event by the holder of each Electing Share shall be deemed to be the weighted average of the kinds and amounts so receivable per share by the holders of the Electing Shares). The amount of
Exchange Property receivable upon any Reorganization Event shall be determined based upon the Conversion Rate in effect on such Reorganization Effective Time. 
 The above provisions of this Section 7 shall similarly apply to successive Reorganization Events and the provisions of Section 8 shall apply to any shares of capital stock of the Corporation (or
any successor) received by the holders of Common Stock in any such Reorganization Event. 
 The Corporation (or any successor)
shall, within 20 days of the Reorganization Effective Time of any Reorganization Event, provide written notice to the Holders of the occurrence of such event and of the kind and amount of the cash, securities or other property that constitute the
Exchange Property. Failure to deliver such notice shall not affect the operation or effect of this Section 7. 
 The
Corporation shall not enter into any agreement for a transaction constituting a Reorganization Event unless such agreement provides for or does not interfere with or prevent (as applicable) conversion of the Series A Preferred Stock into the
Exchange Property in a manner that is consistent with and gives effect to this Section 7. 
 Section 8. Reservation of
Common Stock. 
 (a) Following the receipt of the Shareholder Approvals, the Corporation shall at all times reserve and keep
available out of its authorized and unissued Common Stock or shares held in the treasury of the Corporation, solely for issuance upon the conversion of shares of Series A Preferred Stock as herein provided, free from any preemptive or other similar
rights, such number of shares of Common Stock as shall from time to time be issuable upon the conversion of all the shares of Series A Preferred Stock then outstanding. For purposes of this Section 8 (a), the number of shares of Common Stock
that shall be deliverable upon the conversion of all outstanding shares of Series A Preferred Stock shall be computed as if at the time of computation all such outstanding shares were held by a single Holder. 

(b) Notwithstanding the foregoing Section 8(a), the Corporation shall be entitled to deliver upon conversion of shares of Series A
Preferred Stock, as herein provided, shares of Common Stock reacquired and held in the treasury of the Corporation (in lieu of the issuance of authorized and unissued shares of Common Stock), so long as any such treasury shares are free and clear of
all liens, claims, charges, security interests or encumbrances (other than liens, claims, charges, security interests and other encumbrances, if any, created by the Holders) (“Liens”). 

(c) All shares of Common Stock delivered upon conversion of the Series A Preferred Stock shall be duly authorized, validly issued, fully
paid and non-assessable, free and clear of all Liens. 
 (d) Prior to the delivery of any securities that the Corporation shall
be obligated to deliver upon conversion of the Series A Preferred Stock, the Corporation shall use its reasonable best efforts to comply with all federal and state laws and regulations thereunder requiring the registration of such securities with,
or any approval of or consent to the delivery thereof by, any governmental or regulatory authority. 
  

  
 15 

 (e) The Corporation hereby covenants and agrees that, if at any time the Common Stock shall
be listed on the Nasdaq Global Market or any other national securities exchange or automated quotation system, the Corporation shall, if permitted by the rules of such exchange or automated quotation system, list and keep listed, so long as the
Common Stock shall be so listed on such exchange or automated quotation system, all Common Stock issuable upon conversion of the Series A Preferred Stock; provided, however, that if the rules of such exchange or automated quotation system
permit the Corporation to defer the listing of such Common Stock until the first conversion of shares of Series A Preferred Stock into Common Stock in accordance with the provisions hereof, the Corporation covenants to list such Common Stock
issuable upon conversion of shares of Series A Preferred Stock in accordance with the requirements of such exchange or automated quotation system at such time. 
 Section 9. Fractional Shares. 
 (a) No fractional shares of Common Stock
shall be issued as a result of any conversion of shares of Series A Preferred Stock. 
 (b) In lieu of any fractional share of
Common Stock otherwise issuable in respect of any Conversion, the Corporation shall at its option either (i) issue to such Holder an amount of shares rounded up to the next whole share of Common Stock or (ii) pay an amount in cash
(computed to the nearest cent) equal to the same fraction of the Current Market Price of the Common Stock as of the end of the Trading Day preceding the Conversion Date. 
 (c) If more than one share of the Series A Preferred Stock is surrendered for conversion at one time by or for the same Holder, the number of full shares of Common Stock issuable upon conversion thereof
shall be computed on the basis of the aggregate number of shares of the Series A Preferred Stock so surrendered. 
 Section
10. Liquidation Rights. 
 (a) Voluntary or Involuntary Liquidation. In the event of any liquidation, dissolution or
winding up of the affairs of the Corporation, whether voluntary or involuntary, each Holder of shares of Series A Preferred Stock shall be entitled to receive for each share of Series A Preferred Stock, out of the assets of the Corporation or
proceeds thereof (whether capital, surplus or other) available for distribution to shareholders of the Corporation, subject to the rights of any creditors of the Corporation, before any distribution of such assets or proceeds is made to or set aside
for the holders of Common Stock and any other Junior Stock of the Corporation, payment in full in an amount equal to the sum of (i) Liquidation Amount per share of Series A Preferred Stock and (ii) any declared and unpaid dividends on such
share to the extent provided in Section 4 (all such amounts collectively, the “Liquidation Preference”). 

(b) Partial Payment. If any distribution described in Section 10(a) of the Corporation’s assets or the proceeds thereof
are not sufficient to pay in full the amounts payable with respect to all outstanding shares of Series A Preferred Stock and the corresponding amounts payable with respect of any other Corporation capital stock ranking equally with Series A
Preferred Stock as to such distribution, Holders of Series A Preferred Stock and the holders of such other stock shall share ratably in any such distribution in proportion to the full respective distributions (including, if applicable, dividends on
such amount) to which they are entitled. 
 (c) Residual Distributions. If the Liquidation Preference has been paid in
full to all Holders of Series A Preferred Stock and the corresponding amounts payable with respect of any other Corporation capital stock ranking equally with Series A Preferred Stock as to such distribution has been paid in full, the Holders of the
Series A Preferred Stock will have no right or claim to any of the remaining assets of the Corporation (or the proceeds thereof). 

  
 16 

 (d) Merger, Consolidation and Sale of Assets Not a Liquidation. For purposes of this
Section 10, a Reorganization Event, including, without limitation, the merger or consolidation of the Corporation with any other corporation or other entity, including a merger or consolidation in which the Holders of shares of Series A
Preferred Stock receive cash, securities or other property for their shares, or the sale, lease, or exchange (for cash, securities or other property) or pledge of all or substantially all of the assets of the Corporation, shall not constitute a
liquidation, dissolution or winding up of the Corporation. 
 Section 11. No Sinking Fund, etc. The shares of
Series A Preferred Stock will not be subject to any mandatory redemption, sinking fund or other similar provisions. Holders of shares of Series A Preferred Stock will have no right to require the Corporation to redeem or repurchase any shares of
Series A Preferred Stock. 
 Section 12. Status of Repurchased Shares. Shares of Series A Preferred Stock that are
converted into Common Stock or repurchased or otherwise acquired by the Corporation shall revert to authorized but unissued shares of Preferred Stock undesignated as to series (provided that any such cancelled shares of Series A Preferred
Stock may be reissued only as shares of any series of Preferred Stock other than Series A Preferred Stock). 
 Section 13.
Voting Rights. 
 (a) General. The Holders of shares of Series A Preferred Stock shall not have any voting rights
except as set forth below or as otherwise from time to time required by law. Holders of shares of Series A Preferred Stock will be entitled to one vote for each such share on any matter on which Holders of shares of Series A Preferred Stock are
entitled to vote, including any action by written consent. 
 (b) Voting Rights as to Particular Matters. So long as any
shares of Series A Preferred Stock are outstanding, in addition to any other vote or consent of shareholders required by law or by the Articles, the affirmative vote or consent of the Holders of at least 66 2/3% of the shares of Series A Preferred
Stock at the time outstanding, voting as a separate class, given in person or by proxy, by vote at any meeting called for the purpose, shall be necessary for effecting or validating: 

 

	 	(i)	Authorization of Senior Stock. Any amendment or alteration of the Articles or any articles of amendment thereto to authorize or create or increase the authorized
amount of, or any issuance of, any shares of, or any securities convertible into or exchangeable or exercisable for shares of, any class or series of Corporation capital stock Corporation ranking senior to the Series A Preferred Stock with respect
to either or both the payment of dividends and/or the distribution of assets on any liquidation, dissolution or winding up of the Corporation; 

  

	 	(ii)	Amendment of Series A Preferred Stock. Any amendment, alteration or repeal of any provision of the Articles or these Articles of Amendment thereto (including,
unless no vote on such merger, consolidation or other transaction is required by clause (iii) below, any amendment, alteration or repeal by means of a merger, consolidation or otherwise) so as to adversely affect the rights, preferences,
privileges or voting powers of shares of Series A Preferred Stock; or 

  

	 	(iii)	 Share Exchanges, Reclassifications, Mergers and Consolidations. Any Reorganization Event, including, without limitation, a binding share
exchange or reclassification involving the shares of Series A Preferred Stock, or of a merger or consolidation of the Corporation with another corporation or other entity, unless in each case (x) the shares of Series A Preferred Stock remain
outstanding or, in the case of any such merger, consolidation or share exchange with respect to which the Corporation is not the surviving or resulting entity, are converted into or exchanged for preference securities of the surviving or resulting
entity or its ultimate parent, and (y) such shares remaining outstanding or such preference securities, as the case may be, have such rights, preferences, 

  
 17 

	 	
privileges and voting powers, and limitations and restrictions thereof, taken as a whole, as are not materially less favorable to the holders thereof than the rights, preferences, privileges and
voting powers, and limitations and restrictions thereof, of shares of Series A Preferred Stock immediately prior to such consummation, taken as a whole; provided, however, any changes described in Sections 13(b)(i) or (ii) in connection
with or as a result of a Reorganization Event or other event described in Section 13(b)(iii) shall require the vote of the Holders of the Series A Preferred Stock; 

 provided further, however, that for all purposes of this Section 13(b), the creation and issuance, or an increase in the authorized or issued amount, whether pursuant to preemptive or similar
rights or otherwise, of any other series of Preferred Stock, or any securities convertible into or exchangeable or exercisable for any other series of Preferred Stock, ranking equally with and/or junior to Series A Preferred Stock with respect to
the payment of dividends (whether such dividends are cumulative or noncumulative) and the distribution of assets upon liquidation, dissolution or winding up of the Corporation will not be deemed to adversely affect the rights, preferences,
privileges or voting powers, and shall not require the affirmative vote or consent of, the Holders of outstanding shares of the Series A Preferred Stock. 
 (c) Procedures for Voting and Consents. The rules and procedures for calling and conducting any meeting of the Holders of Series A Preferred Stock (including, without limitation, the fixing of a
record date in connection therewith), the solicitation and use of proxies at such a meeting, the obtaining of written consents and any other aspect or matter with regard to such a meeting or such consents shall be governed by any rules of the Board
of Directors, in its discretion, may adopt from time to time, which rules and procedures shall conform to the requirements of the Corporation’s Articles, the Corporation’s Bylaws and applicable law and the rules of Nasdaq or any national
securities exchange or other trading facility, if any, on which Series A Preferred Stock is listed or traded at the time. 

Section 14. Record Holders. To the fullest extent permitted by applicable law, the Corporation and the Transfer Agent may
deem and treat the Record Holder of any share of Series A Preferred Stock as the true and lawful owner thereof for all purposes, and neither the Corporation nor such transfer agent shall be affected by any notice to the contrary. 

Section 15. Notices. All notices or communications in respect of Series A Preferred Stock shall be sufficiently given if
given in writing and delivered in person, by overnight courier, or by first class mail, postage prepaid, or if given in such other manner as may be permitted in these Articles of Amendment, in the Articles or Bylaws or by applicable law.
Notwithstanding the foregoing, if shares of Series A Preferred Stock are issued in book-entry form through DTC or any similar facility, such notices may be given to the Holders of Series A Preferred Stock in any manner permitted by or customarily
used by such facility and its participants. 
 Section 16. No Preemptive Rights; No Redemption Rights. No share of
Series A Preferred Stock shall have any preemptive rights whatsoever under the Articles and these Articles of Amendment as to any securities of the Corporation, or any warrants, rights or options issued or granted with respect thereto, regardless of
how such securities, or such warrants, rights or options, may be designated, issued or granted. No holder of shares of Series A Preferred Stock shall have at any time the right to put such shares of Series A Preferred Stock to the Corporation or to
have the Corporation redeem any shares of Series A Preferred Stock. 
 Section 17. Redemption by the Corporation.
The Series A Preferred Stock shall not be redeemable by the Corporation. In all events, any repurchase or redemption of Series A Preferred Stock shall be subject to the prior approval of the Corporation’s primary federal banking regulator, if
required by applicable law or regulation or if such approval is a requirement to the Series A Preferred Stock being classified as Tier 1 capital (or the equivalent) for bank regulatory purposes, together with any other required regulatory
approvals. 
 Section 18. Replacement Stock Certificates. If any of the Series A Preferred Stock Certificates
shall be mutilated, lost, stolen or destroyed, the Corporation shall, at the expense of the Holder, issue, in exchange and in substitution for and upon cancellation of the mutilated Series A Preferred Stock Certificate, or in lieu of and
substitution for the Series A Preferred Stock Certificate lost, stolen or destroyed, a new Series A Preferred Stock 

  
 18 

 
Certificate of like tenor and representing an equivalent amount of shares of Series A Preferred Stock, but only upon receipt of evidence of such loss, theft or destruction of such Series A
Preferred Stock Certificate and indemnity, if requested, satisfactory to the Corporation and the Transfer Agent. 
 Section
19. Transfer Agent, Registrar, Conversion and Dividend Paying Agent. The duly appointed transfer agent, registrar, conversion and dividend paying agent for shares of Series A Preferred Stock shall be the Transfer Agent. The Corporation
may, in its sole discretion, remove the Transfer Agent in accordance with the agreement between the Corporation and the Transfer Agent; provided that the Corporation shall appoint a successor transfer agent who shall accept such appointment
prior to the effectiveness of such removal. Upon any such removal or appointment, the Corporation shall send notice thereof by first-class mail, postage prepaid, to the Holders of shares of Series A Preferred Stock. 

Section 20. Form. The Series A Preferred Stock shall be issued in the form of one or more definitive shares in fully
registered form in substantially the form attached hereto as Exhibit A (each, a “Series A Preferred Stock Certificate”), which is hereby incorporated in and expressly made a part of these Articles of Amendment. Each Series A
Preferred Stock Certificate shall reflect the number of shares of Series A Preferred Stock represented thereby, and may have notations, legends or endorsements required by applicable law, applicable Nasdaq or other securities exchange or DTC rules
and arrangements, agreements to which the Corporation is subject, if any, (provided that any such notation, legend or endorsement is in a form acceptable to the Corporation). Each Series A Preferred Stock Certificate shall be registered in the name
or names of the Person or Persons specified by the Corporation in a written instrument to the Transfer Agent. 
 Two duly
authorized officers of the Corporation shall sign each Series A Preferred Stock Certificate for the Corporation, in accordance with the Corporation’s Bylaws and applicable law, by manual or facsimile signature. If an officer whose signature is
on a Series A Preferred Stock Certificate no longer holds that office at the time the Transfer Agent countersigned the Series A Preferred Stock Certificate, the Series A Preferred Stock Certificate shall be valid nevertheless. A Series A Preferred
Stock Certificate shall not be valid until an authorized signatory of the Transfer Agent manually countersigns Series A Preferred Stock Certificate. Each Series A Preferred Stock Certificate shall be dated the date of its countersignature.

 Section 21. Stock Transfer and Stamp Taxes. The Corporation shall pay any and all stock transfer and
documentary stamp taxes that may be payable in respect of any initial issuance or delivery of shares of Series A Preferred Stock or shares of Common Stock or other securities issued on account of Series A Preferred Stock pursuant hereto or
certificates representing such shares or securities. The Corporation shall not, however, be required to pay any such tax that may be payable in respect of any transfer involved in the issuance or delivery of shares of Series A Preferred Stock or
Common Stock or other securities in a name other than that in which the shares of Series A Preferred Stock with respect to which such shares or other securities are issued or delivered were registered, or in respect of any payment to any person
other than a payment to the Holder thereof, and shall not be required to make any such issuance, delivery or payment unless and until the person otherwise entitled to such issuance, delivery or payment has paid to the Corporation the amount of any
such tax or has established, to the satisfaction of the Corporation, that such tax has been paid or is not payable. 

Section 22. Other Rights. The shares of Series A Preferred Stock shall not have any rights, preferences, privileges or
voting powers or relative, participating, optional or other special rights, or qualifications, limitations or restrictions thereof, other than as set forth herein, or in the Articles or as provided by applicable law. 

III. 
 These
Articles of Amendment were duly adopted by the Board of Directors on ____________, 2012. 
 [Signature Page to Follow]

  
 19 

 IN WITNESS WHEREOF, the Corporation has authorized and caused these Articles of Amendment to
be signed by its President and Chief Executive Officer as of ____________, 2012. 
  

			
	JACKSONVILLE BANCORP, INC.
		
	By:	 	 
	Name: Stephen C. Green
	Title: President and Chief Executive Officer

  
 20 

 Exhibit A 

 

					
	 Number
 PA [ ]
	 		 	 Shares
 [Number of Shares]

 JACKSONVILLE BANCORP, INC. 
 INCORPORATED UNDER THE LAWS OF THE STATE OF FLORIDA 
  

					
	 THIS CERTIFIES THAT
  

is the owner of
	 	 NAME
  

[NUMBER OF SHARES]
	 	

 FULLY PAID AND NON-ASSESSABLE SHARES OF MANDATORILY CONVERTIBLE, 

NONCUMULATIVE, NONVOTING, PERPETUAL PREFERRED STOCK, SERIES A, $0.01 PAR VALUE OF 

JACKSONVILLE BANCORP, INC., 
 transferable on the books of the Corporation by the holder hereof, in person or by duly authorized attorney, upon surrender of this Certificate properly endorsed. This Certificate and the shares
represented hereby are issued and shall be subject to all of the provisions of the Articles of Incorporation, as amended, and By-laws of the Corporation as now or hereafter amended to all of which the holder hereof by acceptance hereby assents.

 This certificate is not valid unless countersigned by the Transfer Agent. 

WITNESS the facsimile seal of the Corporation and the facsimile signatures of its duly authorized officers. 

 

					
	Dated:	 		 	 COUNTERSIGNED AND
 REGISTERED
 Registrar and Transfer Company

			
	  
	 		 	
	PRESIDENT & CHIEF EXECUTIVE OFFICER	 		 	 TRANSFER AGENT AND
 REGISTRAR

			
	  
	 	[CORPORATE SEAL]	 	By:__________________________
	CORPORATE SECRETARY	 		 	Authorized Signature

  
 21 

 JACKSONVILLE BANCORP, INC. 

THE SECURITIES REPRESENTED BY THIS INSTRUMENT ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF A BANK AND ARE NOT INSURED BY THE FDIC OR ANY
OTHER GOVERNMENTAL AGENCY. 
 THE CORPORATION WILL FURNISH WITHOUT CHARGE TO EACH STOCKHOLDER OF THE CORPORATION WHO SO REQUESTS
THE POWERS, DESIGNATIONS, PREFERENCES AND RELATIVE PARTICIPATING, OPTIONAL OR SPECIAL RIGHTS OF EACH CLASS OF STOCK OR SERIES THEREOF OF THE CORPORATION AND THE QUALIFICATIONS, LIMITATIONS OR RESTRICTIONS OF SUCH PREFERENCES AND/OR RIGHTS. SUCH
REQUEST SHOULD BE ADDRESSED TO THE CORPORATION OR THE TRANSFER AGENT. 
 THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN
REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, OR SECURITIES LAWS OF ANY STATE AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
RELATING THERETO UNDER SUCH ACT AND APPLICABLE STATE SECURITIES LAWS OR PURSUANT TO AN AVAILABLE EXEMPTION FROM REGISTRATION UNDER SUCH ACT OR SUCH LAWS. 
 THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO TRANSFER AND OTHER RESTRICTIONS SET FORTH IN A STOCK PURCHASE AGREEMENT, EFFECTIVE AS OF THE EFFECTIVENESS DATE THEREOF, COPIES OF WHICH ARE
ON FILE WITH THE SECRETARY OF THE CORPORATION AT THE CORPORATION’S PRINCIPAL EXECUTIVE OFFICES. 
 The following
abbreviations, when used in the inscription on the face of this certificate, shall be construed as though they were written out in full according to applicable laws or regulations: 

 

			
	TEN COM - as tenants in common	 	 UNIF GIFT MIN ACT - _______ Custodian ________
                                   
        (Cust)                       (Minor)
 under Uniform Gifts to Minors Act _________________

                         
                                         
      (State)

		
	 TEN ENT - as tenants by the entireties
 JT TEN - as joint tenants with right of survivorship and not as tenants in common
	 	

 Additional abbreviations may also be used though not in the above list. 

 

			
		 	 PLEASE INSERT SOCIAL SECURITY OR
 OTHER
 IDENTIFYING NUMBER OF
ASSIGNEE

 For value received, _______________________________________do hereby sell, assign and
transfer unto 
 ________________________________________________________________________________________________Shares of the Mandatorily
Convertible Noncumulative Nonvoting Preferred Stock, Series A, represented by the within Certificate, and do hereby irrevocably constitute and appoint 
 ________________________________________________________________________________________________Attorney to transfer the Shares on the books of the within-named Corporation with full power of substitution
in the premises. 
  

			
	Dated: ________________	 	THE SIGNATURE(S) SHOULD BE GUARANTEED BY AN “ELIGIBLE GUARANTOR INSTITUTION”

  
 22 

			
		 	WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE MEDALLION PROGRAM PURSUANT TO S.E.C. RULE 17Ad-15 UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED.
	Notice: The signature(s) to this assignment must correspond with the name(s) as written upon the face of the certificate, in every particular, without alternation or
enlargement, or any change whatever.	 	SIGNATURE GUARANTEED BY:

  
 23 

 SCHEDULE II 

SUBSIDIARIES 

Subsidiaries of Jacksonville Bancorp, Inc.: 
 The Jacksonville Bank, a non-member banking corporation organized in the State of Florida 

Atlantic BancGroup, Inc. Statutory Trust I, a Delaware statutory trust 
 Jacksonville Statutory Trust I, a Delaware statutory trust 
 Jacksonville Statutory Trust II, a
Delaware statutory trust 
 Jacksonville Bancorp, Inc. Statutory Trust III, a Delaware statutory trust 

Subsidiaries of The Jacksonville Bank: 

East Arlington, Inc., a Florida corporation 

Fountain Financial, Inc., a Florida corporation 

Jarrett Point, LLC, a Florida limited liability company 
 Parman Place, Inc., a Florida corporation 
 S. PT. Properties, Inc., a Florida corporation

 TJB Properties, LLC, a Florida limited liability company 

 SCHEDULE III 

FORM OF SHARE INCREASE AMENDMENT 

 ARTICLES OF AMENDMENT TO 

AMENDED AND RESTATED ARTICLES OF INCORPORATION OF 
 JACKSONVILLE BANCORP, INC. 
 Pursuant to Section 607.1006 of the
Florida Business Corporation Act, the undersigned Corporation adopts these Articles of Amendment. 
 FIRST: The name of the
Corporation is JACKSONVILLE BANCORP, INC. 
 SECOND: The Amended and Restated Articles of Incorporation of this Corporation are
amended by replacing paragraph 4.01 of Article IV so that, as amended, said paragraph shall read as follows: 
 “4.01 General. The total number of shares of all classes of capital stock of the Corporation (“Shares”) that the Corporation shall have the authority to issue is 360 million,
consisting of the following classes: 
 (1) 350 million Shares of common stock, $0.01 par value per share
(“Common Stock”); and 
 (2) 10 million Shares of preferred stock, $0.01 par value per share
(“Preferred Stock”).” 
 THIRD: The amendment to the Amended and Restated Articles of Incorporation of the
Corporation set forth above was adopted on ______________, 2012. 
 FOURTH: The amendment was approved by the Corporation’s
shareholders. The number of votes cast for the amendment by the shareholders was sufficient for approval. 
 Signed on
________________, 2012. 
  

			
	JACKSONVILLE BANCORP, INC.
		
	By:	 	 
		 	Stephen C. Green, President & CEO

 SCHEDULE IV 

FORM OF INCENTIVE PLAN AMENDMENT 

 APPENDIX A 

SECOND AMENDMENT TO THE 
 2008 AMENDMENT AND RESTATEMENT OF THE 
 JACKSONVILLE BANCORP, INC. 2006
STOCK INCENTIVE PLAN 
 This SECOND AMENDMENT (the “Amendment”) to the 2008 Amendment and Restatement of the
Jacksonville Bancorp, Inc. 2006 Stock Incentive Plan by Jacksonville Bancorp, Inc., a Florida corporation (the “Company”), shall be effective upon the date of approval (the “Effective Date”) of the Amendment by the affirmative
vote of the holders of a majority of the votes cast at the ___________, 2012 Special Meeting of the Company’s shareholders. 
 WHEREAS, the Company maintains the 2008 Amendment and Restatement of the Jacksonville Bancorp, Inc. 2006 Stock Incentive Plan, effective April 29, 2008 (the “Plan”). 

WHEREAS, pursuant to Section 14 of the Plan, the Board of Directors of the Company desires to (i) increase the number of shares
of common stock available for issuance under the Plan, and (ii) eliminate certain minimum vesting conditions for awards of restricted stock and restricted stock units. 
 NOW, THEREFORE, the Plan is amended as follows as of the Effective Date: 
  

	I.	Section 4(a) of the Plan shall be amended by deleting it in its entirety and replacing it with the following: 

“(a) Subject to Section 15 of the Plan, there shall be reserved for issuance under the Plan an aggregate of
[________] common shares of Company Stock, which shall be authorized but unissued shares. All of the shares available for issuance to Participants who are employees of the Company or its subsidiaries may, but need not, be issued pursuant to the
exercise of Incentive Stock Options. Shares covered by an Incentive Award granted under the Plan shall not be counted as used unless and until they are actually issued and delivered to a Participant.” 

 

	II.	Section 7(d) of the Plan shall be amended by deleting it in its entirety and replacing it with the following: 

“(d) The Committee shall establish as to each award of Restricted Stock the terms and conditions upon which the restrictions set
forth in paragraph (b) above shall expire. The terms and conditions may include the achievement of a Performance Goal. The Committee may, in its discretion, grant a Restricted Stock award all or any portion of which is immediately vested as of
the Date of Grant. The terms and conditions of a Restricted Stock award shall be governed by the provisions of Section 10 to the extent that the award is intended to comply with the requirements of Code Section 162(m).” 

	III.	Section 8(b) of the Plan shall be amended by deleting it in its entirety and replacing it with the following: 

“(b) Restricted Stock Units shall be subject to such restrictions as the Committee determines, including, without limitation, any of
the following: 
 (i) a prohibition against sale, assignment, transfer, pledge, hypothecation or other encumbrance for a
specified period; or 
 (ii) a requirement that the holder forfeit such units in the event of termination of employment during
the period of restriction. 
 All restrictions shall expire at such times as the Committee shall specify. The Committee may, in
its discretion, grant a Restricted Stock Unit award all or any portion of which is immediately vested as of the Date of Grant. In addition, the Committee may at any time, in its sole discretion, modify the terms and conditions of a Restricted Stock
Unit award (including any or all of the restrictions applicable thereto), subject to the restrictions of Section 10 as to any Performance Goal if the award is intended to comply with the requirements of Code Section 162(m).”

  

	IV.	In all respects not amended above, the Plan is hereby ratified and confirmed. 

 *        *        *        *        *

 To record adoption of the Second Amendment as set forth above, the Company has caused this document to be signed on this ________ day of
__________, 2012. 
  

			
	JACKSONVILLE BANCORP, INC.
		
	By:	 	 
	Name:	 	
	Title:	 	

  
 2 

 SCHEDULE V 

FORM OF DIRECTOR AND OFFICER WAIVER 
 AND ACKNOWLEDGEMENT AGREEMENT 
 [See attached.] 

 WAIVER AND ACKNOWLEDGMENT AGREEMENT 

THIS WAIVER AND ACKNOWLEDGEMENT AGREEMENT (“Agreement”) dated as of August ___, 2012 is by and among JACKSONVILLE
BANCORP, INC., a Florida corporation (the “Company”), THE JACKSONVILLE BANK, a Florida state-charted commercial bank and wholly owned subsidiary of the Company (the “Bank”), and the undersigned individual who is an
officer or director of the Company and/or the Bank (the “Official”). This Agreement is being executed and delivered pursuant to the terms of the Stock Purchase Agreement dated as of August 22, 2012 (the “Stock Purchase
Agreement”), by and among the Company, CapGen Capital Group IV LP (“CapGen”) and various other investors signatories thereto (collectively, CapGen and such other investors are called the “Investors”). The
Company is offering an aggregate of 50,000 shares of the Company’s Mandatorily Convertible, Noncumulative, Nonvoting Perpetual Preferred Stock, Series A, liquidation preference $1,000.00 per share (the “Convertible Preferred
Stock”), on the terms and conditions set forth in the Stock Purchase Agreement. Capitalized terms used but not defined herein shall have the respective meanings provided in the Stock Purchase Agreement. 

WHEREAS, certain agreements and plans of the Company, the Bank, and their affiliates may provide benefits or rights to the Official upon
the occurrence of a “change of control,” “change in control” or similar transaction or event (individually and collectively, “CIC Event”) involving the Company and/or the Bank; 

WHEREAS, as a condition to the Investors’ investment in the Company, the Investors have required that each Official enter into this
Agreement to ensure that the Stock Purchase Agreement and the transactions contemplated therein will not cause or trigger any payment, termination, acceleration or vesting of payment or benefit of any type or other rights as a result of a CIC Event
or under any similar provision in any employment, severance or other agreements, plans, benefits, awards, insurance policies, severance plans or policies, retirement plans or policies, and other policies or practices to which the Company, the Bank
or any of their Subsidiaries is a sponsor or party, or to which the Official is a party, holder, beneficiary or has any rights (collectively, all such agreements, plans, benefits awards and policies are called “Company Agreements”)
upon a CIC Event with respect to the Company and/or the Bank and their Subsidiaries; and 
 WHEREAS the Official desires to
execute, deliver and perform this Agreement to induce the Investors to enter into the Stock Purchase Agreement and complete the Transaction; 
 NOW THEREFORE, in consideration of the premises, the substantial benefits to be derived by the Official as a result of the Stock Purchase Agreement and the transactions contemplated thereby, and other
good and valuable consideration, the receipt and sufficiency of which is acknowledged, the undersigned, intending to be legally bound, agree as follows: 
 1. Waiver. The Official hereby irrevocably waives any and all rights, and agrees not to assert any claims, demands, actions and proceedings of any type or kind, that he or she may have under any
Company Agreement with respect to any payment, benefit, termination, 

 
acceleration of vesting or payment or benefit of any type, and all other rights, payments and benefits of any kind whatsoever upon or following a CIC Event that may arise or result from the Stock
Purchase Agreement, the issuance and Conversion of the Convertible Preferred Stock, and the other transactions contemplated in the Stock Purchase Agreement. 
 2. Reliance. The Official acknowledges and understands that the Investors would not have entered into the Stock Purchase Agreement without this Agreement and that each Investor is an express
third-party beneficiary hereof. 
 3. Miscellaneous. 

(a) As used herein, the singular shall include the plural and any reference to gender shall include all other genders.
The terms “include,” “including” and similar phrases shall mean including without limitation, whether by enumeration or otherwise. 

(b) All notices, requests, claims, demands and other communications under this Agreement shall be in writing and shall be
deemed given if delivered personally or sent by reliable overnight delivery or by facsimile to the parties at the following addresses (or at such other address for a party as shall be specified by like notice): (i) if to the Company, at the
Company’s corporate office, and (ii) if to the Official, at the address shown under his or her signature on the signature page of this Agreement. 
 (c) The headings contained in this Agreement are for convenience of reference only and shall not affect in any way the meaning or interpretation of this Agreement. 

(d) This Agreement may be executed in two or more counterparts, all of which shall be considered one and the same
agreement. A facsimile or electronic signature shall be binding and shall constitute and have the same force and effect as an original signature for all purposes. 

(e) This Agreement (including the documents and instruments referred to herein) constitutes the entire agreement and
understanding of the parties with respect to the subject matter hereof, and supersedes all prior agreements and understandings, both written and oral, among the parties with respect to the subject matter hereof. 

(f) This Agreement shall be governed by, and construed in accordance with, the laws of the State of Florida, without
regard to the applicable conflicts of laws principles thereof. This Agreement shall be binding upon and inure to the benefit of the undersigned and their successors, assigns, estates, legatees, heirs and personal and legal representatives, and
transferees of shares of Common Stock. 
 (g) The Official understands and agrees that irreparable damage would
occur and that none of the Company, the Bank or the Investors would have any adequate remedy at law in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached. It
is accordingly agreed that the Company, the Bank and/or the Investors shall be entitled to an injunction or injunctions and other equitable relief, including specific performance, to 

 
prevent breaches or attempted breaches by the Official of this Agreement and to enforce specifically the terms and provisions of this Agreement in any court of the United States located in the
State of Florida or in Florida state court, this being in addition to any other remedy to which they are entitled at law or in equity, including damages. In addition, each of the parties hereto (i) consents to submit such party to the personal
jurisdiction of any federal court located in the State of Florida or any Florida state court in the event any dispute arises out of this Agreement or any of the transactions contemplated hereby, (ii) agrees that such party will not attempt to
deny or defeat such personal jurisdiction by motion or other request for leave from any such court, (iii) agrees that such party will not bring any action relating to this Agreement or any of the transactions contemplated hereby in any court
other than a federal court sitting in the State of Florida or Florida state court and (iv) shall not seek or require the Company to post any bond or security in connection with enforcing this Agreement. 

(h) If any term, provision, covenant or restriction herein, or the application thereof to any circumstance, shall, to any
extent, be held by a court of competent jurisdiction to be invalid, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions herein and the application thereof to any other circumstances, shall remain in full force
and effect, shall not in any way be affected, impaired or invalidated, and shall be enforced to the fullest extent permitted by law. 
 (i) In the event that a party seeks to obtain or enforce any right or benefit provided by this Agreement through legal proceedings, and in the event that such party prevails in any such legal proceedings
pursuant to which an arbitral panel, court or other governmental authority issues a final order, judgment, decree or award granting substantially the relief sought, then the prevailing party shall be entitled upon demand to be paid by the other
party, all reasonable costs incurred in connection with such legal proceedings, including the reasonable legal fees and charges of one counsel, provided no party shall be entitled to any punitive or exemplary damages, which are hereby waived;

 (j) No amendment, modification or waiver in respect of this Agreement shall be effective against any party
unless it shall be in writing and signed by the Company, the Bank and the Official, following unanimous approval by the Company’s and the Bank’s boards of directors (excluding the vote of any requesting Official who is a director),
provided the affected Official shall be recused from the board of directors’ consideration and vote upon any such proposed amendment, modification of waiver. 
 [Signatures on following page.] 

 IN WITNESS WHEREOF, this Agreement has been duly executed and delivered by the
parties hereto as of the date first herein above written. 
  

			
	JACKSONVILLE BANCORP, INC.
		
	By:	 	 
		 	Name:
		 	Title:
	
	THE JACKSONVILLE BANK
		
	By:	 	 
		 	Name:
		 	Title:
	
	OFFICIAL
	
	 
		 	Name:
		 	Address:
	
	 
	
	 
	
	 

 [signature page to Acknowledgement and Waiver] 

 SCHEDULE VI 

FORM OF DIRECTOR AND EXECUTIVE OFFICER SUPPORT AGREEMENT 

 August __, 2012 
 CONFIDENTIAL 
 Jacksonville Bancorp, Inc. 

100 North Laura Street 
 Suite 100 

Jacksonville, Florida 32202 
 Re:
Director and Officer Support Agreement of Capital Raise 
 In connection with the current offering (the
“Offering”) by Jacksonville Bancorp, Inc. (the “Company”) of its Mandatorily Convertible, Noncumulative, Nonvoting Perpetual Preferred Stock, Series A, liquidation preference $1,000.00 per share (the
“Convertible Preferred Stock”), the undersigned irrevocably agrees, and grants the Company an irrevocable proxy coupled with an interest, to vote all shares of the Company’s common stock in favor of the following proposals:
(i) the amendment of the Company’s amended and restated articles of incorporation (the “Articles of Incorporation”) to increase the number of authorized shares of its common stock; (ii) the issuance of shares of the
Company’s common stock upon the conversion of the Convertible Preferred Stock; (iii) the amendment to the 2008 Amendment and Restatement of the Jacksonville Bancorp, Inc. 2006 Stock Incentive Plan, as set forth in Schedule IV to the Stock
Purchase Agreement dated as of August 22, 2012, by and among the Company, The Jacksonville Bank and the various Investors signatory thereto; and (iv) authorization of an amendment to the Articles of Incorporation to effect a reverse stock
split of the outstanding shares of the Company’s common stock at a ratio of up to 1-for-20, in the sole discretion of the Company’s board of directors (proposals (i)-(iv), the “Proposals”), at any shareholder meeting held
following the Offering in which one or more of the Proposals are submitted to the Company’s shareholders for approval. 
  

					
	Yours very truly,
		
	By:	 	 
		 	Name:	 	 
		 	Title:	 	 

  

	cc:	Scott Clark 

	    	Sandler O’Neill & Partners, L.P. 

 SCHEDULE VII 

FORM OF REGISTRATION RIGHTS AGREEMENT 
 [See Exhibit 10.2.]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00207-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00207-of-00352.parquet"}]]